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COMPOSED OF LIVER EXTRACELLULAR MATRIX 
Denver Michael Faulk, PhD 
University of Pittsburgh, 2015  
Liver disease is a leading cause of mortality in the United States resulting in over 30,000 deaths 
annually.  Allogenic liver transplantation represents the treatment of choice for end-stage liver 
failure, but the shortage of viable donor livers, the need for immunosuppressive drugs, and high 
cost are all limiting factors. The concept of whole organ engineering of the liver has emerged as 
a potential solution. This approach involves perfusion decellularization of a xenogeneic liver 
followed by repopulating the resultant three-dimensional biologic scaffold with an autologous 
cell source.  Current limitations preventing this approach from becoming a clinical reality 
include the re-establishment of a non-thrombotic microvasculature and an effective method for 
delivering functional parenchymal cells to their native location within the three-dimensional 
scaffold.  
The first objective of this work was to determine the effects of commonly used 
decellularization agents upon the resulting scaffold and its ability to support endothelial cell 
attachment and growth. Results showed that when a tissue is decellularized with harsh anionic 
detergents, such as sodium dodecyl sulfate, it is stripped of naturally occurring bioactive 
components and the native fiber architecture of the extracellular matrix is significantly damaged. 
Conversely, when less harsh non-ionic detergents are used for decellularization, such as Triton 
X-100, the resulting scaffold maintains the native microstructure of the extracellular matrix
iv
resulting in improved endothelial cell attachment. Thus, the choice of detergents used for tissue 
decellularization can have a marked effect upon the integrity of the resultant bioscaffold. 
The second objective of the present work was to systematically investigate key variables 
associated with reconstructing a functional hepatic vascular network.  Four factors of endothelial 
cell seeding (1) rate of media perfusion, (2) seeding density, (3) duration of culture, and (4) the 
addition of an anti-thrombotic heparin coating were investigated by means of two outcomes: 
endothelial coverage of the scaffold vasculature and cell viability. Within three days of culture, 
seeded human endothelial cells attached to the three-dimensional liver scaffold, displayed a 
normal flattened appearance, and formed microvasculature throughout.  
The final objective of this work was to develop a preferred method of delivering 
hepatocytes to achieve effective and viable cell engraftment, anatomically appropriate spatial 
location, and functionality.  Two hepatocyte seeding techniques were developed and evaluated: 
(1) syringe injection through the Glisson’s capsule and (2) infusion through portal and hepatic
veins. Metabolic activity and cell viability of the engrafted hepatocytes was evaluated by 
quantification of albumin and urea production, engrafted cell morphology, and expression of 
hepatic specific genes.  Results also showed high hepatocyte viability (>80%), excellent cell 
morphology, albumin and urea production, and hepatocyte specific gene expression with the 
syringe injection technique. The findings from this work represent notable steps toward clinical 
translation of whole organ engineering. 
v
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1.0 BIOLOGIC SCAFFOLDS FOR TISSUE ENGINEERING AND REGENERATIVE 
MEDICINE APPLICATIONS 
1.1 ABSTRACT 
This chapter reviews the use of naturally occurring biomaterials for tissue repair and 
regeneration and the effects of tissue source and processing methods for these materials upon the 
host response. The pros and cons of naturally biologic scaffolds are discussed.   Methods for 
preparation of biologic scaffolds are shown to have a critical effect upon functionality of the 
device. The mechanisms by which biologic scaffolds composed of extracellular matrix (ECM) 
can alter the default wound healing response from the well described pro-inflammatory and 
scarring events toward a more constructive remodeling response, i.e., the site appropriate 
formation of functional tissue, are discussed in detail. The information discussed in this chapter 
is the foundation and justification for using naturally derived biologic scaffolds for engineering 
functional hepatic tissue. 
1.2 INTRODUCTION 
1.2.1 Naturally Occurring Biomaterials 
Naturally occurring biomaterials are commonly used as surgical mesh devices for a 
number of clinical applications and are increasingly recognized in regenerative medicine for their 
inductive properties in tissue and organ engineering. Ventral hernia repair is one of the most 
frequent clinical applications of ECM scaffolds. Most surgical mesh devices used for ventral 
hernia repair are composed of synthetic materials with robust mechanical strength, and are 
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typically incorporated quickly into the host tissue [1-5]. While these mesh materials provide 
more than enough strength to prevent hernia recurrence, such devices are associated with non- 
trivial complications including adhesion, infection, fistula formation, and contraction [6-8]. 
Additionally, the innate immune response to the synthetic materials is classically a chronic pro-
inflammatory foreign body reaction that promotes fibrotic encapsulation. This fibrotic 
encapsulation is associated with long-term patient discomfort, which can lead to revision surgery 
and surgical mesh removal [9]. The intensity of the inflammatory response to an implanted mesh 
may be linked to the degree of tissue ingrowth and scar formation, and modulation of this 
response can have marked downstream effects [10]. Surgical mesh materials composed of 
naturally occurring allogeneic or xenogeneic extracellular matrix (ECM) have been used as an 
alternative to synthetic materials to abrogate the foreign body response, prevent infection, and 
minimize or avoid excessive fibrosis [11-14]. In these circumstances, facilitating a constructive 
host remodeling response is an advantage to the dense scar tissue deposition in the response to 
synthetic mesh materials [15]. This logic has also justified the use of ECM scaffolds in 
applications such as breast reconstruction, where constructive remodeling is preferred to dense 
scar tissue. 
Naturally derived ECM is a material consisting of the secreted structural and functional 
components of resident cells.  The specific composition and ultrastructure of ECM will vary 
depending on the source tissue.  The composition of ECM scaffolds includes a complex mixture 
of molecules arranged in unique three-dimensional (3-D) patterns that are ideally suited to the 
tissue from which the ECM is harvested.  The ECM provides signals which cue cell migration, 
proliferation, and differentiation[16-22].  Maintaining the native ultrastructure and composition 
of the ECM during the tissue/organ decellularization process is essential for optimal outcomes 
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with biologic scaffolds[23-27].   ECM scaffold materials are derived from a variety of tissues 
and organs including blood vessels [28-30], ligaments[31] heart valves[32-38], skin [39], 
nerves[40, 41], skeletal muscle, tendons[42, 43], small intestinal submucosa (SIS)[44-46], 
heart[47, 48], urinary bladder[49-51] and liver [52].   Although a number of studies have been 
conducted with many different ECM materials, the most comprehensive studies regarding 
structure-function relationships have been reported for urinary bladder matrix (UBM) and SIS.  
ECM scaffold materials are biodegradable unless processed with crosslinking agents, and their 
degradation products have been shown to be important bioactive contributors to the constructive 
remodeling process [53, 54].   Furthermore, incomplete removal of cellular material from the 
source tissue results in an undesirable host remodeling response [55].   A more detailed 
discussion of the mechanisms by which naturally occurring biologic materials support 
constructive remodeling can be found later in this chapter, in section 1.5. 
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Table 1. Examples of clinical products composed of decellularized tissues. 
1.2.2 Synthetic Biomaterials 
New generations of synthetic biomaterials which attempt to mimic the native extracellular matrix 
are being developed at a rapid pace for use as three-dimensional scaffolds.  Poly(glycolic acid) 
(PGA), poly(lactic acid) (PLA), and the copolymer PLGA have been extensively used as 
synthetic 3D scaffold biomaterials. Biomimetic synthetic polymers have been created to elicit 
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specific cellular functions and to direct cell-cell interactions. The use of synthetic materials for 
regenerative medicine applications can be effective, but there are inherent limitations to the use 
of synthetic materials.  Of note, synthetic or chemically crosslinked biologic materials, 
invariably elicit a foreign body response.  
Generally, the presence of an absorbable component as part or the entirety of a synthetic 
device or a natural device results in a less severe foreign body response than a nondegradable 
device. The effective ability of the host to effectively degrade and remodel an implanted 
biomaterial facilitates the integration of the implanted device with surrounding tissue and 
minimizes the formation of dense capsule formation.   
1.2.3 Utilizing Nature’s Engineered Scaffold Material 
Individual ECM components or combinations of specific ECM components have been used as 
substrates for in vitro cell culture systems for several decades.  Although cell culture substrates 
composed of proteins such as collagen type I, laminin, and fibronectin have facilitated cell 
attachment, proliferation, and differentiation, these systems are far from physiologically relevant. 
The lack of an intact ECM structure negatively affects cell–cell interaction, cell–ECM 
interaction, physical–chemical influences, and the effects mechanical stimuli upon the cultured 
cells. As a result, the cells in culture eventually lose their functional cell phenotype and initiate a 
de-differentiation process. Studies have shown that intact ECM provides a more favorable 
substrate than the use of individual components of ECM for the growth and differentiation of 
various cell types. Squamous epithelial, fibroblastic (Swiss 3T3), glandular epithelial 
(adenocarcinoma), and smooth muscle-like (urinary bladder) cells cultured on SIS-ECM 
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maintained superior expression of tissue-specific phenotype than those same cells cultured on 
plastic, Vitrogen, or Matrigel.  In a study that used human islet cells, SIS enhanced the insulin 
producing function of the cells in-vitro better than islets cultured on standard islet substrates[56-
58].  Lin et al. compared hepatocytes cultured on L-ECM to the well-characterized hepatocyte 
culture models, double-gel (sandwich) cultures, and adsorbed collagen monolayers.  Hepatocytes 
survived up to 45 days on L-ECM, and several liver-specific functions, such as albumin 
synthesis, urea production, and P- 450 IA1 activity, were significantly greater than the growth 
and metabolism of cells cultured on collagen[59]. 
In summary, there is an increasing body of evidence that tissue specific signals are present 
within the ECM from each tissue and organ.  This property may be important in selected 
regenerative medicine strategies.   
1.3 ECM COMPOSITION AND TISSUE-SPECIFIC ULTRASTRUCTURE 
The ECM provides a physical substratum for the attachment and spatial organization of cells[60]. 
Well-known biophysical properties such as ECM composition and 3-dimensional surface 
topography play an important role in cell phenotype and behavior[61-65].  The 3-dimensional 
surface topography of ECM derived from different tissues includes variation in pore diameter, 
distance between the pores[66], surface texture[64, 67], hydrophobicity, hydrophilicity, and the 
presence or absence of a basement membrane.  In addition to surface topography, the spatial 
presentation of the surface proteins contacting the cells can alter cell attachment, migration, 
proliferation, and differentiation (Figure 1). 
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FIGURE 1. SEM images of naturally occurring ECM scaffold derived from (A) adrenal, (B) 
dermal, (C) liver, and (D) and pancreas tissues. These images demonstrate a distinct, tissue 
specific architecture. 
Studies have suggested that tissue- and organ-specific ECM can promote site-appropriate 
differentiation of progenitor cells[68, 69] and maintain site-appropriate phenotype in in vitro 
culture systems[70].  Since the ECM of each tissue and organ is produced by the resident cells 
and logically represents the ideal scaffold or substrate for these cells, it is intuitive that a 
substrate composed of a tissue specific ECM would be favorable for that tissue’s cells.  It has 
been shown that biologic ECM scaffolds support tissue-specific cell phenotype. Hepatic 
sinusoidal endothelial cells maintained their differentiated phenotype longer when cultured on 
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ECM derived from the liver compared to sinusoidal endothelial cells cultured on ECM derived 
from small intestine or urinary bladder[70]. These results suggest that ECM biologic scaffolds 
provide a set of unique, tissue-specific signals that are dependent upon the tissue from which an 
ECM is derived. Lin et al. compared rat hepatocytes cultured on porcine liver ECM biologic 
scaffolds to well-characterized hepatocyte culture models (type-I collagen sandwich 
configuration or a single layer of type-I collagen)[59]. Hepatocytes survived up to 45 days on a 
sheet form of porcine liver ECM and several liver-specific functions such as albumin synthesis, 
urea production, and P-450 IA1 activity were markedly enhanced compared with the growth and 
metabolism of cells cultured on a single layer of type-I collagen. 
Zeisberg et al. isolated liver-derived basement membrane matrix from human or bovine 
liver, and used the substrate for culture of human hepatocytes[71]. Human hepatocytes adhered 
more efficiently to liver-derived basement membrane matrix and expressed lower levels of 
vimentin and cytokeratin-18, which are markers of hepatocyte dedifferentiation, compared with 
hepatocytes cultured on Matrigel or type-I collagen. However, maintenance of liver-specific 
functions in vitro was not reported[71].  
Biologic scaffolds composed of ECM provide a more physiologically relevant culture 
substrate compared to reconstituted ECM proteins and have unique biochemical profiles that are 
dependent upon the tissue from which an ECM scaffold is derived. Minimally processed ECM 
scaffolds and gels, such as PLECM, provide a combination of ECM proteins derived from the 
liver that are in physiologically relevant amounts (e.g. Type-I, IV, VI, III, XI, XIX, heparin 
sulfate proteoglycan, ECM-bound growth factors, laminin, biglycan, tenascin, fibronectin)[67, 
72, 73]. 
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1.4 ROLE OF ECM IN ORGAN DEVELOPMENT 
ECM represents the secreted products of the resident cells of each tissue and organ and is 
in a state of dynamic reciprocity with its surrounding microenvironment [74]. The structure and 
functional molecules of the ECM provide cues that affect cell migration and cell proliferation 
[16, 54, 75], cell differentiation [72, 76-79], and modulate the host innate immune response [53, 
80-82]. The creation of an ECM biologic scaffold involves decellularization of a source tissue or
organ with the ultimate goal of preservation of the native ECM ultrastructure and composition. 
Reviews of tissue decellularization techniques and their effect upon ECM properties are 
available [83, 84].  When properly processed to remove cellular antigens that may cause an 
adverse host immune response while maintaining as much as possible of the native architecture 
and biologically active molecules, ECM scaffolds can promote the formation of site-appropriate 
tissue, constructive remodeling [85] after injury. It is likely that the three-dimensional 
ultrastructure, surface topology, surface ligand landscape, and composition of the ECM all 
contribute to these constructive effects. These characteristics of ECM make it the ideal biological 
scaffold to promote constructive and functional remodeling of tissues and organs.  
While it is beyond the scope of this chapter to detail all of the components of the 
extracellular matrix it is important to note that many of the main components, specifically 
several forms of collagen, are evolutionarily highly conserved across all metazoans [86] [87]. 
The matrix consists of a complex mixture of proteins, glycans and molecules that, while diverse 
in form and function, play very important roles in embryonic development by influencing cell  
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behavior and differentiation. As tissue matures the ECM assumes roles to maintain cell and 
organ function, to serve as a communication network between cells, and to provide the role of 
structural support for the organs. 
The embryonic role of ECM begins immediately fertilization and attachment to the 
uterine wall [88-90]. As matrix is synthesized and secreted during the blastula and gastrula 
stages [91], molecules such as laminin become determinant in the separation of germ layers.  The 
importance of ECM in development has been recognized for well over 20 years [92, 93] and has 
been the subject of several recent reviews [94-98]. Early stages of development rely upon the 
ECM to guide cellular proliferation and migration. Basement membranes, a form of ECM, are 
responsible for endodermal cell migration of the developing blastocyst [99]. ECM-cell 
interactions have been shown to be responsible for epithelium to mesenchymal transformation 
[100] interactions [101] and mesenchymal cell spreading [102] throughout the embryo.
Individual ECM components have been extensively investigated as to specific roles in
development. For example, an ECM molecule specific to the developing sea urchin, and only 
expressed during development, is thought to be critically important for gastrulation [103]. 
Fibronectin is required for mesoblast cell migration and the emigration of primitive streak cells 
[104]. Tenascin has been speculated to be involved in forming initial barriers between epithelium 
and mesenchyme [105]. 
Following initial germ layer formation and early cell fate determination, ECM becomes 
involved in both morphogenesis and organogenesis of the developing embryo. Morphogenesis 
refers to the general shaping of the embryo or parts thereof. ECM proteins are responsible for 
basic axis patterning of the developing embryo [106], paraxial mesoderm to epithelial 
transformation in the chick [107] and somite formation [108, 109].  The morphogenesis of 
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branching structures involves the degradation and deposition of ECM in a highly dynamic but 
repeated pattern of bifurcation [110] also seen in glomeruli formation in the developing kidney 
[111]. 
Hyaluronic acid (HA) has been shown to be crucial for basic patterning of the digits and 
proper skeletal elongation [112, 113]. Early muscle morphogenesis, myoblast and myotube 
alignment, is driven by fibronectin deposited by neighboring connective tissue [114]. Collagens 
and non-collagenous glycoproteins are required for neuronal cell migration and early brain 
morphogenesis [115]. 
As development continues, organogenesis, the formation of the internal organs, begins as 
tissue differentiates and specializes.  Changes in temporal and spatial arrangement of ECM drive 
cellular architecture of the developing organs, as seen in the developing brain [116] and heart 
[117]. 
ECM components, specifically HA, are responsible for initiating chondrogenesis and the 
maturation of those chondrocytes.  The changes in the ECM brought about by the chondrocytes 
leads to full maturation of cartilage and formation of synovial joints, a process that may continue 
with osteoblasts during osteogenesis [113, 118]. 
Hemonectin expression during development matches the changing pattern of 
hematological development, moving from the yolk sac to the liver and spleen and eventually to 
the bone marrow of the developing mouse.  While hemonectin is not exclusively expressed in 
these developing blood locations the patterning of this extracellular matrix molecule appears 
crucial to granulocyte production [119]. 
In summary, while the ECM was originally thought to mainly function as structural 
support for the cells [120], it is now clear that dynamically reciprocal communication between 
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cells and ECM allows for continual modification of the microenvironment that is associated with 
the physical structure of the ECM [121].  However there is ample evidence to show that the 
physical properties of ECM, such as stiffness, drive some of the morphogenesis of the 
developing embryo.  The complex twisting the embryo undergoes during development, 
specifically gastrulation, is highly dependent on the mechanical properties of the ECM present 
[122]. One of the major structural difficulties observed during development is that neighboring 
organs may develop and grow at different rates.  The ECM must be structurally deposited and/or 
remodeled in ways that allow for this differential growth otherwise defects may occur [123]. 
This structural and signaling role is also seen in blastemal limb regeneration as 
developmental recapitulation occurs.  It has been shown that the regenerating blastemal ECM 
takes on instructive roles that cause muscle cells to dedifferentiate, migrate and possibly 
proliferate. Temporal changes due to cell-ECM interactions then drive undifferentiated cells 
down required lineages [124].  The blastemal tissue has also been shown to be less stiff than the 
residual muscle in the remaining stump and this physical difference may play a role in cellular 
migration and behavior [125]. 
ECM constituents have also been extensively studied in the context of stem cell biology, 
though content is outside the scope of this chapter.  However it has clearly been shown that 
ECMs can be used to maintain stem and progenitor cell potency but are also crucial for 
determining stem cell lineage fate [126, 127]. 
Understanding the embryonic genesis and patterning of the ECM and how it influences and is 
influenced by cells is important for regenerative medicine strategies that attempt to recapitulate 
these processes.  This concept has been reviewed by Caplan (2003) in the context of skeletal 
defects but can be used to form more general guidelines for the entire field. 
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1.5 PRODUCTION OF NATURALLY OCCURRING BIOMATERIALS FROM 
DECELLULARIZED TISSUES 
Decellularization of anatomically distinct tissues to produce an ECM bioscaffold has been 
reported for hollow organs such as small intestinal, urinary bladder[128, 129], and dermis[130] 
as well as solid organs such as liver[131] and heart[132]. The use of these bioscaffolds to support 
tissue reconstruction varies, from bridging repairs to structural replacement (i.e. heart 
valves[133, 134]). There have been several comprehensive reviews of commonly used 
decellularization methods, which will be briefly discussed below[84, 129, 135]. 
While the specific methods used to decellularize the tissue can vary greatly, the physical 
form of the resulting extracellular matrix (ECM) can vary greatly. Hollow organs such as the 
urinary bladder or small intestine are typically incised and split opened, thus forming a sheet-like 
structure. The sheet form can be air dried or lyophilized and further processed into a comminuted 
powdered form. The sheet form is typically very thin; therefore, multiple sheets can be laminated 
together by vacuum pressing to increase strength of the resulting multilayer construct. 
Lamination can also be used to create more complex 3-D shapes such as tubes by molding the 
sheets around a mandrel. Lamination however is limited by the nature of the starting sheets and 
by casting requirements of particular shapes.    
The sheet form of ECM has many advantages, not the least of which is that it is usually 
rapidly produced, often requiring only a couple of processing steps and easily scaled for mass 
production. The sheet or laminate sheet form lends itself well to patch, bridging or soft tissue  
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reinforcement applications for which robust strength is usually required.  The comminuted form 
in contrast, is well suited for filling of volumetric injuries and can be applied by minimally 
invasive methods such as injection. 
The maintenance of 3-dimensional organ morphology has recently emerged as a method 
for organ engineering[136]. Organs such as the heart, liver, kidney, and lung are decellularized 
by using the native vasculature to deliver decellularizing agents.  This method leaves the organ 
as semi-transparent in appearance while retaining the shape of the native organ with intact 
vasculature.  The benefit of this method is the ability to subsequently connect the vasculature of 
the decellularized organ to the recipient circulatory system.  Re-endothelialization of the 3-D 
ECM construct is necessary to prevent thrombosis.   
14
FIGURE 2. Naturally occurring scaffolds processed in various formats: (A) sheet, (B) hydrogel, 
(C) powder, and (D) 3D whole organ.
1.5.1 Techniques Used to Decellularize Tissue 
The most effective agents for decellularization of each tissue and organ will depend upon many 
factors, including the tissue’s cellularity (e.g. liver vs. tendon), density (e.g. dermis vs. adipose 
tissue), lipid content (e.g. brain vs. urinary bladder), and thickness (e.g. dermis vs. pericardium). 
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It should be understood that all cell removal agents and methods will disrupt ECM composition 
and ultrastructure. Minimization of these undesirable effects rather than complete avoidance is 
the objective of optimal decellularization.  
The optimal recipe of of decellularization agents is dependent upon tissue characteristics 
such as thickness and density, the agents being used, and the intended clinical application of the 
decellularized tissue. Prior to applying decellularization agents, undesirable excess tissue may be 
removed to simplify the cell removal process. Cell removal may focus on retention of key ECM 
components such as the basement membrane. Mechanical or physical methods may be used to 
facilitate decellularization. For thin tissue structures such as urinary bladder, intestine, 
pericardium, and amnion, the most commonly used decellularization techniques include freezing 
and thawing, mechanical removal of undesirable layers such as muscle or submucosa, and 
relatively brief exposure to easily-removed detergents or acids followed by rinsing. Thicker 
tissue structures such as dermis may require more extensive biochemical exposure and longer 
rinse times. Fatty, amorphous organs and tissues such as adipose tissue, brain, and pancreas often 
require the addition of lipid solvents such as alcohols. The complexity and length of the 
decellularization protocol is usually proportional to the degree of geometric and biologic 
conservation desired for the post-processed tissue (e.g. macrostructure, ultrastructure, matrix and 
basement membrane proteins, growth factors, etc.), especially for composite tissues and whole 
organs.  
Regardless of the decellularization method chosen, minimizing the disruption of matrix 
molecules is of paramount importance.  The method used to decellularize the tissue can be 
broadly divided into physical, enzymatic or chemical techniques with many protocols mixing 
various methods and agents to optimize decellularization while maintaining native structure and 
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composition. Physical methods typically involve separation of the epithelial and muscular layer 
of an organ from the adjacent submucosal layers but can also include freezing or osmotic shock 
with hyper- and/or hypotonic solutions.  
While there are many potential enzymatic methods of disrupting cells, trypsin is one of 
the most commonly used and effective enzymes. Trypsin cleaves peptide chains mainly at the 
carboxyl side of the amino acids lysine or arginine, except when either is followed by proline. 
This results in cellular detachment from the matrix and cell lysis. One of the disadvantages of 
using enzymes is the destruction of matrix proteins, especially with prolonged exposure which 
can also disrupt the native matrix architecture. Following enzymatic treatment the tissue must be 
thoroughly rinsed to remove or inactivate any remnant enzyme and to remove cellular material. 
Enzymes are often used in conjunction with other methods in a step-wise process to facilitate 
dislodgement of the cells while follow-up methods target the remaining, often damaged, cells. 
Chemical methods of decellularization are varied in nature and mechanism of action. 
Detergents, changes of pH, and solvents or chelators can all be effectively used to decellularize 
tissue. Detergents comprise some of the most commonly used chemicals for decellularization, 
including sodium dodecyl sulfate (SDS), deoxycholate and Triton X-100. SDS and deoxycholate 
are ionic detergents that solubilize cellular membranes but also disrupt protein-protein 
interactions that may damage the ECM ulstrastructure and protein integrity. Triton X-100 is a 
non-ionic detergent that disrupts lipid interactions while leaving protein interactions intact. 
Zwitterionic detergents, such as CHAPS, mix properties of both ionic and non-ionic detergents 
but are less commonly used. 
Placing tissues in acidic or alkaline solutions can effectively disrupt cells but can also 
irreversibly damage ECM proteins. Peracetic acid (PAA) is a relatively weak acid that has been 
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widely used as a decellularizing agent and a disinfectant, especially with ECMs such as small 
intestinal submucosa (SIS) and urinary bladder matrix (UBM), which have a thin cross-sectional 
area.  
Following cell lysis, the membranes and cytoplasmic debris must be removed from the 
matrix, which is usually accomplished by aggressive rinsing in sterile water. This washing 
procedure also serves to remove any remnant detergents or enzymes from the decellularization 
process. The use of iso-, hyper- or hypotonic washing solutions can facilitate additional cell lysis 
as a physical method of decellularization as described above. 
1.5.2 Criteria for Decellularization 
Following decellularization the tissue usually assumes a pale or translucent quality. 
However, macroscopic appearance alone is insufficient to determine the extent of 
decellularization. While there is no universal consensus for criteria for adequate 
decellularization, standard metrics are beginning to emerge. It has been proposed that three 
relatively stringent criteria must be met to establish sufficient decellularization: 1) tissue must 
have less than 50ng of dsDNA per mg of dry weight, 2) DNA fragments less than 200 bp in 
length and 3) no visible nuclear material in histologic analysis with DAPI or H&E[84, 137, 138]. 
Failure to completely decellularize a tissue leads to negative outcomes upon in-vivo 
implantation, including a pro-inflammatory response with recruitment of M1 macrophages and 
subsequent fibrosis[139].  Such a reaction is likely caused in part by damage associated 
molecular pattern (DAMP) molecules and can lead to seroma formation, sterile abscess 
formation, and chronic inflammation[140].  
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1.5.3 Chemical Crosslinking and Sterilization 
Following decellularization, further processing of the ECM can include dehydration, 
lyophilization, and/or comminution.  Once comminuted, the powder can be enzymatically 
solubilized (e.g., pepsin) to produce a liquid form that can be subsequently induced to gel[130, 
141-144]. This soluble form allows for minimally invasive applications such as needle or
catheter based injections[143]. The viscosity of the soluble ECM can be adjusted so that it can be 
induced to conform to the contours of native tissue or irregularly shaped tissue defects. Although 
solubilization of an ECM scaffold obviously destroys the 3-dimensional architecture, entrapped 
growth factors and newly created bioactive cryptic peptides may be released.  
Terminal sterilization of an ECM bioscaffold is required prior to in-vivo implantation. 
Gamma irradiation, e-beam, glutaraldehyde , ethylene oxide  and peracetic acid   have all been 
used as methods of sterilization and have been extensively evaluated for their effect on 
bioscaffold mechanical and biological integrity.  In addition to sterilization, glutaraldehyde 
effectively crosslinks ECM proteins.  Other chemical agents, such as carbodiimide and genipin, 
are also crosslinking agents prior to sterilization.  Chemical crosslinking of ECM proteins (e.g. 
collagen) stabilizes and strengthens the ECM structure and severely inhibits in-vivo degradation.  
Chemically crosslinked and non-degradable ECM elicits a foreign body response very similar to 
non-degradable synthetic polymer scaffolds (e.g., polypropylene). 
1.5.4 Source Material of ECM 
Surgical mesh materials composed of ECM are harvested from a variety of allogeneic or 
xenogeneic tissue sources, including dermis, urinary bladder, small intestine, mesothelium, 
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pericardium, and heart valves, and from several different species. Although there have been no 
reported differences in the host remodeling response as a function of species source, there are 
clear differences with respect to age[145], anatomic location of the source tissue, and other 
factors[138].  The potential for disease transmission to humans is much less for a xenogeneic 
ECM compared to allogeneic (human) ECMs.  Although a certain amount of biologic variability 
is unavoidable with naturally occurring biomaterials, such variability can be minimized by 
controlling for factors such as age, weight, breed, and diet of the source animals. 
1.6 MECHANISMS BY WHICH BIOMATERIALS SUPPORT CONSTRUCTIVE 
REMODELING 
ECM scaffolds can change the default wound healing response from the well described pro-
inflammatory and scarring events toward a more constructive remodeling response[146].  Site 
appropriate formation of functional tissue has been shown for a variety of anatomic locations 
including dermis[147], esophagus[148], skeletal muscle[149-151], and heart[143, 152-156], 
temporomandibular joint meniscus, among others.  There currently exists strong evidence for 
three mechanisms by which biomaterials support constructive remodeling:  (1) contribution from 
bioactive cryptic peptides released during the process of in-vivo ECM degradation[157, 158], (2) 
recruitment of endogenous stem and progenitor cells to the site of ECM remodeling[157, 158] 
and (3) modulation of the host immune response toward an M2-Th2 phenotype[53, 140, 159, 
160]. 
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1.6.1 Cryptic Peptides and Bioactive Molecules 
The host response to an ECM that is not chemically crosslinked is distinctly different from the 
response to synthetic scaffold materials and from the response to either purified components of 
ECM such as collagen I or chemically crosslinked forms of ECM. The purified components elicit 
a specific response to the particular molecule: for example, angiogenesis in response to VEGF or 
bone formation in response to BMP. The specific response may be desirable for particular 
medical/surgical needs but typically lacks the complex constructive wound healing response 
observed when the intact ECM is used as a reparative scaffold.  It has been shown that MMPs 
can cause release of matricryptic peptides from ECM, such as endostatin[161], restin[162], and 
arrestin[163].  Macrophages can release matricryptic angiostatic factors from ECM[164].  
Degradation and remodeling of the ECM by heparanases can release bioactive matricryptic 
peptides[165, 166]. 
ECM scaffolds in preclinical studies have been shown to result in constructive tissue 
remodeling, promote angiogenesis, and to resist deliberate bacterial infection[146, 167].  In vitro 
studies have shown that degradation of ECM generates low molecular weight peptides with 
biological properties such as chemotaxis, angiogenesis, and antimicrobial activity[168, 169].  In 
contrast, intact ECM does not possess such activity[170], suggesting that these biological 
activities are associated with and dependent upon the products of ECM degradation, rather than 
molecules present in intact ECM. Low molecular weight peptides isolated from acid-hydrolyzed 
small intestinal submucosa (SIS-ECM) have been shown to possess chemotactic activity for 
primary murine adult liver, heart, and kidney endothelial cells and to promote vascularization in 
vivo in Matrigel plug assays[171].  A recent study has shown that in vivo degradation of urinary 
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bladder-derived ECM can produce bioactive matricryptic peptides that cause chemotaxis of 
multi-potential progenitor cells[172]. Previous studies have also shown that subcutaneous 
implantation of porcine SIS-ECM induces migration of bone marrow-derived cells to the site of 
constructive remodeling[173], and that this phenomenon is associated with complete degradation 
of the ECM scaffold.  
The concept of functional matricryptic peptides is not new. During ECM degradation, 
many large insoluble molecules present within the matrix are reduced to fragments which 
possess biological activities that are not possessed by the parent molecules. In addition to 
proteolysis-generated bioactive fragments, functional sites of the parent molecules that are 
hidden and inactive within the ECM can also become active due to conformational changes[174]. 
Some of the ECM molecules that have been shown to possess this property are collagen[162, 
175, 176], fibronectin[177], laminin[178-180], and hyaluronan[181], all of which are present in 
ECM scaffold materials[146]. 
1.6.2 Recruitment of Progenitor Cells to the Site of Injury  
The second mechanism of site-specific ECM scaffold remodeling involves the 
recruitment of multipotent or lineage-directed progenitor cells by scaffold degradation products.  
Both the age and species of the tissue from which the ECM is harvested have an effect upon this 
chemoattractant potential.  Transitional ECM instructs cell behavior in both the blastema and in 
mammalian skeletal muscle regeneration.  Especially tenascin-C, hyaluronic acid and 
fibronectin[182].   
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Studies have shown degradation products of human fetal skin-derived ECM possess 
stronger chemoattractant activity for skin-specific lineage-directed stem and progenitor cells than 
do degradation products of human adult skin-derived ECM. In addition, degradation products of 
porcine adult skin-derived ECM showed stronger chemoattractant activity than degradation 
products of human adult skin-derived ECM. These results suggest that ECM degradation 
products from younger tissue sources may have more potent chemoattractant activity for local 
tissue stem or progenitor cells than older tissue sources, and that the species of the tissue source 
also has an effect on chemoattractant activity. 
The early gestation human fetus (less than 24 weeks gestation), unlike the later-gestation 
fetus or adult, is able to heal incisional skin wounds without scarring[183]. This scarless wound 
healing ability of fetal skin may be due to the fetal cells and/or the fetal ECM. Fetal platelets, 
inflammatory cells, and fibroblasts all demonstrate differences from their adult counterparts that 
may contribute to the scarless wound healing phenomenon. Fetal ECM contains a higher 
proportion of type III collagen and a greater concentration of hyaluronic acid than ECM of adult 
skin. Unwounded fetal skin at gestational ages associated with scarless wound healing has also 
been shown to express low levels of TGFβ1, high levels of TGFβ3, and increased expression of 
matrix metalloproteinases, a family of proteases associated with ECM degradation and 
remodeling[184]. Although studies have not addressed the relative contribution of cells vs. ECM 
to scarless fetal wound healing, it appears clear that the ECM, which represents the secreted 
product of local cells, contains signaling molecules that can affect stem and progenitor cell 
activity. 
The results of a previous study show that degradation products of ECM possess 
chemoattractant activity for local tissue progenitor and stem cells, and that this chemoattractant 
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activity may decline as a function of the age of the tissue from which the ECM is harvested[185], 
and that ECM may vary between different species. These findings add a new perspective to the 
role of ECM in wound healing and the differences between fetal and adult wound healing. 
Though fetal ECM is not a likely candidate for tissue engineering/regenerative medicine 
applications because of the scarce availability of the raw material, these findings could be 
applied to the development of methods to induce migration of lineage-directed progenitor cells to 
tissue sites in need of repair, thereby facilitating a regenerative tissue response rather than default 
scar tissue formation. 
1.6.3 Modulation of the Host Immune Response – Push Towards an M2 Constructive 
Remodeling Macrophage Phenotypes 
The exact mechanisms by which certain biologic mesh materials are capable of modulating the 
host macrophage population towards a more constructive remodeling phenotype are not fully 
understood.  However, it has been shown that the presence of large amounts of cellular remnant 
material as a result of ineffective tissue decellularization and chemical cross-linking have 
detrimental effects upon the host remodeling response[53, 147, 186]. This response is not 
surprising in the case of xenogeneic cellular components, such as the α-Gal epitope, which may 
be recognized by the host immune system and elicit an immune response following implantation. 
Other molecules, including those associated with cell death, are also known to have potent 
immunomodulatory effects. These cell-death-associated molecules, collectively termed damage-
associated molecular pattern molecules (DAMPs), are recognized by pattern recognition 
receptors on cells of the innate immune system. Therefore, large amounts of these molecules 
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within biologic materials that derive from mammalian tissues as a result of inefficient removal 
during processing or due to cellular death upon implantation may have detrimental effects upon 
the ability of ECM scaffold materials to promote constructive tissue remodeling. 
Macrophages are a heterogeneous subset of the mononuclear cell population involved in 
the host response to implanted materials. Macrophages are activated in response to tissue damage 
or infection, causing an increase in the production of cytokines, chemokines, and other 
inflammatory molecules to which they are exposed. Recently, macrophage phenotype has been 
characterized based on distinct functional properties, surface markers, and the cytokine profile of 
the microenvironment. Polarized macrophages are referred to as either M1 or M2 cells, 
mimicking the Th1/Th2 nomenclature. 
Macrophages are a plastic cell population capable of sequentially changing their 
polarization in response to local stimuli during the process of wound healing. The macrophages 
participating in the host response to an implanted material are exposed to multiple stimuli 
including cytokines and effector molecules secreted by cells including other macrophages that 
are participating in the host response, microbial agents, epitopes associated with the implanted 
biomaterial, and the degradation products of the biomaterial, among others. Therefore, it is 
logical to assume that the host macrophage response after implantation of a biomaterial is 
modulated via “cross-talk” between macrophages and the other cells involved in the host 
response as well as factors within the local microenvironment. 
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Considerable variability has been seen in the host immune response to xenogeneic 
biologic scaffolds depending upon the source of the ECM, method of decellularization and the 
presence of any modifications such as chemical crosslinking. Crosslinking of ECM with 
carbodiimide has been correlated with delayed degradation, a chronic mononuclear cell 
accumulation around the device and a foreign body reaction.  
Pro-inflammatory responses toward biomaterials are typically associated with 
encapsulation and a foreign body reaction. However, the bioactive and bioinductive molecules 
within the extracellular matrix (ECM) that induce polarization are unclear, although it is likely 
that cellular remnants such as damage associated molecular patterns (DAMPs) retained within 
the scaffold may play a role. Investigation of the immunomodulatory effects of common ECM 
scaffolds. Results showed that tissue source, decellularization method and chemical crosslinking 
modifications affect the presence of the well-characterized DAMP - HMGB1. In addition, these 
factors were correlated with differences in cell proliferation, death, secretion of the chemokines 
CCL2 and CCL4, and up regulation of the pro-inflammatory signaling receptor toll-like receptor 
4 (TLR4). Inhibition of HMGB1 with glycyrrhizin increased the pro-inflammatory response, 
increasing cell death and up regulating chemokine and TLR4 mRNA expression. This suggests 
the importance of HMGB1 and other DAMPS as bioinductive molecules within the ECM 
scaffold. Identification and evaluation of other ECM bioactive molecules will be an area of 
future interest for new biomaterial development. 
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2.0 DECELLULARIZATION AND CELL SEEDING OF WHOLE LIVER BIOLOGIC 
SCAFFOLDS COMPOSED OF EXTRACELLULAR MATRIX 
2.1 ABSTRACT 
Liver failure causes over 30,000 deaths every year in the United States alone, with over 2 million 
deaths estimated worldwide. When this process occurs in a healthy individual, it is termed acute 
liver failure (ALF) or fulminant hepatic failure (FHF). On the other hand, when loss of liver 
function complicates an existing chronic liver disease, the term ‘acute-on-chronic liver failure’ is 
commonly utilized [187]. Loss of liver function leads to deficiencies in synthesis of proteins, 
including clotting factors, albumin, and antiproteases. Accumulation of ammonia and other toxic 
byproducts (i.e. bilirubin) normally metabolized by the liver is typically associated with multiple 
organ failure, jaundice, coagulopathy, encephalopathy, hepatic coma and brain death [188].  
The definitive treatment for patients with end-stage liver disease is orthotropic 
transplantation. However, this option is limited by the disparity between the number of patients 
needing transplantation and the number of available livers. This issue is becoming more severe 
as the population ages and as the number of new cases of end-stage liver failure increases.  
Patients fortunate enough to receive a transplant are required to receive immunosuppressive 
therapy and must live with the associated morbidity.  Whole organ engineering of the liver may 
offer a solution to this liver donor shortfall.  It has been shown that perfusion decellularization of 
a whole allogeneic or xenogeneic liver generates a three-dimensional ECM scaffold with intact 
macro and micro architecture of the native liver. A decellularized liver provides an ideal 
transplantable scaffold with all the necessary ultrastructure and signaling cues for cell 
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attachment, differentiation, vascularization, and function. In this chapter, an overview of 
complementary strategies for creating functional liver grafts suitable for transplantation is 
provided. Early milestones have been met by combining stem and progenitor cells with 
increasingly complex scaffold materials and culture conditions.  
2.2 INTRODUCTION 
2.2.1 Concept of Whole Organ Engineering 
Allogeneic liver transplantation is the “gold standard” for patients with end-stage liver disease 
but is limited by its high cost and the severe donor organ shortage [189]. Both 
xenotransplantation and hepatocyte transplantation represent alternative therapies, but these 
approaches have had limited clinical success. Xenotransplantation could provide a limitless 
supply of donor organs; however, previous attempts have resulted in hyperacute rejection and 
death. Hepatocyte transplantation offers much promise for correcting nonemergency conditions 
such as genetic defects of the liver.  Delivery of isolated hepatocytes in suspension is typically 
performed by intravenous or peritoneal administration. This mode of cellular therapy aims to 
take advantage of hepatocyte ability to regenerate and reconstitute liver functions upon 
engraftment into the spleen or liver. However, low efficiency of engraftment, long-term 
immunosuppression from the use of allogeneic cells, and a lag time of 48 hours for the 
transplanted hepatocytes to become functional in vivo have limited the clinical success [190, 
191]. Biohybrid artificial liver (BAL) devices provide temporary support for patients waiting for 
an allogeneic liver transplant, and since the liver can regenerate, the temporary support provided 
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by BAL may allow sufficient time for this process. However, the lack of a reliable cell source 
combined with the inability of BAL to maintain the functionality of hepatocytes for long periods 
of time has limited its clinical utility [192]. 
These therapeutic challenges have catalyzed the concept of whole organ engineering 
using three-dimensional biologic scaffolds composed of extracellular matrix (ECM). Whole 
organ engineering of the liver is based upon three fundamental concepts: 1) the native ECM of 
the liver represents an ideal and required substrate for liver regeneration, 2) three-dimensional 
acellular liver scaffolds retain the three-dimensional macrostructure, the native microvascular 
network, and the bile drainage system; allowing for complete recellularization of all native cell 
types, and 3) liver regeneration can be promoted when reseeded three-dimensional acellular liver 
grafts are placed in the appropriate three-dimensional microenvironment, specifically, in-situ in 
patients with liver failure. The general approach taken for engineering functional liver tissue with 
ECM scaffolds can be found in Diagram 1. 
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Liver ECM represents the secreted product of the resident cells of the liver, and it is 
therefore logical that L-ECM is the ideal microenvironment in which hepatocytes can maintain 
their phenotype and functionality. The liver ECM (i.e., stroma) has also been shown to be 
essential for liver generation following injury. Whole liver decellularization can be accomplished 
by vascular perfusion with a cocktail of enzymes, proteases, detergents, and hypotonic saline 
rinses that completely remove all cellular elements while largely maintaining the native 
composition and ultrastructure of the underlying three-dimensional matrix [193-195]. The 
creation of a functional liver has not been accomplished to date, but several intermediate 
milestones have been reached by tissue engineers of the heart [196], liver [24, 193-195, 197-
200], lung [25, 201-203], pancreas [204], and kidney [205, 206]. By integrating increasingly 
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complex cell combinations, scaffold materials and culture environments, these efforts have 
successfully recapitulated different aspects of organ development and provided valid lessons that 
can be applied to future liver tissue engineering work.  
2.2.2 Overview of the Liver 
The liver is an organ of the digestive tract and is located in the abdominal cavity. It is the second 
largest organ of the body (skin being the largest), weighs ~1200-1600 grams in an adult human, 
and receives ~25% of the cardiac output [207]. Anatomically, it is separated into a large right 
and a small left lobe. The blood supply to the liver comes from two major blood vessels on its 
right lobe: the hepatic artery (one-third of the blood) and the portal vein (two-thirds). The portal 
vein brings nutrient- and hormone-rich venous blood from the spleen, pancreas, and small 
intestines to the liver for processing before entry into the systemic circulation. The hepatic veins 
drain directly into the inferior vena cava posterior to the liver. The liver possesses a remarkable 
capacity to regenerate itself after injury. Within a few weeks after partial hepatectomy (surgical 
removal of two-thirds of the liver), liver mass can return to pre-surgery levels[208]. 
In order to engineer a microenvironment for liver cells that maintains their key 
phenotypic functions, one can look at the precisely defined architecture of the liver in vivo where 
hepatocytes interact with extracellular matrix, nonparenchymal cells and soluble factors (i.e. 
hormones). In the repeating functional unit of the liver called the lobule, hepatocytes are 
arranged in unicellular plates along the sinusoid where they experience homotypic cell 
interactions. Lobules are polyhedrons (typically pentagonal or hexagonal) that are centered on a 
draining central vein. Portal triads at each corner of a lobule contain portal venules, arterioles 
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and bile ductules. Sinusoids are small capillaries coursing through the space of Disse, which 
lacks a basement membrane and is lined by a fenestrated endothelium. Hepatocytes constitute 
~70% of the liver mass. Several types of junctions (i.e. gap junctions, cadherins, and tight 
junctions) and bile canaliculi at the interface of hepatocytes facilitate the coordinated excretion 
of bile to the bile duct and subsequently to the gall bladder. Several types of nonparenchymal 
cells including stellate cells, cholangiocytes (biliary ductal cells), fenestrated sinusoidal 
endothelial cells, and Kupffer cells (macrophages) interact with hepatocytes to modulate their 
functions. Furthermore, hepatocytes are sandwiched between layers of extracellular matrix in the 
space of Disse, the composition of which varies along the length of the sinusoid[209]. Finally, 
physiochemical gradients (i.e. oxygen, hormones) provide hepatocytes in various parts of the 
sinusoid with different functions. Therefore, a precisely defined micro-architecture, coupled with 
specific cell-cell and cell-matrix interactions allows the liver to carry out its many diverse 
functions. 
2.2.3 Hepatic Specific Functions 
The liver can be simply described as the chemical factory of the body with over 500 functions. 
Some of these functions include protein synthesis (albumin, clotting factors), cholesterol 
metabolism, bile production, glucose and fatty acid metabolism, and detoxification of 
endogenous (bilirubin, ammonia) and exogenous (drugs and environmental compounds) 
substances. Subset of liver-specific functions (i.e. detoxification) has to be retained in an 
engineered hepatic tissue for it to be effective in cell-based therapies for liver disease. 
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The liver is the major organ for the biotransformation of xenobiotics, which can enter the 
body either intentionally (drugs) or unintentionally (environmental toxins). Xenobiotics undergo 
three phases of metabolism in hepatocytes. Phase I is the first-pass metabolism of lipophilic 
compounds into water-soluble metabolites for the purpose of removal from the body. Phase I 
reactions are mainly mediated by the cytochrome P450 enzyme family (CYP450) which 
specializes in oxidation and reduction reactions. The key CYP450 isoforms in human liver 
include 1A2, 2A6, 2C9, 2C19, 2D6, 2E1 and 3A4. Of these enzymes, CYP3A4 is present in the 
highest quantity and participates in the biotransformation of over 50% of current xenobiotics. 
Phase II enzymes conjugate highly polar molecules such as glucose, sulfate or glutathione to 
xenobiotics and/or their metabolites. The highly polar products of phase II are transported out of 
hepatocytes via the bile canaliculi into the bile, or they are released back into the blood for 
excretion via the kidneys (sometimes referred to as Phase III). Metabolites can be de-conjugated 
by gut bacteria and reabsorbed, which leads to a repeat of phase I-III metabolism in the liver 
(sometimes called enterohepatic recirculation). Though the aforementioned sequence of events in 
the liver is typically referred to as ‘metabolic detoxification’, many xenobiotics can be 
metabolized into pharmacologically active or highly toxic compounds [210]. 
Within the liver lobule, hepatocytes are partitioned into three zones based on 
morphological and functional variations along the length of the sinusoid from the portal triad to 
the central vein [211]. Zonal differences have been observed in many hepatocytes functions, 
including oxidative energy metabolism, carbohydrate metabolism, lipid metabolism, nitrogen 
metabolism, bile conjugation, and xenobiotic metabolism [212, 213]. Such compartmentalization 
of gene expression is thought to underlie the liver’s ability to operate as a ‘glucostat’. Zonal 
differences in expression of CYP450 enzymes has also been implicated in the zonal 
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hepatotoxicity observed with some xenobiotics [214]. Possible modulators of zonation include 
blood-borne hormones, oxygen tension, pH levels, extracellular matrix composition, and 
innervation. 
2.3 EXTRACELLULAR MATRIX AS A BIOLOGIC SCAFFOLD 
Biologic scaffolds composed of allogeneic or xenogeneic ECM have been used in millions of 
human patients to reconstruct a variety of tissues including the skin [215], body wall [216, 217], 
urinary bladder [218], and rotator cuff [218], among others. The ECM is in a state of dynamic 
reciprocity with resident cells in response to changes in the microenvironment and has been 
shown to provide cues that affect cell migration and cell proliferation [219-221], cell 
differentiation [83, 84, 172, 222, 223], and host innate immune response modulation [80, 185, 
223, 224].  
The creation of an acellular ECM scaffold involves decellularization of a source tissue or 
organ with the ultimate goal of preserving the native ECM ultrastructure and composition. 
Reviews of tissue decellularization techniques and their effect upon ECM properties are 
available [54, 225], and new techniques are continually being developed for application to whole 
organs. The deleterious in vivo effects of ineffective decellularization with the retention of 
residual cellular material are recognized [55]. However, definitive quantitative standards for 
effective decellularization of whole organs have yet to be established.  This topic will be further 
discussed in section 3.2. 
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Biologic scaffold materials are typically, but not always, marketed and regulated as 
surgical mesh devices. These materials are composed of ECM harvested from a variety of 
allogeneic or xenogeneic tissue sources including dermis (e.g., AlloDerm® Lifecell Corp.), 
urinary bladder (e.g., MatriStem®, Acell Inc), small intestine (e.g., Biodesign® Cook Biotech 
Inc.), mesothelium (e.g., Meso BioMatrix™, Kensey Nash Corp.), and pericardium (e.g., 
Lyoplant®, B. Braun Melsungen AG), among others. Clinical products composed of ECM have 
been manufactured from many of these tissues and from a variety of species including human, 
porcine, bovine, and equine. There is evidence that tissue specific bioscaffolds are preferred, or 
even required, for functional reconstruction of whole organs such as lung and liver. However, 
tissue specificity of the biologic scaffold does not appear to be a requirement for reconstruction 
of many tissues such as skeletal muscle [226], esophagus [227-230], and urinary bladder [231, 
232].  The mechanisms by which ECM bioscaffolds facilitate functional and constructive tissue 
remodeling include positive effects upon cell mitogenesis and chemotaxis [54, 75, 185, 233], cell 
differentiation [72, 76, 77, 79, 234], and modulation of the host innate immune response [53, 80-
82, 138, 235]. It is likely that the three-dimensional ultrastructure, surface topology, surface 
ligand landscape, and composition of the ECM all contribute to these constructive effects. 
2.3.1 Innate Host Response to ECM Scaffolds 
Macrophages are a heterogeneous subset of mononuclear phagocytes that play an 
important role in the host response to implanted biomaterials. The macrophages participating in 
the host response following implantation of a biomaterial are exposed to multiple stimuli 
including cytokines and effector molecules secreted by cells (including other macrophages) 
35
active at the implantation site, microbial agents, epitopes associated with the implanted 
biomaterial, and the degradation products of the biomaterial, among others [236]. Similar to the 
Th1/Th2 paradigm, populations of macrophages can be classified phenotypically and 
functionally along a spectrum ranging from cytotoxic/pro-inflammatory types (designated as M1 
“classically activated” macrophages) or wound healing/anti-inflammatory types (designated as 
M2 “alternatively activated” macrophages) [82]. It has been shown that in response to the 
implantation of ECM scaffolds, cytokine expression is consistent with a predominant M2 and 
Th2 response. Macrophages are required for scaffold degradation in vivo and determine the 
overall remodeling outcome [81, 138]. 
2.3.2 ECM Degradation 
It has been shown that most ECM scaffolds are rapidly degraded in vivo. A previous 
study showed that 14C labeled ECM scaffolds were 60% degraded at 30 days post implantation 
and 100% at 90 days post-surgery in a model of canine Achilles tendon repair. During this 
period, the scaffold was populated and degraded by host cells and resulted in the formation of 
site-specific functional host tissue[237]. The major mechanism of excretion of the degraded 
scaffold was via hematogenous circulation and elimination by the renal excretion. Recent 
findings suggest that the degradation products of ECM scaffolds are bioactive [54, 169, 185, 234, 
238]. One of the biologic effects of ECM degradation products is the recruitment of tissue 
specific stem and progenitor host cells to the site of degradation [75, 185, 238]. Therefore, not 
only does a biologic scaffold, such as liver ECM, modulate the host innate immune response 
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toward a constructive phenotype [53, 81, 82], but a biologic scaffold also has the potential to 
recruit endogenous progenitor cells to the site which can participate in the reconstitution of 
functional liver tissue. It is expected that the three-dimensional L-ECM scaffolds will also 
rapidly degrade and be replaced by new matrix secreted by the seeded hepatocytes. 
2.3.3 Liver Specific ECM 
As previously stated, tissue specific bioscaffolds are required for constructive remodeling of 
select tissues, including the liver. This requirement may be due to the selective nature of 
hepatocytes, which are notorious for losing functional phenotype quickly in culture. The use of 
complex ECM substrates derived from mammalian tissues for effective hepatocyte culture began 
more than two decades ago. Early culture models utilized ECM substrates derived from either rat 
liver or the Engelbreth-House sarcoma mouse tumor (i.e., Matrigel). Rat hepatocytes cultured on 
type-1 collagen show less cell attachment and survival compared to rat hepatocytes cultured 
upon a biomatrix derived from solubilized rat liver. This result further demonstrates that liver 
specific ECM is important in maintaining cells introduced to a decellularized scaffold. 
ECM substrates derived from porcine, bovine, and human livers have been used to 
improve hepatocyte survival, polarity and liver-specific functions in vitro. Lin et. al. compared 
rat hepatocytes cultured on ECM biologic scaffolds derived from porcine liver (PLECM) to well 
characterized hepatocyte culture models (type-1 collagen sandwich configuration or a single 
layer of type-1 collagen) [59]. Hepatocytes survived up to 45 days on a sheet form of PLECM  
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and several liver-specific functions such as albumin synthesis, urea production, and P-450 IA1 
activity were markedly enhanced compared to the growth and metabolism of cells cultured on a 
single layer of type-1 collagen. 
In a previous study, two different biologic substrates were compared for their ability to 
support primary human hepatocyte function in vitro: porcine-liver-derived extracellular matrix 
(PLECM) and Matrigel [52]. Albumin secretion, hepatic transport activity, and ammonia 
metabolism were used to determine hepatocyte function. Hepatocytes cultured between two 
layers of PLECM or Matrigel showed equally high levels of albumin expression and secretion, 
ammonia metabolism, and hepatic transporter expression and function. In another study, three 
different acellular ECM scaffolds were investigated in a physiologically relevant in vitro culture 
model for their ability to maintain hepatic sinusoidal endothelial cell (SEC) phenotype [70]. The 
cell culture model used SECs only or a coculture of SECs with hepatocytes on ECM substrates 
derived from the liver (L-ECM), bladder (UBM-ECM), or small intestinal submucosa (SIS-
ECM). The effect of the ECM substrate upon SEC dedifferentiation was evaluated using 
scanning electron microscopy (SEM) and confocal microscopy. When SECs alone were cultured 
on uncoated glass slides, collagen I, UBM-ECM, or SIS-ECM, SECs showed signs of 
dedifferentiation after 1 day. In contrast, SECs alone cultured on L-ECM maintained their 
differentiated phenotype for at least 3 days, indicated by the presence of many fenestrations on 
SEC surface, expression of anti-rat hepatic sinusoidal endothelial cells mouse IgG MoAb (SE-1), 
and lack of expression of CD31. When SECs were cocultured with hepatocytes on any of the 
ECM scaffolds, the SECs maintained a near-normal fenestrated phenotype for at least 1 day. 
However, SEM revealed that the shape, size, frequency, and organization of the fenestrations 
varied greatly depending on ECM source. At all-time points, SECs cocultured with hepatocytes 
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on L-ECM maintained the greatest degree of differentiation. This study demonstrated that the 
acellular ECM scaffold derived from the liver maintained SEC differentiation in culture longer 
than any of the other tested substrate materials and that contact and crosstalk between different 
cell types of the same tissue may also be beneficial to preserving or promoting proper function. 
The conclusion of these studies supports the hypothesis that L-ECM provides a preferred 
substrate and microenvironment for maintaining hepatic cell viability and function 
2.3.4 Methods of Liver Decellularization and Scaffold Processing 
Isolating the extracellular matrix from an intact liver requires a process that removes cellular 
material, while preserving the ultrastructure, composition, and ligand landscape of the underlying 
matrix. Minimal damage to vascular structures is essential for eventual re-endothelialization, 
anastomosis, and in-vivo implantation of three-dimensional liver scaffolds. Removal of cells 
from their integrin-bound anchors and intercellular adhesion complexes while maintaining 
extracellular matrix surface topography and resident ligands is challenging. A combination of 
physical, ionic, chemical, and enzymatic methods are typically used to accomplish 
decellularization.  Organs, such as the heart [23, 48, 239], liver [24, 195], kidney [205], Pancreas 
[204], and lung [201], have been decellularized by using each organ’s vascular network to 
deliver decellularizing solutions. This method leaves the organ semitransparent in appearance 
while retaining the ultrastructure of the whole organ with intact vascular basement membranes 
and architecture. Re-endothelialization of the denuded vascular network is necessary to support 
blood flow and to prevent thrombosis. Reviews of tissue decellularization techniques and their 
effect upon ECM properties are available [83, 84].  
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The most effective protocol for the decellularization of a liver will depend upon 
characteristics of the source liver, including species (e.g., porcine vs. non-human primate), age 
(e.g., neonatal vs. adult), and lipid content (e.g., high vs. low fat diet).  Regardless of the 
processing method used, preservation of the native hepatic matrix composition and ultrastructure 
is the primary objective. All methods used for decellularization are inherently disruptive with 
unavoidable adverse effects upon the native architecture and key proteins and/or growth factors. 
However, the extent of disruption can be minimized with careful consideration of the method 
used.  
2.3.5 Current Methods of Whole Liver Decellularization 
In 2008, perfusion decellularization was reported as a technique to generate acellular whole 
organ scaffolds from cadaveric organs [23]. In this approach, decellularizing agents are delivered 
via the native vasculature of the organ and are thereby equally distributed across the entire mass 
of the organ. By applying physiologic perfusion pressures, decellularization solutions can 
effectively permeate the organ via arteries, arterioles and capillaries and remove cellular debris 
via the venous system, thereby minimizing their retention within the scaffold. The minimum 
exposure of the source organ to the decellularization solutions lowers the risk of the chemical or 
physical alterations of ECM proteins and growth factor loss, thus facilitating the generation of a 
more biocompatible scaffold for organ engineering. Although previous studies utilizing 
perfusion decellularization have reported a combination of SDS, Triton X-100 and PBS 
perfusion, the ideal detergent recipe must be tailored to the specifics of the harvested liver (i.e. 
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species and age). There have been several published methods for generating an acellular liver 
scaffold.  An overview of these methods can be found in Table 2.  Perfusion decellularization of 
whole liver generates an acellular ECM scaffold with intact three-dimensional anatomical 
structures and patent vasculature conduits that can be re-endothelialized. Decellularized liver 
scaffolds have been shown to be free of significant DNA content and nuclear fragments, while 
retaining major ECM proteins (collagen I, III, laminin, fibronectin and glycosaminoglycans).  
Table 2. Methods of Whole Liver Decellularization 
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Table 2 (continued). 
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2.3.6 Criteria for Decellularization 
Following whole liver decellularization, the organ usually assumes a pale or translucent quality. 
However, macroscopic appearance alone is insufficient to determine the extent of 
decellularization. While there is no universal consensus on criteria for adequate decellularization, 
standard metrics are beginning to emerge. Three relatively stringent criteria have been proposed 
to establish sufficient decellularization: specifically, the remaining ECM scaffold must have 1) 
less than 50ng of dsDNA per mg of dry weight, 2) DNA fragments less than 200 bp in length, 
and 3) no visible nuclear material in histologic analysis with DAPI or H&E [84]. 
Failure to completely decellularize a tissue leads to negative outcomes upon in vivo 
implantation, including a pro-inflammatory response with associated M1 macrophages and 
subsequent fibrosis. Such a reaction is likely caused in part by damage associated molecular 
pattern (DAMP) molecules and can lead to seroma formation, sterile abscess formation, and 
chronic inflammation. A recently published study determined the association between 
decellularization efficacy and host response by qualitative and quantitative methods[240].  ECM 
devices containing significantly more cellular material showed a predominantly M1 pro-
inflammatroy macrophage response while ECM device containing less DNA resulted in a 
macrophage response predominantly of an M2 phenotype. Other studies have shown that a 
scaffold that contains cellular material promotes a clear M1 phenotype macrophage response at 3 
days; whereas, the equivalent acellular scaffold promotes a strong M2 phenotype [36]. Rieder et 
al. have shown that decellularization can reduce the chemotactic potential of heart valve tissue 
for macrophages but does not inhibit the activation of macrophages although they did not study  
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macrophage polarization [60]. Ariganello et al. have shown that in vitro exposure of a 
macrophage cell line to decellularized tissue elicited lower esterase and phosphatase activity 
consistent with a subdued inflammatory response comparable to the M2 phenotype [35]. 
2.3.7 The Effects of Detergents on ECM Scaffolds 
The choice of detergent used for whole liver decellularization is an important factor because the 
recellularization process will be dependent on the integrity of the remaining substrate. Each 
detergent, depending on its chemical characteristics, has unique and distinct effects on ECM 
composition and structure. Less harsh detergents, such as Triton X-100 or other non-ionic 
detergents are preferred for maintaining the native ECM structure and composition compared to 
detergents such as SDS, which can denature essential ligands and proteins within the ECM.  
Detergents commonly used in the decellularization of organs and tissues include triton X-
100 [131, 241], 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) [18], 
deoxycholic acid [132], and sodium dodecyl sulfate (SDS) [23, 242-245].  Detergents can 
solubilize cell membranes and dissociate DNA from proteins, making them attractive for the 
decellularization process. Ionic detergents can be more effective for cellular removal than non-
ionic and zwitterionic detergents [40].  However, subjecting tissue to harsh detergents, such as 
SDS, can disrupt the ECM structure [246], eliminate growth factors [67], and/or denature 
essential proteins [35].   
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In chapter 5, a study is described in which four detergents commonly used for 
decellularization of tissues and organs were systematically evaluated and compared for their 
effect on the basement membrane complex (BMC) [247].  The ability of the resulting scaffold to 
support human microvascular endothelial cells (HMECs) in vitro was determined. This study is 
relevant because the success of whole liver engineering will be critically dependent upon the re-
endothelialization of the organ’s vasculature. The detergents investigated were 3% Triton X-100, 
4% sodium deoxycholate, 8 mM CHAPS, and 1% SDS.  Key findings of this study were as 
follows: 
Collagen Content 
Scaffolds treated with 3% Triton X-100, 8 mM CHAPS and 4% sodium deoxycholate retained a 
soluble collagen content similar to that of the non-detergent water control. Treatment with 1% 
SDS resulted in a significant loss of detectable soluble collagen. This finding suggests that 
detergent treatment with SDS resulted in either a decrease in soluble collagen present or 
modification of the molecular structure of this collagen to the point of insolubility.  
GAG Content 
Scaffolds treated with 3% Triton X-100, 4% sodium deoxycholate and 8 mM CHAPS retained 
GAG similar to that of the water control, while scaffolds treated with 1% SDS retained a smaller 
amount of detectable GAG than the water control. 
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Elastin Content 
Scaffolds treated with Triton X-100 and sodium deoxycholate retained elastin fibers: whereas, 
CHAPS had no visible elastin fibers, and SDS had only a small amount of thin fragmented 
fibers.  
Fiber Network Analysis 
Differences in scaffold surface fiber organization and evidence of collagen fiber denaturation 
were apparent from both SEM inspection and the results of automated image algorithms.  SDS 
and CHAPS caused marked alterations of collagen fiber architecture while Triton X-100 and 
sodium deoxycholate were better tolerated and showed the surface of the BMC maintained an 
appearance that more closely resembled that of the no-detergent control.  These structural 
changes and the associated changes in the ligand landscape provide insight into the results of the 
cell seeding experiments. When HMECs were cultured on basement membrane exposed to the 
chosen detergents, clear differences were seen in cell morphology, confluence, infiltration depth, 
and integrin β-1 expression. 
ECM-Cell Interactions 
HMECs cultured on the BMC prepared with 3% Triton X-100 had a similar level of confluence, 
infiltration depth, and phenotype compared to cells cultured on scaffolds treated with type I 
water (control). These HMECs were characterized by a flat morphology. HMECs cultured on the 
BMC prepared with 8 mM CHAPS were less confluent, had a greater infiltration depth, and an 
atypical phenotype compared to HMECs cultured on the control.    HMECs cultured on scaffolds 
prepared with 4% sodium deoxycholate were less confluent, had a similar infiltration depth, and 
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an atypical phenotype compared to cells cultured on a no-detergent control.  HMECs cultured on 
scaffolds prepared with 1% SDS had a similar percentage of confluence, similar infiltration 
depth, but a less normal phenotype compared to cell cultured on a no-detergent control.  
HMECs cultured on the BMC prepared with 8 mM CHAPS and 1% SDS had a lower 
number of cells stain positive for integrin β-1 compared to HMECs cultured on the BMC not 
subjected to a detergent.  HMECs cultured on the BMC prepared with 3% Triton X-100 and 4% 
sodium deoxycholate had a similar percentage of cells expressing integrin β-1 compared to cells 
cultured on the no-detergent control tissue.  The percent of cells positive for Ki67 was below 3% 
for all groups, and no significant differences were seen when comparing to the control. 
This study shows that each detergent, depending on its chemical characteristics, has 
distinct effects on ECM composition and structure.  Less disruptive detergents, such as Triton X-
100 or other non-ionic detergents are preferred for maintaining the native ECM structure and 
composition compared to more harsh detergents, such as SDS, which can denature essential 
ligands and proteins within the BMC.  The disruption or denaturation of the native BMC 
architecture can negatively impact the interaction of cells with the scaffold.  The results of this 
study can aid in the formulation of tissue and organ decellularization protocols such that the 
native biological activity of the resulting extracellular matrix scaffold is maximally preserved. 
2.3.8 Enzymes 
There have been several published methods for generating biologic scaffolds composed of ECM, 
each of which describes a unique and specific recipe of enzymes and detergents to be used on the 
source tissue. Trypsin is an enzyme commonly used in the decellularization process because it is 
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a well-characterized protease naturally found in the digestive tract of many vertebrates. As a 
protease, trypsin disrupts cell adhesion molecules (i.e. integrins) and cleaves peptide bonds with 
remarkable specificity.  
Trypsin can disrupt both cell-cell and cell-ECM bonds as well as cleave cell surface 
proteins. In conjunction with EDTA, an ion chelating agent that disrupts cell-cell cadherin 
adhesions, trypsin is a powerful decellularization agent. Perfusing an organ with a solution of 
trypsin/EDTA is an effective initial step in the process of whole organ decellularization. 
However, the perfusion with trypsin is time dependent and must be performed at low 
concentrations to preserve the proteins within the ECM to the maximum extent possible. The 
combination of trypsin followed by a detergent is typically necessary to achieve complete 
decellularization. 
2.4 STERILIZATION OF WHOLE LIVER SCAFFOLDS 
Recellularization and implantation of a whole liver scaffold will obviously require sterility. 
Gamma irradiation, e-beam, glutaraldehyde, ethylene oxide and peracetic acid have all been used 
as methods of sterilization and have been extensively evaluated for their effect on bioscaffold 
mechanical and biological integrity. In addition to sterilization, glutaraldehyde effectively 
crosslinks ECM proteins. Other chemical agents, such as carbodiimide and genipin, are also 
crosslinking agents, which can be used prior to sterilization. Chemical crosslinking of ECM 
proteins (e.g. collagen) stabilizes and strengthens the ECM structure and severely inhibits in vivo 
degradation. However, sterilization techniques that also crosslink must be avoided because 
crosslinked ECM scaffolds have been shown to elicit a foreign body response very similar to 
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non-degradable synthetic polymer scaffolds (e.g., polypropylene) [138]. This response is 
predominantly M1 in nature, causing fibrosis leading to chronic inflammation [80]. 
2.5 WHOLE LIVER ECM SCAFFOLD RECELLULARIZATION 
There have been several published methods for cell seeding a whole liver ECM scaffold.  An 
overview of these methods can be found in Table 3. The methods employed in recellularization 
of whole-organ scaffolds are typically adaptations of techniques from a wide range of procedures 
including traditional cell culture, tissue-engineering methods, cell-transplantation therapies, and 
isolated-organ perfusion. The recellularization process can be considered in two major steps. The 
first is cell seeding, in which the goal is distribution of appropriate cell types to all areas of the 
three-dimensional liver scaffold. The second is perfusion culture, which is typically utilized to 
prepare the cells for in vivo function by exposing them to physiological conditions. 
Table 3. Published Methods for Cell Seeding a Whole Liver ECM Scaffold. 
The first challenge in recellularization of decellularized liver scaffolds is its repopulation 
with an appropriate mixture and number of cells as well as directing each cell type to necessary 
niches within the scaffold to match the native distribution. In addition, non-parenchymal cells 
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such as fibroblasts and endothelial cells enhance the functional phenotype of the hepatocytes and 
contribute to the organization of the cellular architecture of the liver.  
Endothelial cells are necessary to provide a non-thrombogenic barrier for the 
decellularized liver matrix and assure that blood flow in vivo is confined to the vascular spaces 
and that the parenchymal cells are protected from the shear stress created by the flow. A major 
advantage of whole-organ scaffolds is the presence of intact vascular networks, but full 
utilization of this vascular system to direct flow within the tissue in vivo requires adequate 
endothelialization. Functional long-term endothelialization of a liver bioscaffold has yet to be 
demonstrated, although initial attempts have been promising in showing endothelial cell 
attachment. Strategies to improve the endothelialization of three-dimensional organ constructs 
are under investigation.  
2.5.1 Delivery of Cells Within a Decellularized Scaffold 
Seeding techniques currently employed in recellularization of whole-organ grafts are essentially 
adaptations of the approaches employed in cell-transplantation therapies. Cells are either injected 
directly into the organ or injected into the circulation with the expectation that the cells will 
home to the injury site. These techniques include intramural injection of cells or infusion of cells 
into the vasculature followed by continuous perfusion.  
In the report for whole-rat heart recellularization, recellularization occurred with 50–
75×106 neonatal cardiac cells delivered in five injections of 200 µl each into the anterior left 
ventricle with a seeding efficiency of approximately 50% [23]. This approach resulted in 
approximately 34% of recellularization proximal to the injection sites with decreasing 
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percentages distally. Furthermore, 2×107 endothelial cells were placed by direct infusion into the 
aorta, which yielded 550.7 ± 99 cells per mm2 on the endocardial surface and 264.8 ± 49.2 cells 
per mm2 within the vascular tree after 7 days of perfusion culture.  
A study conducted by Soto-Gutierrez et al. compared three different methods for 
hepatocyte seeding of a three-dimensional liver scaffold.  The three evaluated methods were (1) 
direct parenchymal injection, (2) multistep infusion, or (3) continuous perfusion. The three-
dimensional liver matrix reseeded with the multistep infusion of hepatocytes generated ∼90% of 
cell engraftment and supported liver-specific functional capacities of the engrafted cells, 
including albumin production, urea metabolism, and cytochrome P450 induction [195].   
2.5.2 Cell Type and Source 
Hepatocytes are the parenchymal cells of the liver and account for approximately 80% of all 
liver cells [248]. Hepatocytes perform most of the functions of the liver and work in concert with 
a number of other cell types to perform the functions essential for survival of the individual. The 
non-parenchymal cells (NPCs) of the liver include sinusoidal endothelial cells, Kupffer cells, and 
stellate cells [248]. It is likely the addition of liver-derived NPCs will be necessary in the 
recellularization of a three-dimensional liver scaffold. Co-cultivation of primary human 
hepatocytes with other cells types can maintain liver-specific functions for several weeks in vitro 
[249]. Liver-derived NPCs as well as non-hepatic endothelial cells, epithelial cells, and 
fibroblasts have been co-cultured with hepatocytes to maintain hepatocyte morphology and a  
51
variety of synthetic, metabolic, and detoxification functions of the liver. Bhatia et al. have 
provided an extensive summary of studies used to preserve hepatocyte-specific functions in vitro 
through co-culture with other cells [250].  
The cell source used to seed three-dimensional ECM scaffolds is an open and 
unanswered question.  Availability of human donor livers for hepatocyte isolation is inadequate: 
thus, alternatives to autologous primary hepatocytes should be considered. Induced pluripotent 
stem cell populations are attractive due to their typically rapid and extensive proliferation and 
their potential to be used without immunosuppressant drugs.  However, many questions 
regarding induced pluripotent stem cells remain unanswered. The in vitro differentiation state of 
stem cells that leads to optimal survival in vivo is unknown. It is believed that early-stage 
progenitor cells may be more efficient than fully differentiated liver cells because they can give 
rise not only to hepatocytes but also to other cell types (non-parenchymal liver cells) including 
bile duct epithelial cells required for the formation of the sophisticated hepatic anatomy. 
2.5.3 Construction of a Vascular Network 
It has previously been shown that the basement membrane and elastin fibers of the vascular 
network of the decellularized liver matrix were intact following whole liver decellularization 
[195].  A corrosion cast of the liver matrix was created and showed the existence and 
preservation of the entire vascular system (portal vein, hepatic artery vasculature, central vein 
and biliary tract) similar to normal liver. This vascular network integrity is an important feature 
for subsequent endothelialization. These denuded vascular conduits must be re-endothelialized to 
prevent coagulation.  Prevention of blood coagulation is typically difficult to achieve and failure 
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to do so hinders long-term in vivo testing of engineered livers. Blood contact is normally 
restricted to the endothelium, and the coagulation cascade is initiated if blood is exposed to tissue 
collagen through direct and indirect interactions of collagen with platelet glycoprotein surface 
receptors. Unless the graft has been fully endothelialized to conceal collagen, coagulation will 
occur when the graft is exposed to circulating blood. Coagulation can be prevented in vivo by 
covering the vascular bed in the decellularized liver matrix with endothelial cells. In practice, 
achieving near-perfect endothelial cell coverage of the vasculature in the scaffold is challenging. 
A potential solution is to deposit heparin throughout the vasculature of the scaffold.   
2.6 CHALLENGES AND FUTURE DIRECTIONS 
The key limiting step for successful implementation of an engineered liver is the establishment a 
functional non-thrombotic vascular network throughout. Several groups have attempted the 
implantation of a seeded ECM construct, only to have it thrombose shortly after implantation.  
Furthermore, delivering all cell types to their native spatial location and recapitulating the liver’s 
complex cellular organizations is challenging. The liver is composed of several distinct cell 
types, including hepatocytes, sinusoid endothelial, Kupffer, stellate and biliary epithelial cells. 
These cells function in a highly sophisticated and integrated manner, which is difficult to 
engineer in-vitro.  However, it is believed that liver regeneration can be promoted when seeded 
three-dimensional acellular liver grafts are placed in the appropriate three-dimensional 
microenvironment, specifically, in-situ in patients with liver failure.  Studies aimed at successful 
implantation of an engineered liver graft in pre-clinical large animal models are in progress.  
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3.0 OBJECTIVE 
A regenerative medicine strategy for the reconstitution of functional liver tissue is proposed. This 
whole organ replacement strategy that is based upon the concept that functional hepatic tissue 
can be engineered by the effective delivery of autologous hepatic parenchymal and non-
parenchymal cells within a 3-dimensional liver scaffold composed of liver extracellular matrix 
(3D L-ECM). This approach would include immediate or near immediate in-situ transplantation 
of the cell seeded scaffold, providing the requisite perfusion by the host circulation that supplies 
appropriate microenvironmental cues, nutrients, and signaling factors necessary for liver 
regeneration. The long-term goal of this work is to establish the decellularization, 
recellularization and transplantation criteria necessary to produce the first fully functional 
bioengineered liver for organ transplantation 
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Figure 3. Conceptual overview of a regenerative medicine strategy for engineering functional 
liver tissue.  Healthy porcine livers would be harvested and decellularized to produce a three-
dimensional biologic scaffold composed of liver specific ECM.  This scaffold would 
subsequently be seeded with the patient’s cells to produce a functioning autologous liver graft 
suitable for implantation into the patient. 
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4.0 CENTRAL HYPOTHESIS AND SPECIFIC AIMS 
The central hypothesis for this following work is that a whole organ biologic scaffold composed 
of hepatic ECM is ideal for engineering a fully functional liver graft because (1) it provides the 
necessary hepatic microenvironment for seeded cells and (2) it elicits a constructive immune 
response following in-vivo implantation. 
4.1 Specific Aim 1: To determine the effects of decellularization agents on the 
interation between 3D L-ECM scaffolds and seeded parenchymal and non-
parenchymal cells.  
Hypothesis: Decellularization agents change the ultrastructure and composition of the 
ECM scaffold, and thus, the behavior of seeded cells.  
Rationale: The decellularization of tissues for the purpose of utilizing the extracellular matrix 
(ECM) as a bioscaffold for reconstructive surgical procedures or whole organ engineering 
involves the use of various enzymes, detergents and mechanical/physical methods[16, 83, 84]. 
During the process of decellularization, parenchymal and non-parenchymal (e.g., vascular 
endothelium) cells within the source tissues are destroyed and/or removed[52, 83, 84, 251-253]. The 
remaining vascular network, devoid of endothelial cells, has been proposed as a potential guide 
and substrate for revascularization[23]. Therefore, determining the effects of decellularization 
methods upon the structure and composition of the scaffold, as well as the scaffold’s ability to 
support hepatic cells in culture, is critical for subsequent recellularization.  
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4.2 Specific Aim 2: To reconstruct a vascular venous and arterial network within a 
decellularized rat liver scaffold. 
Hypothesis: Preferred seeding of endothelial cells will be accomplished via the infusion of small 
numbers of cells into all vascular inlets of the decellularized scaffold (1) portal vein, (2) hepatic 
vein, and (3) hepatic artery. Increased seeding density and media perfusion rate will result in 
high vascular formation within the scaffold. 
Rationale: It has been shown that L-ECM is a preferred substrate for sinusoidal endothelial 
cells[52] and, but effective delivery of endothelial cells into the sinusoidal vascular structures is 
challenging. Several attempts to repopulate 3D L-ECM scaffolds by perfusion techniques have 
shown partial success [24, 195]. However, no one has taken a systematic approach to investigating 
key seeding/culture variables associated with the reconstruction of a functional hepatic vascular 
network.  Furthermore, re-endothelialization of both the venous and arterial networks has yet to 
be achieved. Multiple delivery methods, flow rates and cell concentrations will be tested. Each 
seeding technique will be evaluated for cell survival, liver specific functions, spatial distribution 
and cellular adhesion complexes. 
57
4.3 Specific Aim 3: To develop preferred methods for seeding hepatocytes within a 
decellularized rat liver, achieving cellular attachment, survival, and prolonged graft 
functionality. 
Subaim 1: Compare two seeding methods (1) direct parenchymal injection (2) infusion via the 
vascular network 
Subaim 2: Systematic evaluation of key seeding variables (1) cell concentration, (2) injection 
volume, and (3) the addition of NPCs 
Subaim 3: Combined the preferred hepatocyte seeding method with the endothelial cell seeding 
technique developed in Specific Aim 2 
Hypothesis: Seeding of hepatocytes within a decellularized pig liver will be accomplished via 
small volume syringe into the scaffold’s parenchymal space with a minimized injection volume. 
Rationale: It has been shown that L-ECM is a preferred substrate for hepatic parenchymal 
cells[52] and for hepatic sinusoidal endothelial cells[70], but effective delivery of cells within a 
honey-combed shaped, 3-dimensional network of hepatic cords and vascular structures is 
challenging. Several attempts to repopulate 3D L-ECM scaffolds by perfusion techniques have 
shown partial success [24, 195] and we have recently shown 90% engraftment efficiency with a 
multistep perfusion method [195]. However, spatial distribution of seeded hepatocytes was not 
uniform. It is likely that the autologous cells for use in eventual clinical translation will be 
limited in number and it is critical that an optimal method for cell delivery be developed. 3D L-
ECM scaffolds will be seeded with hepatic parenchymal and non-parenchymal cells. Multiple 
delivery methods, flow rates and cell concentrations will be tested. Each seeding technique will 
be evaluated for cell survival, liver specific functions, spatial distribution and cellular adhesion 
complexes. 
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5.0 THE EFFECT OF DETERGENTS ON THE BASEMENT MEMBRANE COMPLEX
OF A BIOLOGIC SCAFFOLD MATERIAL 
5.1 ABSTRACT 
The basement membrane complex (BMC) is a critical component of the extracellular matrix 
(ECM) that supports and facilitates the growth of cells. This study investigates four detergents 
commonly used in the process of tissue decellularization and their effect upon the BMC. The 
BMC of porcine urinary bladder was subjected to 3% Triton-X 100, 8mM 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 4% sodium deoxycholate or 
1% sodium dodecyl sulfate (SDS) for 24 h. The BMC structure for each treatment group was 
assessed by immunolabeling, scanning electron microscopy (SEM) and second harmonic 
generation (SHG) imaging of the fiber network. The composition was assessed by quantification 
of dsDNA, glycosaminoglycans (GAG) and collagen content. The results showed that collagen 
fibers within samples treated with 1% SDS and 8 mM CHAPS were denatured, and the ECM 
contained fewer GAG compared with samples treated with 3% Triton X-100 or 4% sodium 
deoxycholate. Human microvas- cular endothelial cells (HMEC) were seeded onto each BMC 
and cultured for 7 days. Cell–ECM interactions were investigated by immunolabeling for 
integrin b-1, SEM imaging and semi-quantitative assessment of cellular infiltration, phenotype 
and confluence. HMEC cultured on a BMC treated with 3% Triton X-100 were more confluent 
and had a normal phenotype compared with HMEC cultured on a BMC treated with 4% sodium 
deoxycholate, 8 mM CHAPS and 1% SDS. Both 8 mM CHAPS and 1% SDS damaged the BMC 
to the extent that seeded HMEC were able to infiltrate the damaged sub-basement membrane 
tissue, showed decreased confluence and an atypical phenotype. The choice of detergents used 
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for tissue decell- ularization can have a marked effect upon the integrity of the BMC of the 
resultant bioscaffold. 
5.2 INTRODUCTION 
The decellularization of tissues for the purpose of utilizing the extracellular matrix (ECM) as a 
bioscaffold for reconstructive surgical procedures or whole organ engineering involves the use of 
various enzymes, detergents and mechanical/physical methods[16, 84, 135]. During the process 
of decellularization, parenchymal cells within the source tissues and organs such as the dermis, 
small intestine, urinary bladder, liver and lung are destroyed and/or removed[84, 130, 135, 253-
255]. However, the less abundant but equally important non-parenchymal cells are also removed 
in the process.  Such cells include the endothelial cells of the resident vascular network structures 
and any site appropriate epithelial cell populations. The remaining vascular network, devoid of 
endothelial cells, has been proposed as a potential guide and substrate for revascularization[23, 
241, 256, 257]. Therefore, the effects of decellularization methods upon the structure and 
composition of the basement membrane complex (BMC) are critical for subsequent in-vitro or 
in-vivo recellularization.  
There have been several published methods for decellularizing tissues and generating 
biologic scaffolds composed of ECM, each of which describes a unique and specific recipe of 
enzymes and detergents.  Commonly used detergents include Triton X-100[131, 241], 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)[18], sodium 
deoxycholate[132], and sodium dodecyl sulfate (SDS)[23, 242-245].  Detergents are able to 
solubilize cell membranes and dissociate DNA from proteins, making such agents attractive for 
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the decellularization process.  Studies have shown that ionic detergents can be more effective for 
cellular removal than non-ionic and zwitterionic detergents[40].  However, subjecting tissue to 
harsh detergents, such as SDS, can disrupt the ECM structure[246], eliminate growth 
factors[258], and/or denature essential proteins[35].    
The present study compared the effects of four commonly used decellularization agents upon 
the BMC and its ability to support endothelial cells in vitro. The findings have relevance for 
decellularization strategies used in the production of ECM derived biologic scaffolds and whole 
organ engineering.  
5.3 MATERIALS AND METHODS 
5.3.1 Scaffold Preparation and Decellularization 
Porcine urinary bladders were obtained from animals (∼120 kg) at a local abattoir (Thoma's Meat
Market, Saxonburg, PA).  Bladders were frozen (>16 h at −80 °C) and thawed completely before 
use. The BMC and underlying lamina propria were isolated and harvested from the bladders as 
previously described [50, 253, 259]. The tissue was then placed in 0.02% Trypsin/0.05% EGTA 
solution for two hours at 37oC with physical agitation to detach cells from the extracellular 
matrix.  Tissue samples were then subjected to either, 3% Triton-X 100 (Sigma-Aldrich), 8 mM 
CHAPS (Sigma-Aldrich), 4% sodium deoxycholate (Sigma-Aldrich) , 1% SDS (Bio-Rad), or 
Type I water (non-detergent control) for 24 hours with physical agitation (300 rpm on an orbital 
shaker).  Scaffolds were next rinsed with 1X PBS for 15 min followed by water for 15 min and 
each repeated.  A 24 hour 1X PBS wash followed.  Scaffolds were subsequently rinsed with 1X 
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PBS followed by water for 15 min each and repeated. Lastly, scaffolds were sterilized via 
gamma irradiation at a dose of 2 x 106 RADS.   
5.3.2 dsDNA Quantification 
Scaffolds were digested in 0.6% Proteinase K solution for at least 24 hours at 50°C until no 
visible tissue remained.  Phenol/Chloroform/Isoamyl alcohol was added and samples were 
centrifuged at 10,000xg for 10 min at 4°C.  The top aqueous phase containing the DNA was 
transferred into a new tube.   Sodium acetate and ethanol was added to each sample and the 
solution was mixed and placed at -80°C overnight.  While still frozen, the samples were 
centrifuged at 4°C for 10 min at 10,000xg.  Supernatant was discarded and all residual alcohol 
was removed.  Pellet was suspended in TE buffer.  Double stranded DNA was quantified using 
Quant-iT PicoGreen Reagent (Invitrogen Corp., Carlsbad, CA, USA) according to the 
manufacturer’s instructions.  The dsDNA assay was performed in duplicate, and was performed 
two times. 
5.3.3 Preparation of Urea-Heparin Extracts for Growth Factor Assays 
Three hundred (300) mg of ECM powder was suspended in 4.5 ml of urea-heparin extraction 
buffer. The extraction buffer consisted of 2 M urea and 5 mg/ml heparin in 50 mM Tris with 
protease inhibitors [1mM Phenylmethylsulfonyl Fluoride (PMSF), 5 mM Benzamidine, and 10 
mM N-Ethylmaleimide (NEM)] at pH 7.4.  The extraction mixture was rocked at 4oC for 24 
hours and then centrifuged at 3,000 g for 30 minutes at 4oC. Supernatants were collected and 4.5 
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ml of freshly prepared urea-heparin extraction buffer was added to each pellet. Pellets with 
extraction buffer were again rocked at 4oC for 24 hours, centrifuged at 3,000 g for 30 minutes at 
4oC, and supernatants were collected. Supernatants from first and second extractions were 
dialyzed against Barnstead filtered water (three changes, 80 to 100 volumes per change) in Slide-
A-Lyzer Dialysis Cassettes, 3500 MWCO (Pierce, Rockford, IL).  The concentration of total
protein in each dialyzed extract was determined by the bicinchoninic acid (BCA) Protein Assay 
(Pierce, Rockford, IL) following the manufacturer’s protocol, and extracts were frozen in 
aliquots until time of assay.  
5.3.4 Growth Factor Assays 
Concentrations of basic fibroblast growth factor (bFGF),and vascular endothelial growth factor 
(VEGF) in urea-heparin extracts of dermis samples were determined with the Quantikine Human 
FGF basic Immunoassay (R&D Systems, Minneapolis, MN), and the Quantikine Human VEGF 
Immunoassay (R&D Systems).  Manufacturer’s instructions were followed for both growth 
factor assays. Each assay for bFGF and VEGF was performed in duplicate, and each growth 
factor assay was performed two times. Results are reported as mean ± standard error. It should be 
noted that growth factor assays measured the concentration of each growth factor and did not 
measure growth factor activity.  
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5.3.5 Soluble Collagen and Sulfated GAG Quantification 
10 mg ECM/ml (dry weight) were enzymatically digested in a solution of 1 mg/ml porcine 
pepsin (SigmaeAldrich, St. Louis, MO) in 0.01 N HCl under a constant stir rate for 72 h at room 
temperature. The pH neutralized pepsin digests were diluted and assayed for soluble, triple 
helical collagen content using the Sircol Collagen Assay (Biocolor Ltd., Carrickfergus, United 
Kingdom) per the manufacturer’s instructions. The pH neutralized pepsin digest were also 
analyzed for total protein recovered using the BCA protein assay (Pierce). A pepsin buffer 
solution was used as the negative control and subtracted from the signal. Similarly, 50 mg/ml of 
powdered ECM in 100 mM Tris (pH 7.5) was digested with 0.1 mg/ml proteinase K (Sigma) at 
50 ºC for 24 h with gentle agitation. The proteinase K digests were then assayed for sulfated 
GAG concentration using the Blyscan Sulfated Glycosaminoglycan Assay (Biocolor Ltd.) per 
the manufacturer’s instructions. All results were normalized to dry weight tissue. Assays were 
performed in duplicate on three independent samples for each treatment group.  
5.3.6 Histologic Staining and Immunolabeling of the BMC 
Formalin fixed scaffolds were embedded in paraffin and cut into 5µm sections. Sections were 
either stained with Hematoxylin and Eosin (H&E), Movat’s Pentachrome, or used for 
immunolabeling. For immunolabeling, slides were manually deparaffinized, placed in Citrate 
Antigen Retrieval Buffer (10 mM, pH 6), and heated to 95°C for 20 min. Slides were then cooled 
to room temperature, rinsed in 1X PBS three times for 3 min, placed in humidity chamber to 
incubate for 1 hr with blocking solution (2% Goat Serum, 1% BSA 0.1% Triton X-100 0.1% 
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Tween) at room temperature, then incubated overnight at 4°C with anti-collagen I antibody 
(Sigma-Aldrich, C2456, 1:1000) in blocking solution. Slides were then rinsed with 1X PBS as 
above, treated with 3% hydrogen peroxide in methanol solution for 30 min, and re-rinsed. 
Biotinylated secondary antibody Horse Anti-Mouse IgG (Vector Labs, 1:100) was then applied 
for 30 min. Slides were rinsed as above, ABC solution applied for 30 min in humidity chamber 
at 37°C, re-rinsed, and 3,3'-diaminobenzidine (DAB, Vector Labs) was applied under 
microscope.  To stain collagen IV (ab6586, Abcam, 1:500), laminin (L9393, Sigma-Aldrich, 
1:100), and Collagen VII (C6805, Sigma-Aldrich, 1:10) the same protocol as used for collagen I 
was applied with an added 0.05% pepsin in 0.01 mM hydrochloric acid for 15 minutes in 
humidity chamber at 37°C following citrate acid buffer antigen retrieval. Staining for collagen 
VII also used a blocking solution that contained 4% goat serum and 2% BSA, and a 1 hour 
hydrogen peroxide incubation time. After DAB staining, all slides were counterstained with 
hematoxylin, dehydrated and manually coverslipped using standard mounting medium. Images 
were taken at the luminal interface of the tissue. 
5.3.7 Analysis of the ECM Fiber Network of the BMC Luminal Surface 
A complete set of fiber network descriptors was collected from SEM images of each BMC 
including: pore size distribution, node density (number of fibers intersections per µm2), and fiber 
diameter. Porosity was described by the mean of the pore size (µm2) histogram. Automated 
extraction of these fiber architectural features was achieved with an algorithm, which has been 
previously described in detail [260]. Briefly, the SEM image was digitally processed by a 
cascade of steps including equalization with a 3x3 median filter, local thresholding through the 
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Otsu method, thinning, smoothing, morphological operators, skeletonization, binary filtering for 
Delaunay network refinement, and ultimately the detection of fiber network architecture and its 
descriptors. For each treatment group ten images were analyzed. 
5.3.8 Quantification of Collagen Fiber Denaturation via SHG 
To both visualize and quantify the integrity of the collagen fiber network of the basement 
membrane, intact samples were imaged enface from the surface of the BMC with an Olympus 
FV1000 multiphoton system (MPM). The Olympus FV1000 MPM system was operated with 
Olympus Fluroview software, and was equipped with a Chameleon ultra diode-pumped laser, 
and a 25x XL Plan N objective with a N.A. of 1.05 and a field of view of 500 um. The excitation 
wavelength was chosen at 800 nm at a 5% laser transmissivity. The photomultiplier voltage was 
maintained at 400 V across all samples for subsequent signal intensity analysis. The emission 
wavelength was received by  a  filter  set  to  400±100nm  for  second  harmonic  generation  
signal  of  collagen.  Image scans were performed at a depth of 25 µm, 50 µm, 75 µm, and 100 
µm to encompass the BMC with a sampling speed set to 2 µs/pixel with a 2 line Kalman filter. 
Image sections were then imported into ImageJ for intensity analysis through a background 
subtraction, and then applying the integrated density function whereby area*intensity. This 
parameter provides a relative measurement of the SHG signal. It has previously been found that 
denaturation of collagen fibers results in the destruction of the SHG due to the loss of the 
noncentrosymmetric crystalline structure at the molecular level[261]. Additional image stacks 
were acquired for select samples with an incremental z-step of 0.5 µm to a depth of 100 µm for 
3D reconstruction and visualization using Imaris software. 
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5.3.9 Endothelial Cell Seeding and Culture 
Sterilized scaffolds were placed with the BMC luminal surface facing up in a 6 well plate.  
HMECs (a gift from Francisco Candal, Center for Disease Control and Prevention, Atlanta, GA) 
were cultivated in MCDB-131 medium containing 10% fetal bovine serum, 2 mM L-glutamine, 
100 U/mL penicillin and 100 ug/mL streptomycin. MCDB-131 medium was from Invitrogen 
(Carlsbad, CA); all other reagents for cell growth were from Thermo Fisher Hyclone (Logan, 
Utah). Cells were grown at 37°C in 5% CO2 and were harvested for seeding when they were 
approximately 100% confluent. HMECs were seeded on the BMC surface of each treatment 
group in triplicate.  A total of 1 x 106 cells were cultured on each scaffold within a 2cm diameter 
stainless steel culture ring containing 5 ml of culture medium.  Scaffolds were then placed in an 
incubator at 37°C in 5% CO2 for 24 hrs of culture, at which time the culture rings were removed 
and the seeded scaffolds were transferred to a new 6 well plate with fresh media.  Culture media 
was then replaced on day 2 and day 5. After 7 days of culture, seeded scaffolds were fixed in 
10% neutral buffered formalin, gluteraldehyde, or liquid nitrogen for subsequent analysis. 
5.3.10 Immunolabeling of Seeded HMECs 
After 7 days of culture samples were fixed in formalin for at least 24 hours, embedded in paraffin 
and cut into 5 µm transverse sections. Sections were either stained with Hematoxylin and Eosin 
(H&E), or used for Ki67 and integrin β-1 immunolabeling. Slides for immunolabeling were 
deparaffinized and rehydrated with decreasing concentration of alcohol and water. Antigen 
retrieval was performed with Citrate Antigen Retrieval Buffer (10mM, pH6).  Retrieval buffer 
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was heated until a boiling point was reached, slides were immersed, removed from heat, and 
cooled for 20 min. Slides were washed with 1X PBS 3x for 3 min each. 0.05% Pepsin digest was 
applied to samples for 15 min minutes in humidity chamber at 37°C. Blocking solution was 
applied (2% Goat serum 1% BSA 0.1% Triton 0.1% Tween) for 1hr at room temp.  Slides were 
washed with 1X PBS as above.  Rabbit anti-integrin β-1 (Abcam, AB52971, 1:1000) in blocking 
buffer was applied to each sample. Rabbit anti-Ki67 (Abcam, AB15580, 1:100) in blocking was 
applied to each sample on a separate slide. The samples were then incubated at 4°C overnight.  
Slides were washed with 1X PBS as above.  Alexa-Flour 594 goat anti rabbit (Invitrogen, 1:200) 
was applied for 1 hr at room temperature for the anti-integrin β-1sample.  Alexa-Flour 488 goat 
anti rabbit (Invitrogen, 1:200) was applied for 1 hr at room temperature for the anti-Ki67 
samples. Slides were washed with 1X PBS as above.  Coverslips were added with anti-FADE 
containing DAPI (Invitrogen, P36931). Analysis of apoptosis in tissue sections was performed 
with a DeadEnd™ Colorimetric TUNEL System (Promega Corp. PR-G7130) according to the 
manufacturer’s specifications.  
5.3.11 Semi-Quantitative Scoring of HMECs  
Fixed seeded scaffolds were embedded in paraffin and cut into 5µm sections. Sections were 
stained with H&E and images were taken of the HMECs. The images were then evaluated by 
five blinded investigators using a standardized system as previously described [258].  Criteria 
included cellular infiltration, confluence, and cell phenotype.  Associated descriptions of these 
metrics can be found in Table 4 and graphical examples in supplementary Fig. 3 All aspects were 
evaluated on a scale of 0 to 100.   
68
Table 4. Definitions and descriptions of the metrics used for semi-quantitative scoring of the 
HMEC. 
5.3.12 Scanning Electron Microscopy 
SEM was used to examine the surface topology of urinary bladders treated with each detergent.  
Scanning electron micrographs were also taken of the HMEC seeded scaffolds after 7 days of 
culture on each sample.  Samples were fixed in 2.5% glutaraldehyde in 1X PBS, cut into blocks 
of approximately 8mm3, and washed thoroughly in 1X PBS for three times at 15 minutes each.  
Samples were then fixed in 1% OsO4 in 1X PBS for 15 minutes each, dehydrated in graded 
series of alcohol (30%-100%) baths for 15 minutes each.  Samples were then critically point 
dried with hexamethyldisiloxane mounted on studs, sputter coated, and stored in a desiccator 
until imaged. SEM images were captured using a JEOL 6335F Field Emission SEM with 
backscatter detector.   
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5.3.13 Statistical Analysis 
Results are shown as averages ± standard error. A one-way analysis of variance was performed 
to determine whether a particular detergent group was significantly different, followed by a post-
hoc Dunnets test to determine whether any detergent treatment was different from the non-
detergent control group (p<0.05). 
5.4 RESULTS 
5.4.1 dsDNA Content 
No visible nuclei were observed by imaging of Hematoxylin and Eosin stained sections for any 
of the detergent groups (Figure 4C-G). Double stranded DNA quantification of the scaffolds 
showed that each detergent caused markedly greater removal of the dsDNA compared to 
treatment with Type I water (Figure 4B). Scaffolds treated with 1% SDS contained less dsDNA 
than those treated with 8 mM CHAPS (P<0.05) or 4% sodium deoxycholate (P<0.05).  1% SDS 
was the only detergent able to meet a previously established decellularization criterion of 50 ng 
dsDNA/mg tissue (Figure 4F) [135]. 
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Figure 4. (A) Overview of the process used to prepare the BMC scaffolds. (B) Double-stranded 
DNA quantification of the scaffolds treated with each detergent showed significant removal 
compared with those treated with Type I water. H&E stained sections of BMC scaffolds 
prepared with (C) no detergent, (D) Triton X-100, (E) CHAPS, (F) sodium deoxycholate and (G) 
SDS. No signs of nuclear material are visible for any of the detergent groups. Scale bar 
represents 200 µm. 
5.4.2 Collagen and Sulfated GAG Content 
While scaffolds treated with 3% Triton X-100, 8 mM CHAPS, and 4% sodium deoxycholate 
retained a soluble collagen content similar to that of the water control, treatment with 1% SDS 
resulted in a significant loss of detectable soluble collagen (Figure 5B). The assay used detected 
only soluble collagen, therefore non-soluble remnant collagen may still be present. This finding 
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suggests that detergent treatment with SDS resulted in either a decrease in soluble collagen 
present or modification of the molecular structure of this collagen to the point of insolubility. 
The greater amount of soluble collagen for Triton X-100 compared to the water control is an 
artifact of the normalization to dry weight. More specifically, the relative density of ECM to total 
weight is increased after decellularization for Triton X-100 after removal of cellular content 
compared to the water control. Scaffolds treated with 3% Triton X-100, 4% sodium 
deoxycholate, and 8mM CHAPS retained GAGs similar to that of the water control, while 
scaffolds treated with 1% SDS retained a lesser amount of detectable GAGs than the water 
control (Figure 5C).  
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Figure 5. Biochemical assays to quantify soluble protein from (A) pepsin extract, (B) collagen 
and (C) sulfated GAG normalized to dry weight tissue. Graph shows mean ± standard error, and ⁄ 
indicates significance at p < 0.05 compared with the water control group. 
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5.4.3 Immunolabeling 
 
The no detergent control showed positive staining at the basement membrane surface of collagen 
I, collagen IV, collagen VII, and laminin (Figure 6A) as previously reported[67].  All scaffold 
treatments were positive for collagen I staining (Figure 6A). No treated scaffolds stained 
positive for collagen IV, VII, or laminin except for Triton X-100 and sodium deoxycholate 
treated scaffolds, both of which had positive expression of collagen IV (Figure 6A). However, 
this positive staining was not localized to the surface as would be expected for an intact 
basement membrane. 
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Figure 6. (A) Immunolabeling of collagen I, collagen IV, collagen VII and laminin for BMC 
scaffolds prepared with water, Triton X-100, CHAPS, sodium deoxycholate and SDS. (B) 
Movats Pentachrome stains for Triton X-100, (C) sodium deoxycholate, (D) CHAPS and (E) 
SDS, where yellow, blue and purple represent collagen, proteoglycans and GAG, and elastin, 
respectively. Scale bar represents 100 µm. 
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5.4.4 Movats Stain 
Scaffolds treated with Triton X-100 and sodium deoxycholate retained elastin fibers, whereas 
CHAPS had no visible elastin fibers and SDS had only a small amount of thin fragmented fibers. 
GAGs were visible in both Triton X-100 and CHAPS while not visible for sodium deoxycholate 
and SDS confirming the observations from sulfated GAG quantification (Figure 6B).  
5.4.5 Analysis of the BMC Fiber Network 
Quantitative assessment of the SEM of the BMC luminal surface showed that treatment without 
a detergent, with 3% Triton X-100, or with 4% sodium deoxycholate retained an intricate fiber 
network (Figure 7 B, C& E). However, treatment with 8 mM CHAPS and 1% SDS resulted in 
an amorphous structure lacking distinct fibers (Figure 7 D&F). The fiber diameter was not 
different with treatment of Triton X-100 or sodium deoxycholate compared to the no detergent 
control (Figure 7I). While there was a slightly smaller pore size for Triton X-100 and sodium 
deoxycholate compared to the no detergent control(Figure 7J), and a higher node density for 
Triton X-100 these changes were small compared to previously published variations(Figure 7K) 
[130, 260] . Thus, treatment with Triton X-100 and sodium deoxycholate were able to retain the 
original configuration of the fiber network. Multiphoton imaging confirmed a loss of a distinct 
fiber network for SDS compared to Triton X-100 beneath the surface of the sample (Figure 7A-
C). The lower collagen signal intensity for SDS indicates fiber denaturation (Figure 8D). The 
higher signal intensity value for triton x-100 and sodium deoxycholate compared to the water 
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control may be due an increase in the density of ECM constituents due to loss of cellular 
material. These values provide a relative comparison of the effects of detergent treatments that 
are consistent in finding with visual observations of both SHG volumes and SEM images. 
Figure 7. SEM of the BMC fiber network for scaffolds prepared with (A) water as a no-
detergent control, (B) Triton X-100, (C) CHAPS, (D) sodium deoxycholate and (E) SDS. Scale 
bar represents 1 µm. (F, G) An automated algorithm was applied to quantify fiber network 
parameters of (H) fiber diameter, (I) pore size and (J) node density [24]. Graph shows mean ± 
standard error, and ⁄ indicates significance at p < 0.05 compared with the water control group. C, 
T and D denote the water control, Triton X-100 and sodium deoxycholate, respectively. 
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Figure 8. Three-dimensional rendering of collagen fiber network from SHG signal with two 
photon microscopy for BMC scaffolds prepared with (A) water, (B) Triton X-100 and (C) SDS. 
Major tick represents 50 µm, whereby the total length and depth is 500 µm and 100 µm, 
respectively. (D) An integrated density integrity was applied and normalized to the no-detergent 
control. Graph shows mean ± standard error, and ⁄ indicates significance at p < 0.05.5.3.6 Semi-
Quantitative HMEC Scoring 
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5.4.6 Semi-quantitative HMEC Scoring 
HMECs cultured on the BMC prepared with 3% Triton X-100 had a similar level of confluence, 
infiltration depth, and phenotype compared to cells cultured on scaffolds treated with type I 
water (control). These HMECs were characterized by a flat morphology (Figure 9B). HMECs 
cultured on the BMC prepared with 8 mM CHAPS were less confluent, had a greater infiltration 
depth, and an atypical phenotype compared to HMECs cultured on the control (Figure 9).    
HMECs cultured on scaffolds prepared with 4% sodium deoxycholate were less confluent, had a 
similar infiltration depth, and an atypical phenotype compared to cells cultured on a no detergent 
control (Figure 9).  HMECs cultured on scaffolds prepared with 1% SDS had a similar 
percentage of confluence, similar infiltration depth, but a less normal phenotype compared to cell 
cultured on a no detergent control (Figure 9). 
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Figure 9. H&E stained sections of endothelial cells cultured on the BMC of porcine urinary 
bladders subjected to (A) water, (B) Triton X-100, (C) CHAPS, (D) sodium deoxycholate and 
(E) SDS for 24 h. Semi-quantitative analysis of (F) cellular infiltration, (G) phenotype and (H)
level of confluence was performed by five blinded scores. Scale bar represents 50 µm. Graph 
shows mean ± standard error, and ⁄ indicates significance at p < 0.05. 
5.4.7 Integrin β-1 Expression, Ki67, and TUNEL 
HMECs cultured on the BMC prepared with 8 mM CHAPS and 1% SDS had a lower number of 
cells stain positive for integrin β-1 compared to HMECs cultured on the BMC not subjected to a 
detergent (Figure 10).  HMECs cultured on the BMC prepared with 3% Triton X-100 and 4% 
80
sodium deoxycholate had a similar percentage of cells expressing integrin β-1 compared to cells 
cultured on the no detergent control tissue (Figure 10).  The percent of cells positive for Ki67 
was below 3% for all groups and no significant differences were seen when comparing to the 
control (Figure 11).   Minimal TUNEL-positive cells were found on the BMC prepared with 3% 
Triton X-100 (Figure 16). 
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Figure 10. Immunofluorescent images of integrin b-1 (red) and DAPI (blue) of HMEC cultured 
on the BMC of porcine urinary bladders exposed to (A) water, (B) Triton X-100, (C) CHAPS, 
(D) sodium deoxycholate and (E) SDS for 24 h. (F) Percentage of cells positive for integrin b-1
was determined for each group. Scale bar represents 50 lm. Graph shows mean ± standard error, 
and ⁄ indicates significance at p < 0.05. 
5.4.8 SEM of Seeded Endothelial Cells 
SEM images of HMECs cultured on the BMC prepared with 3% Triton X-100 are similar to the 
no detergent control in terms of cell morphology and coverage of the BMC.  SEM images of 
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seeded scaffolds prepared with 4% sodium deoxycholate showed areas of endothelial cell 
coverage as well as exposed ECM.  8 mM CHAPS and 1% SDS, however, showed greater area 
of exposed ECM and less endothelial cell coverage (Figure 11). 
Figure 11. SEM images (2000x) of HMEC cultured for 7 days on BMC scaffolds prepared with 
(A) water, (B) Triton X-100, (C) CHAPS, (D) sodium deoxycholate and (E) SDS. Scale bar
represents 10 lm. SEM images (10,000x) of HMEC cultured for 7 days on BMC scaffolds 
prepared with (F) water, (G) Triton X-100, (H) CHAPS, (I) sodium deoxycholate and (J) SDS. 
Scale bar represents 1 µm. 
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Figure 12. Immunofluorescent images of Ki-67 positive cells (green) and DAPI (blue) of HMEC 
cultured on the BMC of porcine urinary bladders exposed to (A) water, (B) Triton X-100, (C) 
CHAPS, (D) sodium deoxycholate and (E) SDS for 24 h. Percentage of cells positive for Ki-67 
was determined for each group (F). Scale bar represents 50 mm. Graph shows mean ± standard 
error, and * indicates significance at p<0.05. 
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Figure 13. Biochemical assays to quantify (A) soluble protein, (B) VEGF and (C) bFGF 
normalized to dry weight tissue. Graph shows mean ± standard error. 
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Figure 14. Graphical examples of the semi-quantitative scoring of the HMEC. H&E images 
were evaluated by five blinded investigators using a standardized system. Criteria included 
confluence, phenotype and infiltration. The confluence score is defined as the percentage of the 
BMC surface covered with cells. A score of 100 would indicate a fully coated surface with 
adjoining cells and no gaps (A). A score of 85 indicates 15% of the BMC surface is absent of 
cells, as in image (B). They phenotype score is defined as the percentage of healthy appearing 
cells. A healthy cell is flat and fully adhered to surrounding tissue and other cells (C). An 
unhealthy cell is round and does not adhere to the surrounding tissue or other cells. 
Approximately 40% of the cells in image D appear unhealthy. The infiltration score is defined as 
the percentage of the total depth in which cells have migrated within the tissue. For example, in 
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image (E), cells are found throughout the entire depth of the scaffold. Thus, image (E) would 
correspond to an infiltration score of 100. The opposite can be said about image (F), where no 
cells are infiltrating the scaffold. Therefore, image (F) corresponds to a score of 0. 
Figure 15. SEM image of a BMC fiber network where cells were physically removed and no 
chemical treatments were used. 
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Figure 16. TUNEL staining of HMEC cultured on the BMC of porcine urinary bladders exposed 
to (A) water, (B) Triton X-100, (C) CHAPS, (D) sodium deoxycholate and (E) SDS for 24 h. 
Few TUNEL-positive cells were found on the BMC exposed to Triton X-100. Scale bar 
represents 50 µm. 
5.5 DISCUSSION 
Thorough decellularization of tissues and organs is essential for promoting a constructive 
remodeling host response when such decellularized structures are used as therapeutic 
bioscaffolds [55].  If a tissue is not thoroughly decellularized and residual cellular material is 
present, the in-vivo remodeling response is characterized by chronic inflammation, fibrotic 
encapsulation, and scar tissue formation [53, 55, 142]. The basement membrane is one of the 
first extracellular matrix structures made by the developing embryo with its major constituent 
laminin-111 synthesized at the eight cell stage[262]. This basement membrane is the first matrix 
structure with which embryonic stem cells interact and represents a key biosignal for separating 
endoderm from ectoderm; thus, it is logical that the BMC can represent an important structure in 
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a bioscaffold composed of ECM.  Scaffolds containing a BMC are used in a variety of pre-
clinical and clinical applications[153, 263-271]. Some of these scaffolds are seeded with cells 
before use[272-274].  Examples of ECM scaffolds with a BMC structure include several dermal 
ECM products such as Alloderm™ and Strattice®, urinary bladder matrix such as MatriStemTM, 
and virtually all three dimensional whole organ scaffolds such as liver[131, 242, 257, 275-277], 
lung[243, 245, 255] and kidney[136, 244, 278-280]. Therefore, the results of the present study 
have relevance for a variety of biomaterial applications involving the use of ECM scaffold 
materials.  
Four detergents commonly used for decellularization of tissues and organs were 
systematically evaluated and compared for their effect on the BMC and the ability of the 
resulting BMC to support human microvascular endothelial cells in vitro.  The detergents 
investigated were 3% Triton X-100, 4% sodium deoxycholate, 8 mM CHAPS, and 1% SDS. The 
detergents and their respective concentrations were selected because of their frequent use as 
decellularization agents and their different chemical characteristics [1].  All detergents facilitate 
cell lysis and solubilize the released hydrophobic proteins through the formation of micelles. 
Triton X-100 is non-ionic containing an uncharged hydrophilic head group and disrupts lipid–
lipid and lipid–protein interactions, while leaving protein–protein interactions intact. Non-ionic 
detergents are considered a non-denaturant and are widely used in the proteomics field for 
isolating membrane proteins in their biologically active form [281-283]. In contrast, sodium 
deoxycholate and SDS are anionic detergents containing a net negatively charged hydrophilic 
head group that can solubilize cytoplasmic and nuclear membranes, denature ECM proteins, and 
disrupt native tissue structure.  SDS contains a straight hydrocarbon chain whereas sodium 
deoxycholate contains a more complicated rigid steroidal structure. CHAPS is zwitterionic, 
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contains a rigid steroid ring structure, and has properties of both non-ionic and anionic detergents 
while containing a net charge of zero.  Therefore, it is not surprising that these detergents each 
have distinctly different effects on the BMC. Results of the present study show that these 
detergent specific effects change not only the ultrastructure and composition of the BMC, but 
also the behavior of seeded endothelial cells.  
In its native state, the BMC defines the spatial relationships among various populations of 
cells, and influences cell behavior. For ECM scaffold materials that have a BMC on one surface 
but not the opposite surface (i.e., the material has a “sidedness”), it has been shown HMECs 
seeded on the non-BMC side invade below the surface of the material and populate the 
underlying connective tissues.  In contrast, HMECs seeded on the BMC will form confluent 
layers on, but will not invade, the intact surface of the BMC[259].  Results of the present study 
are consistent with these previous findings.  Of note however, the present study also shows that 
tissue exposed to SDS and CHAPS as part of the decellularization process is left with a BMC 
upon which the HMECs are less confluent, can migrate through the BMC into the subjacent 
tissue, and show an atypical phenotype compared to those seeded on an undamaged BMC. 
These findings, combined with the SEM results, altered collagen fiber organization, and loss of 
GAGs lead to the unavoidable conclusion that the ultrastructure and composition of the BMC are 
negatively affected when exposed to SDS and CHAPS. This conclusion, however, must be 
limited to the specific concentrations and exposure times investigated in the present study. These 
timeframes and concentrations were chosen because of their relatively common use. It is also 
unknown whether these findings will apply to tissues with a BMC other than the urinary bladder.  
The compositional and structural complexity of the BMC is noteworthy [259]. The BMC 
contains laminin-111, collagen IV, heparan sulfate proteoglycan, entactin/nidogen, and several 
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growth factors arranged in a three dimensional ultrastructure which promotes cell adhesion, 
growth, migration, and invasion. This complexity provides a rational explanation for the potent 
biological activity of the BMC, and a plausible explanation, in fact expectation, for the finding 
that decellularization processes such as detergent exposure affect cell:matrix interactions.  It is 
likely that cells interact with multiple components within the matrix. Components such as 
laminin-111, collagen IV, heparan sulfate proteoglycan, and entactin interact with adjacent cells 
via integrin receptors and in particular with integrins containing the β1 subunit. Exposure of the 
BMC to 8 mM CHAPS and 1% SDS decreased the number of cells staining positive for integrins 
containing the β1 subunit. These receptors regulate the cellular cytoskeleton and cell behavior. 
Furthermore, many of the major components, such as laminin-111, have multiple active sites for 
binding to cell surface receptors or other ECM components.  Integrins are critical for cellular 
adhesion to the matrix and can induce either proliferative or differentiation responses.   These 
factors emphasize the importance of understanding the effects of variables such as detergent 
exposure upon the subsequent biologic activity of materials composed of ECM derived by 
decellularization of source tissues, particularly when the resultant ECM has a BMC component. 
Differences in scaffold surface fiber organization and evidence of collagen fiber 
denaturation were apparent from both SEM inspection and the results of automated image 
algorithms.  SDS and CHAPS caused marked alterations of collagen fiber architecture while 
Triton X-100 and sodium deoxycholate were better tolerated and showed the surface of the BMC 
maintained an appearance that more closely resembled that of the no detergent control.  These 
structural changes and the associated changes in the ligand landscape provide insight into the 
results of the cell seeding experiments. When HMECs were cultured on porcine urinary bladder 
basement membrane exposed to the chosen detergents, clear differences were seen in cell 
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morphology, confluence, infiltration depth, and integrin β-1 expression.  Findings of the present 
study provide useful information for the rational design of decellularization protocols for various 
tissues and organs.  
5.6 CONCLUSIONS 
The choice of detergent used for the decellularization of a tissue or organ is an important factor 
in the preparation of an ECM scaffold for therapeutic applications.  Each detergent, depending 
on its chemical characteristics, has unique and distinct effects on ECM composition and 
structure.  Less disruptive detergents, such as Triton X-100 or other non-ionic detergents are 
preferred for maintaining the native BMC structure and composition compared to more harsh 
detergents, such as SDS, which can denature essential ligands and proteins within the BMC.  The 
disruption or denaturing of the native BMC architecture can negatively impact the interaction of 
cells with the scaffold.  The results of this study can aid in the formulation of tissue and organ 
decellularization protocols such that the native biological activity of the resulting extracellular 
matrix scaffold is maximally preserved. 
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6.0. SURFACE MOLECULAR FUNCTIONALITY OF BIOLOGIC SCAFFOLDS 
TREATED WITH VARIOUS DECELLULARIZATION AGENTS 
6.1 ABSTRACT 
Decellularization of tissues and organs is a successful platform technology for creating 
scaffolding materials for organ engineering and regenerative medicine applications. It has been 
suggested that the success of these materials upon implantation is due to the molecular signals 
provided by the remaining scaffold extracellular matrix (ECM) components presented to probing 
cells in vivo as they repopulate the surface. Detergents are frequently used to generate these 
biologic scaffolds composed of ECM due to their ability to solubilize cell membranes and 
dissociate DNA from proteins. However, the effect of detergent treatment on the surface 
molecular functionally of biologic scaffolds has yet to be investigated.   
In the described study, decellularized matrices were created from market weight porcine 
bladders and subjected to decellularization agents commonly used for whole organ perfusion 
decellularization. The decellularized matrices were imaged using scanning electron microscopy 
of the surfaces to provide insight into the surface topography of the decellularized tissue 
following exposure to each decellularization agent. Time of flight secondary ion mass 
spectroscopy (ToF-SIMS) was utilized to characterize the surface molecular functionality of the 
basement membrane following detergent exposure. Principle component analysis of the positive 
and negative ion spectra highlighted high mass peaks associated with detergent fragments 
observed on the scaffolds exposed to SDS and deoxycholate. A phosphocholine peak, indicative 
of cell membrane, was observed in all samples, but to a greater extent with scaffolds not exposed 
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to a detergent. These results demonstrate the suitability of the ToF-SIMS technique to detect 
detergent fragments present in decellularized biological scaffolds. This study also demonstrates 
the potential of ToF-SIMS to be used as a criteria used for assessing extent of decellularization. 
Characterization of the effects of detergent exposure on BMC structure, composition and surface 
molecular functionality is critical for developing successful in vitro and in vivo recellularization 
strategies for engineering whole organ constructs.  
6.2 INTRODUCTION 
Decellularized tissue matrices are widely used for tissue engineering and regenerative medicine 
[67, 228, 284, 285]. It is suggested that their success is due to embedded biospecific signals 
found within their protein structures. These materials have been created from a variety of source 
tissues both allogeneic and xenogeneic [84]. The extracellular matrix (ECM) proteins, which 
comprise the bulk of these materials, are highly evolutionarily conserved [286-288]. The process 
of host remodeling of a biologically derived scaffold is dependent upon the immediate and 
subsequent events that occur at the surface of the material following in vivo implantation. For 
whole organ engineering, the ability of the scaffold to support engraftment and proliferation of 
seeded cells is also dependent upon maintaining a favorable surface of the material that is not 
damaged and prevents cellular attachment. The surface topography and ligand landscape of the 
scaffold material will determine the host molecules that bind and the type and behavior of cells 
that mediate the host response.  The cellular components of tissue are primarily responsible for 
the antigenicity and adverse response when implanted in non-autologous hosts [84]. 
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It is probable that the body may take embedded signaling cues from the biomolecular 
structures that comprise these decellularized extracellular matrices and uses these cues to direct 
the in vivo remodeling process. Acellular tissues have been explored in numerous applications 
including full heart constructs, cardiovascular grafts [44], heart valve [37, 289], nerves [290], 
skeletal muscle [291, 292], liver [59, 70, 293], bladder [50], and esophagus [240, 294, 295] 
among others. 
 There have been several published methods for decellularizing tissues and generating 
biologic scaffolds composed of ECM, each of which describes a unique and specific recipe of 
enzymes and detergents.  Commonly used detergents include Triton X-100[131, 241], 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)[18], sodium 
deoxycholate[132], and sodium dodecyl sulfate (SDS)[23, 242-245].  Detergents are able to 
solubilize cell membranes and dissociate DNA from proteins, making such agents attractive for 
the decellularization process.  Studies have shown that ionic detergents can be more effective for 
cellular removal than non-ionic and zwitterionic detergents[40].  However, subjecting tissue to 
harsh detergents, such as SDS, can disrupt the ECM structure[246], eliminate growth 
factors[258], and/or denature essential proteins[35].    
Decellularized tissue scaffolds present a particularly challenging characterization 
problem due to their complex arrangement of interacting ECM components and the probable 
alterations of these structures during the decellularization process. Many different chemical and 
mechanical decellularization techniques have been employed and each method has the potential 
to alter the native three-dimensional ultrastructure of the ECM uniquely [84, 129]. However, 
largely, these ECM scaffolds induce a constructive remodeling response and favorable clinical 
outcome. To date, characterization methods for decellularized matrices have included 
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mechanical property testing along with imaging techniques such as scanning electron 
microscopy and immunohistochemistry [84, 129]. 
Time-of-flight secondary ion mass spectrometry (ToF-SIMS) represents a powerful 
surface-sensitive analytical method for the characterization of implantable decellularized 
materials. Using an energetic primary ion beam to eject surface species, the resulting secondary 
ions are collected and detected with a time-of-flight mass analyzer to yield an information-rich 
spectrum. This technique can detect all elements with masses ranging from hydrogen to 
molecules up to several thousands of Daltons without the need for specific markers or the 
addition of an analysis matrix. However, due to bombardment with highly energetic ions, the 
analyte is subject to fragmentation, which can complicate data interpretation. 
Each ToF-SIMS spectrum thus represents a complete molecular fingerprint of the 
outermost 1-2 nm of the surface under analysis. For every spot analyzed, hundreds of individual 
spectral features can be identified. Multiple spots (spectra) are taken per sample and the spectra 
are overlaid so that comparisons of individual peak variance relationships of within-group and 
between-group changes can be assessed. To understand such complex data sets, multivariate 
analysis (MVA) techniques have been applied to statistically reduce the complexity to 
manageable patterns of captured variance [296-299].  
For this study, principal component analysis (PCA) was employed as the multivariate 
technique. In PCA, a set of new variables called principal components (PCs) are calculated 
which represent new axes within the data space [300-302]. These new axes, or PCs, now bisect 
areas of variance within the original dataset. The first PC will capture the largest percentage of 
the variance in the dataset while each subsequent PC is orthogonal to its predecessor and 
captures sequentially less variance until there are no longer identifiable trends. Specifically, PCA 
96
has been used previously to determine a set of protein-related peaks within ToF-SIMS data sets, 
which can be used to compare amino acid related structures [296]. Variations in the amino acid 
fragment intensities can be related to the identity, conformation and orientation of surface bound 
proteins [25]. 
ToF-SIMS characterization of decellularized ECM-based scaffolds is analytically 
challenging because of the scaffolds’ surface chemical and structural complexity. This surface 
represents the first contact a given cell would encounter once seeded (in vitro) or repopulated (in 
vivo). With this in mind, characterizing surface chemistry precisely could provide vital insight 
into the mechanisms behind the in vivo success of decellularized matrices. ToF-SIMS has the 
power to assess the molecular chemistry and some aspects of the molecular organization 
associated with the outer layer of the scaffold. The challenge lies in the interpretation of the data. 
Previously in the characterization of biomaterials, this technique has been used to study adsorbed 
model protein films [303]. In a recent study, ECM proteins were analyzed after cell lift-off from 
poly(N-isopropyl acrylamide) (polyNIPAAM) [297, 298] and compared to an adsorbed protein 
film model. With the detailed molecular characterization of the surfaces investigated in the 
present study, researchers will have an enhanced understanding of the cellular interactions that 
occur upon implantation. This knowledge could help to improve functionality of future 
generations of these naturally-derived materials as well as guide the production of successful 
synthetic mimetics that incorporate molecular specificity [299]. 
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6.3 MATERIALS AND METHODS 
6.3.1 Scaffold Preparation and Decellularization 
Porcine urinary bladders were obtained from animals (∼120 kg) at a local abattoir (Thoma's Meat 
Market, Saxonburg, PA).  Bladders were frozen (>16 h at −80 °C) and thawed completely before 
use. The BMC and underlying lamina propria were isolated and harvested from the bladders as 
previously described[50, 253, 259]. The tissue was then subjected to either, 0.1% Peracetic Acid 
(PAA), 3% Triton-X 100 (Sigma-Aldrich), 8 mM CHAPS (Sigma-Aldrich), 4% sodium 
deoxycholate (Sigma-Aldrich) , 1% SDS (Bio-Rad), 0.1% SDS (Bio-Rad) or Type I water (non-
detergent control) for 24 hours with physical agitation (300 rpm on an orbital shaker).  Scaffolds 
were next rinsed with 1X PBS for 15 min followed by water for 15 min and each repeated.  Two 
24 hour 1X PBS washes followed.  Scaffolds were subsequently rinsed with 1X PBS followed by 
water for 15 min each and repeated. 
6.3.2 Scanning Electron Microscopy 
SEM was used to examine the surface topology of urinary bladders treated with each detergent.  
Scanning electron micrographs were also taken of the HMEC seeded scaffolds after 7 days of 
culture on each sample.  Samples were fixed in 2.5% glutaraldehyde in 1X PBS, cut into blocks 
of approximately 8mm3, and washed thoroughly in 1X PBS for three times at 15 minutes each.  
Samples were then fixed in 1% OsO4 in 1X PBS for 15 minutes each, dehydrated in graded 
series of alcohol (30%-100%) baths for 15 minutes each.  Samples were then critically point 
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dried with hexamethyldisiloxane mounted on studs, sputter coated, and stored in a desiccator 
until imaged. SEM images were captured using a JEOL 6335F Field Emission SEM with 
backscatter detector.   
6.3.3 Time of Flight Secondary Ion Mass Spectroscopy (ToF-SIMS) 
ToF-SIMS spectra were acquired on an ION-TOF ToF.SIMS 5–100 spectrometer using a 25 keV 
Biþ ion source in the pulsed mode, at a pulse width of approximately 2 ns based on the hydrogen 
peak width, to enhance mass resolution of the spectra. Spectra were acquired for both positive 
and negative secondary ions over a mass range of m/z 1⁄4 0–700. The primary ion current was 
0.8 pA. Secondary ions of a given polarity were extracted and detected using a reflectron time-
of-flight mass analyzer. Spectra were acquired using an analysis area of 0.005–0.01 mm2. 
Positive ion spectra and negative ion spectra were assessed in this study in order to identify 
characteristic peaks. Mass calibration errors were kept below 10 ppm. Mass resolution (m/Dm) 
for a typical spectrum was 3000–7000 at m/z 1⁄4 27. 
6.3.4 Principal Components Analysis (PCA) 
Multivariate analysis was conducted by selecting peak sets from the samples analyzed by ToF-
SIMS. The selected peaks were then normalized to the total ion intensity of all peaks selected to 
account for fluctuations in secondary ion yield between different spectra. PCA was then 
employed to analyze the positive ToF-SIMS data using a Matlab (The MathWorks, Inc., Natick,  
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MA) based in-house program. All spectra were mean-centered before running PCA. PCA was 
used to determine the linear combination of peaks that captured the highest degree of variation in 
a dataset [32]. 
6.4 RESULTS 
6.4.1 Analysis of the Basement Membrane Fiber Network via SEM 
Qualitative assessment of the SEM of the BMC luminal surface showed that treatment with 
water alone, 3% Triton X-100, 4% deoxycholate or with 4% sodium deoxycholate retained an 
intricate fiber network (Figure 17. A,C,D,E). However, treatment with 1% PAA, 1% SDS, and 
0.1% SDS resulted in an amorphous structure lacking distinct fibers (Figure 17 B,F,G). The 
fiber diameter did not appear significantly different with treatment of Triton X-100 or 8mM 
CHAPS compared with the no-detergent control (Fig. 4I). Samples treated with PAA, 1% SDS, 
and 0.1% SDS appear to have significant collagen denaturing, with the 0.1% SDS treated 
samples having less denaturing than the 1% SDS. 
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Figure 17. SEM of the BMC fiber network of porcine urinary bladders prepared with (A) water 
as a no-detergent control, (B) PAA, (C) Triton-X, (D) CHAPS, (E) sodium deoxycholate, (F) 
SDS (0.1%) and (G) SDS (1.0%). 
6.4.2 Negative Ion Spectra 
Representative negative ion spectra of each treatment group revealed clearly noticeable 
differences.  High PO3 (m/z 79) signal in both native and PAA treated samples indicate the 
possible presence of residual DNA.  Samples treated with SDS showed a high SO3- and SO4- 
peaks possibly associated with residual detergent.  It is also clear that a series of distinctive 
higher mass peaks in SDS and dexocyholate treated indicative of residual detergent 
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Figure 18. Representative negative ion spectra of  porcine urinary bladders treated with Water, 
PAA,  3% Triton X-100, 8mM CHAPS, 4% sodium deoxycholate, and 1% SDS. 
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6.3.3 Principal Components Analysis of Negative Ion Spectra 
After running a principal components analysis of the negative ion spectra there is evidence of 
trends separating the treatment groups.  The water and PAA treated samples do not separate from 
each other in either principal components 1 or principal components 2.  In principal components 
1 the Triton X-100, Deoxycholate, and 0.1% SDS samples locate together, whereas the 1% SDS 
group is significantly higher than all groups.  In principal components 2 the Triton X-100, 
CHAPS, and Deoxycholate samples locate together, whereas the 1% SDS and 0.1% SDS groups 
trend higher than all groups.   
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Figure 19. Principal component analysis (PCA) of negative ion spectra. Scores and loadings 
plots for principal components 1 (A, B) and 2 (C, D) are presented. In loadings plots (B, D) 
prominent highly loading peaks are marked and labeled. 
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Table 5: Summary of the polarity, mass, assignment, identity and association of highly loading 
peaks seen in PCA loadings plots shown in Figure 19. 
Polarity m/z Assignment Identity Association PC 
Negative 63.0 PO3- Phosphate Residual 
nuclear 
material 
1 
Negative 79.0 PO4- Phosphate 1 
Negative 80.0 SO3- Sulphate SDS headgroup 
2 
Negative 97.0 SO4- 2 
Negative 265.1 C12H25SO4- Dodecylsulphate SDS 2 
Negative 293.1 C12H25O2Na4- SDS micelle SDS 2 
Negative 391.3 C24H49O4 
Deprotonated 
deoxycholate 
molecular ion 
Deoxycholate 2 
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Figure 20.  Peak intensities of residual SDS (A), Deoxycholate (B) and Triton X-100 (C)  
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6.3.4 Positive Ion Spectra 
The positive ion spectrum reveals clearly noticeable differences between sample types.  A high 
phosphocholine headgroup peak (m/z 184) indicating residual cell membrane were observed in 
native and PAA treated samples.  The detergent treated groups did not show as high intensity of 
the phophocholine headgroup peak indicating they were potentially able to remove residual cell 
membrane.  Many peaks indicative of PDMS contamination were seen in PAA treated samples.  
PDMS contamination was also seen during pilot study in PAA treated samples indicating 
possible contamination of PAA reagent.  Lower levels in other treatment groups suggests 
contamination has not occurred during sample handling, transit, or analysis.  Lastly, there are 
prominent lower mass peaks, characteristic of amino acid fragments.  
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Figure 21. Representative positive ion spectra of  porcine urinary bladders treated with Water, 
PAA,  3% Triton X-100, 8mM CHAPS, 4% sodium deoxycholate, and 1% SDS. 
108
Figure 22. Spatial distribution of phosphocholine headgroup (m/z 183, positive ion spectra) 
indicative of cell membranes.  
Figure 23. PCA of positive ion spectra with scores and loadings plots for principle component 1. 
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Table 6: Summary of the polarity, mass, assignment, identity and association of highly loading 
peaks seen in PCA loadings plots shown in Figure 23. 
Polarity m/z Assignment Identity Association PC 
Positive 184.1 C5H15NPO4+ Phosphocholine Residual cell 
membrane 
1 
Positive 224.1 C9H19NPO4+ Glycerophosphocholine 1 
Positive 104.1 C5H14NO+ Choline 1 
Figure 24.  Peak intensities for cell membrane and nuclear associated compounds with PO2- 
(m/z 63.0), PO3- (m/z 79.0), C5H12NO+, choline (m/z 104.1), C5H15NPO4+, phosphocholine 
head group (m/z 184.1), C9H19NPO4+, phosphocholine (m/z 224.1).  
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6.5 DISCUSSION 
Decellularized matrix scaffolds, such as porcine urinary bladder matrix (UBM) or decellularized 
liver scaffolds, may be prepared through a range of decellularization techniques, commonly 
using ionic, zwitterionic or nonionic detergents. Whilst removal of cellular material is regularly 
assessed, the impact of detergent selection on ECM structure and composition is less commonly 
investigated. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a powerful surface 
analysis technique to probe biological structures with high mass resolution and surface 
specificity. In the described study we report the use of ToF-SIMS to distinguish the basement 
membrane complex of UBM prepared by treatment with water, 0.1% SDS 1% SDS, 4% 
Deoxycholate, 8 mM CHAPS or 3% Triton X-100 for 24 hours. All samples were rinsed 
thoroughly with water following treatment in an attempt to remove any residual detergent.  
Results indicate clear evidence of significant retention of nuclear and membrane 
components with water and PAA treatment.  This is not unexpected because these treatments do 
not adequately decellularize native tissue.  Interestingly, there was a direction correlation 
between the PCA of the positive ion spectra and expected decellularization ability of each 
treatment.  Stated differently, PCA of the positive ion spectra may be an adequate method of 
determining extent of decellularization. Imaging of phosphocholine headgroup peak at m/z 184 
(positive) shows island like spatial distribution of residual cell membrance, particularly in PAA 
treated samples. It was also shown that PCA of the negative ion spectra is capable of separating 
sample types based on residual cellular components (Native and PAA treated) or detergent type 
(SDS vs. Deoxycholate). Furthermore, this study revealed the presence of residual detergent in 
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SDS treated and deoxycholate treated samples.  However, the level of residual detergent content 
between deoxycholate samples varied.  All dexocyholate samples were prepared from the sample 
porcine bladder, so source tissue variation does not explain the variation in residual deoxycholate 
Principal components analysis (PCA) reveals spectral differences between treatment 
groups. In addition to insights into remaining cell debris and traces of residual detergent, we can 
further probe these data sets to investigate how detergent selection impacts proteinaceous ECM 
components. Using a reduced peak list of known characteristic amino acid fragments, PCA 
distinguishes native bladder tissue from decellularized UBM. Additionally, PCA highlights 
spectral differences between UBM treated with ionic and charge-neutral (zwitterionic and 
nonionic) detergents. Notably, the basement membrane surface of UBM prepared with ionic 
detergents SDS and Deoxycholate yield less intense characteristic peaks from hydrophobic 
amino acids than UBM treated with charge neutral detergents CHAPS and Triton X-100. Harsher 
ionic detergents may denature protein structure and break protein-protein interactions through 
binding of their hydrophobic tail to hydrophobic amino acid residues. Such damage is 
hypothesized to cause sub-optimal in vitro and in vivo responses.  
6.6 CONCLUSIONS 
The results of the present study demonstrate that each decellularization agent used to prepare a 
biologic scaffold creates in a unique surface.  The resulting ECM scaffold is associated with 
distinct ultrastructural and compositional characteristics and that these surface characteristics are 
dependent on both the damage the decellularization agent has caused to the native extracellular 
matrix as well as the residual compoents left behind by the decellularization agent. It was also 
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demonstrated that ToF-SIMS is a highly sensitive method for the detection and differentiation of 
the molecular composition of the outermost surface of an ECM scaffold. Further, ToF-SIMS 
may represent a method for future identification of previously unknown surface species as well 
as for the prediction of cell–scaffold interactions and subsequent remodeling events. Finally, the 
richness of molecular detail in the ToF-SIMS spectra suggests that ToF-SIMS may be useful for 
quality control of commercialized ECM-based regenerative scaffold products and for 
standardization of these scaffolds. 
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7.0 RECONSTRUCTION OF A FUNCTIONAL VASCULAR NETWORK WITHIN A 
DECELLULARIZED RAT LIVER SCAFFOLD 
7.1 ABSTRACT 
More than 120,000 patients are on the organ transplant list in the United States alone, and 18 
patients will die every day waiting for a donor organ. Recently, the concept of whole organ 
engineering has emerged as a potential solution for the donor organ shortfall.  This concept 
involves the decellularization of an allogeneic or xenogeneic homologous organ followed by 
recellularization of the resultant three-dimensional stromal scaffold with site appropriate cells.  
Studies by our group and others have shown that decellularization of whole organs such as liver, 
lung, and heart with preservation of the underlying matrix scaffold is possible. However, current 
limitations of this approach for translation to pre-clinical animal models include the re-
establishment of a functional non-thrombotic microvasculature capable of being connected to 
recipient’s circulation upon implantation.  
The objective of the present work was two-fold. The first was to systematically investigate 
key variables associated with reconstructing a functional hepatic vascular network. Four such 
variables including rate of media perfusion, endothelial cell seeding density, duration of culture, 
and the addition of an anti-thrombotic heparin coating were investigated for their effect upon two 
outcome measures: endothelial coverage of the scaffold vasculature and cell viability. The 
second objective was to develop a preferred method of delivering human endothelial cells 
through the venous and arterial networks within a 3-dimensional liver scaffold and achieve cell 
engraftment, high viability, and microvascular formation.  
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Results showed that of the four factors investigated for endothelial seeding, cell density and 
rate of media perfusion had the greatest effect on endothelialization of the vascular network.  As 
seeding density and media perfusion rate were increased, endothelial coverage and viability also 
increased. A multi-day seeding approach also resulted in increased engraftment and re-
endothelialization of the decellularized rat liver scaffold.  
Within three days of culture, seeded endothelial cells attached to the scaffold, displayed a 
normotypic-flattened appearance, and a microvascular network was formed. The location of 
endothelial cells delivered through the portal vein and the hepatic vein were determined using a 
cell tracker fluorescent dye. Co-localization of these cells was found within major vessels and 
throughout the intralobular sinusoidal space. Methods were developed for re-endothelializing the 
arterial hepatic vasculature of a decellularized rat liver scaffold. Micro-vessels as small as 5-10 
microns in diameter were found within the scaffold after 3 days of culture. For hepatocyte 
seeding, results showed higher viability, albumin and urea production with a transcapsular 
injection method compared to infusion via the vasculature. These findings are important for 
eventual clinical translation of whole organ engineering.  
7.2 INTRODUCTION 
The critical shortage of viable donor organs for patients with end-stage organ failure continues to 
worsen with no immediate solution in sight. More than 120,000 patients are on the organ 
transplant list in the United States alone, and 18 patients will die every day waiting for a donor 
organ[304]. Artificial organ devices such as dialysis machines, ventricular assist devices, and 
extracorporeal membrance exygenation (ECMO) machines provide temporary support, but are 
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inadequate long-term replacement of organ function. Whole organ engineering using naturally 
occurring three-dimensional bioscaffolds has emerged in recent years as a potential solution to 
the donor shortage[83, 305, 306]. This approach is based upon the concept that functional organ 
tissue can be engineered by cell seeding a three-dimensional scaffold composed of extracellular 
matrix homologous (ECM). This approach would include immediate or near immediate in-situ 
transplantation of the cell seeded scaffold, providing the requisite perfusion by the host 
circulation with appropriate microenvironmental cues, nutrients, and signaling factors necessary 
for organ development. The long-term goal of this work is to establish the decellularization, 
recellularization and transplantation criteria necessary to produce adequate functional organ 
tissue to sustain life with minimal or no morbidity.  We have chosen the liver as the model organ 
because of its’ remarkable natural ability to regenerate in vivo. 
In 2008, perfusion decellularization was reported as a technique to generate acellular 
whole organ scaffolds from cadaveric organs[23]. Decellularizing agents were delivered via the 
native vasculature of the organ and thereby distributed across the entire mass of the organ. By 
applying physiologic perfusion pressures, decellularization solutions effectively permeate the 
organ via the capillary bed and cellular debris is removed via the venous system.  This technique 
produces an acellular three-dimensional bioscaffold composed of naturally occurring 
extracellular matrix (ECM)[48, 83].  Theoretically, the resultant bioscaffold is ideal because the 
biochemical composition, micro and macro architecture, and extracellular cues are all derived 
from the native organ.  This technique has also been used to decellularize whole livers[193-195]. 
The generation of a fully functional organ has yet to be accomplished, but several 
intermediate milestones have been reached in heart [196], liver [24, 193-195, 197-200], lung [25, 
201-203], pancreas[204], and kidney [205, 206] regeneration. Current hurdles to successful pre-
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clinical animal studies include the re-establishment of a non-thrombotic microvasculature and an 
effective method for delivering and maintaining viable and functional parenchymal cells to their 
native location[25, 307]. Organ specific parenchymal cell function has been reported following 
bioreactor-assisted in vitro cell seeding[24, 194, 195]. However, seeding efficacy of the vascular 
component of the three dimensional liver bioscaffolds has received little attention.  Variables 
such as cell seeding density, perfusion pressures, oxygen concentration, and other factors require 
a systematic approach for optimization. 
Techniques employed in recellularization of whole-organ scaffolds are typically 
adaptations of methods from a wide range of procedures including traditional cell culture, tissue-
engineering, cell-transplantation therapies, and isolated-organ perfusion. The recellularization 
process can be considered in two major steps. The first is cell seeding, in which the goal is 
distribution of parenchymal and non-parenchymal cell types to their native three-dimensional 
location within the liver scaffold. The second is perfusion culture, which is typically utilized to 
prepare the cells for in vivo transplantation by providing them with physiological conditions in-
vitro.  Typically, cells are either injected directly into the organ with a needled syringe or 
introduced via vascular perfusion with the expectation that the cells will migrate to their native 
site, proliferate, and self-assemble. Cell seeding efficiency has varied greatly. 
The objective of the present study was two-fold: 1) to systematically analyze key variables 
associated with reconstructing a functional vascular network within the 3-dimesnional liver 
bioscaffold, and 2) to develop methods for the reconstruction of the venous and arterial vascular 
networks within a 3-dimensional rat liver bioscaffold.   
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7.3 MATERIALS AND METHODS 
7.3.1 Experimental Overview 
Healthy at livers from Sprague-Dawley rats were harvested and decellularized using a minimally 
disruptive non-ionic detergent, Triton X-100. The resulting scaffold was analayzed for growth 
factor content, cellular remnants, and DNA content. Experiments were then conducted with the 
aim of re-endothelializing the rat liver scaffold. Four factors of endothelial cell seeding rate of 
media perfusion, seeding density, duration of culture, and the addition of an anti-thrombotic 
heparin coating were selected and investigated by means of two outcomes: endothelial coverage 
of the scaffold vasculature and cell viability. A multi-day seeding technique was also 
investigated.  Following analysis of each seeding variable, a preferred method was develop for 
delivering human endothelial cells into the venous and arterial vascular networks of the 
deellularized rat liver scaffold.  Endothleial cells delivered into the each network were labeled 
with a fluorescent cell tracker in order to correlate the avenue of delivery with the spatial 
location within the scaffold after culture. 
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7.3.2 Animals 
Female Sprague-Dawley rats (250–300g; Charles River Laboratories) were used for hepatocyte 
isolation and preparation of the three dimensional liver scaffolds.  The animals were cared for in 
accordance with the guidelines set by the Committee on Laboratory Resources, National 
Institutes of Health, and Institutional Animal Care and Use Committee of University of 
Pittsburgh. 
7.3.3 Donor Rat Liver Harvest  
Surgical plane anesthesia was induced and maintained using inhalation of 1.5%–3% of 
isofluorane. The abdominal cavity was opened by a ventral midline incision extending from the 
pubis to the xyphoid process and the animals were injected intravenously with heparin (200 
units). The inferior vena cava (IVC) and the portal vein were clamped. The portal vein and IVC 
were then cannulated with an 18G cannula, and 5–10mL of phosphate-buffered saline (PBS) 
containing heparin was injected. The diaphragm was cut to transect the superior vena cava and 
IVC. The liver was removed and stored in a cell culture dish filled with PBS solution. The liver 
was then rinsed with 10–20mL of PBS solution containing heparin (200 units). The livers were 
frozen at - 80ºC completely immersed in PBS solution before perfusion was performed for organ 
decellularization. 
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7.3.4 Whole Rat Liver Decellularization 
The harvested livers of Sprague-Dawley rats were frozen at -80ºC for at least 24 h before 
decellularization to aid in cell lysis. The liver was thawed at room temperature in 1 x PBS. 
Decellularization was conducted by a retrograde perfusion technique at 8 mL/min, in which 
solutions flowed through the cannula, into the IVC, and throughout the vasculature of the liver. 
Livers were placed in 500mL of 0.02% trypsin/0.05% EGTA solution at 37ºC, allowing the 
solution to flow through the liver for 2 h. Deionized water was perfused through the liver for 15 
min followed by 15 min of 2 x PBS. The 3% Triton X-100/0.05% EGTA solution was perfused 
through the liver vasculature for 18–24 h with the solution being changed after 1, 4, and 16 h. A 
deionized water wash for 15 min followed by 2 x PBS wash for 15 min was repeated once, 
followed by a deionized water wash for 30 min and 2 x PBS wash for 30 min to aid in cellular 
lysis and wash any recirculating debris. The three-dimensional liver ECM was then perfused 
with 0.1% (v/v) peracetic acid/4% EtOH for 1 h. Acidic conditions were neutralized by PBS and 
deionized water washes twice for 15 min each.  
7.3.5 Growth Factor Assays 
Two hundred fifty milligrams of minced rat whole liver or decellularized rat liver was suspended 
in * 3.75 mL of urea heparin extraction buffer. The extraction buffer consisted of 2 M urea and 5 
mg/mL heparin in 50 mM Tris with protease inhibitors (protease inhibitors: 1 mM 
phenylmethylsulfonyl fluoride, 5 mM benzamidine, and 10 mM N-ethylmaleimide) at pH 7.4. 
The extraction mixture was rocked at 4C for 20 to 24 h and then centrifuged at 12,000 g for 30 
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min. Supernatants were collected, and 6 mL of natively prepared ureaheparin extraction buffer 
was added to each pellet. Pellets with extraction buffer were again rocked at 4[degrees]C for 20 
to 24h, centrifuged at 12,000 g for 30 min, and supernatants were collected. Supernatants from 
first and second extractions were dialyzed against Barnstead filtered water (total of three changes 
of dialysis water, 80 to 100 volumes per change) in Slide-A-Lyzer Dialysis Cassettes, 3500 
MWCO (Pierce). The concentration of total protein in each dialyzed extract was determined by 
the BCA protein assay (Pierce #23227; Pierce) following the manufacturer's protocol, and 
extracts were frozen in aliquots until time of assay. Concentrations of basic fibroblast growth 
factor (bFGF), vascular endothelial growth factor (VEGF), and HGF in urea-heparin extracts of 
liver samples were determined with the Quantikine Human FGF basic Immunoassay (R&D 
Systems # DFB50; R&D Systems), the Quantikine Rat VEGF Immunoassay (R&D Systems # 
DFE00; R&D Systems), and the Rat HGF ELISA Kit (B-Bridge International # K2002-1; B-
Bridge International), respectively. Manufacturer's instructions were followed for all three 
growth factor assays. Each growth factor assay was performed in duplicate three times. Results 
are reported as mean [+ or -] standard error. A one-way analysis of variance with Dunnett's 
comparison test was used for each growth factor analysis to test the null hypothesis that the 
growth factor content of the decellularized liver was no different than that of native liver. A p-
value of < 0.05 was considered significant. It should be noted that growth factor assays measured 
the concentration of each growth factor protein and did not measure growth factor activity. 
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7.3.6 DNA Quantification 
DNA content was quantified using methods described previously. (19) In brief, the 
decellularized liver was cut into small strips and digested using Proteinase K (Invitrogen) for 24-
48 h at 50°C until no visible material remained. Phenolchloroform-isoamyl alcohol (25:24:1; 
Acros) was then added in equal amounts to the decellularized liver digest and centrifuged for 10 
min at 10,000 g. The aqueous top layer containing the DNA was then removed and added to 200 
µL of 3M sodium acetate solution to reduce RNA content. Ethanol was then added and the 
solution frozen at - 80°C for at least 12 h. Ethanol was then removed, and samples were allowed 
to fully dry, at which point 1 x TE buffer (Invitrogen) was added. The total amount of DNA was 
quantified using the Picogreen DNA assay (Invitrogen) using the manufacturer's instructions. 
7.3.7 Vascular Corrosion Casting 
Catheterization of the infrahepatic vena cava, portal vein and hepatic artery was performed 
followed by injection of 1-4 mL polymer mixture depending on the liver size using Batson's 17 
anatomic corrosion kit (Polysciences, Inc.) as recommended by the manufacturer. 
Polymerization took 4 h at 4°C and was followed by maceration in 1 N KOH solution or 
proteinase K for 8-24 h. 
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7.3.8 Corline Heparin Conjugate 
The heparin conjugate is schematically presented in Figure 25. The conjugate consists of 
heparin (Mw ~ 13,000 Da, Figure 25a) covalently bound to a polyamine carrier chain (PAV) 
with disulphide bonds using a heterobifunctional coupling agent, SPDP3 (Figure 25c), 
approximately in the proportions 70 mol heparin per mole carrier chain. The SPDP derivate 
forms a coupling unit between heparin and PAV (Figure 25d) and contains a disulfide bond, 
which provides a useful marker unit for the structural evaluation of the PES results. 
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Figure 25. (A) Schematic drawing of the heparin conju gate. (B) The antithrombin binding 
heparin pentasaccharide unite.  (C) The structure of the heterobifunctional coupling agent, SPDP. 
(D) The bond between the carrier chain PAV and the heparin chain. The –NH groups belong to
PAV and heparin, respectively, but are shown for clarification.  
7.3.9 Investigation of Key Endothelial Cell Seeding Variables 
HMECs (a gift from Francisco Candal, Center for Disease Control and Prevention, Atlanta, GA) 
were cultivated in MCDB-131 medium containing 10% fetal bovine serum, 2 mM l-glutamine, 
100 U ml−1 penicillin and 100 µg ml−1 streptomycin. MCDB-131 medium was from Invitrogen 
(Carlsbad, CA); all other reagents for cell growth were from Thermo Fisher Hyclone (Logan, 
UT). Cells were grown at 37 °C in 5% CO2 and were harvested for seeding when they were 
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∼100% confluent. Before seeding the decellularized rat scaffold the HMECs were suspended in
2ml of growth media. The remaining vascular structures of the decellularized liver were utilized 
for delivering the HMECs (Figure 26).  
Half of the cell suspension (1ml) was delivered into the scaffold by infused through the 
portal vein.  The remaining 1ml was then delivered through the hepatic vein.  Four variables of 
endothelial cell seeding and culture process were investigated; seeding density (10.0 – 30.0 x 106 
HMECs per scaffold), media flow rate following seeding (0.0 – 4.0 ml/min), culture duration (0 
– 7 days), and the addition of an anti-thrombotic heparin coating (before and after seeding). An
overview of the various conditions can be seen in Table 7 and Figure 27. Scaffolds were then 
placed in an incubator at 37°C in 5% CO2. After culture, seeded scaffolds were fixed in 10% 
neutral buffered formalin for subsequent histologic analysis. 
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Figure 26. (A) Seeding chamber/bioreactor used for delivering human microvascular endothelial 
cells within the decellularized rat liver scaffolds. (B) Delivery of HMECs via the portal vein  (C) 
Delivery of HMECs via the hepatic vain. 
A 
B 
C 
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Table 7: Overview of human microvascular endothelial cell seeding conditions. 
Figure 27. Schematic representation of the experiment design to systematically investigate key 
variables associated with endothelial cell seeding and culture within a three-dimensional rat liver 
scaffold. 
Three-Dimensional Rat Liver Scaffolds 
(24) 
Seeding Density  
(6) 
10 Million  
(2) 
20 Million  
(2) 
30 Million 
(2) 
Flow Rate  
(6) 
0 ml/min 
(2) 
2 ml/min 
(2) 
4 ml/min 
(2) 
Culture Duration 
(6) 
0 Days 
(2) 
3 Days 
(2) 
7 Days 
(2) 
Heparin Coating 
(6) 
No Coating 
(2) 
Coating Before 
Seeding 
(2) 
Coating After 
Seeding 
(2) 
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7.3.10 Reconstruction of the Venous Network 
HMECs (a gift from Francisco Candal, Center for Disease Control and Prevention, Atlanta, GA) 
were cultivated in MCDB-131 medium containing 10% fetal bovine serum, 2 mM l-glutamine, 
100 U ml−1 penicillin and 100 µg ml−1 streptomycin. MCDB-131 medium was from Invitrogen 
(Carlsbad, CA); all other reagents for cell growth were from Thermo Fisher Hyclone (Logan, 
UT). Cells were grown at 37 °C in 5% CO2 and were harvested for seeding when they were ∼100% confluent. Before seeding the decellularized rat scaffold the HMECs were suspended in
2ml of growth media. The portal vein and hepatic vein of the decellularized liver were utilized 
for delivering the HMECs (Figure 26).  
A multi-day seeding approach was utilized for these experiments. For one decellularized rat 
liver, endothelial cell seeding was performed on 3 separate days (10 million per day) as opposed 
to the previous method of 30 million cells seeded at the same time.  On day 1, 5 million cells 
were infused via the portal vein and 5 million cells were delivered via the hepatic vein.  This 
seeding technique was repeated on days 2 and 3 for the same liver. Scaffolds were then placed in 
an incubator at 37°C in 5% CO2 and cultured for an additional 24 hours following the 3rd 
seeding. After culture, seeded scaffolds were fixed in 10% neutral buffered formalin for 
subsequent histologic analysis. 
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7.3.11 Reconstruction of the Arterial Network 
HMECs (a gift from Francisco Candal, Center for Disease Control and Prevention, Atlanta, GA) 
were cultivated in MCDB-131 medium containing 10% fetal bovine serum, 2 mM l-glutamine, 
100 U ml−1 penicillin and 100 µg ml−1 streptomycin. MCDB-131 medium was from Invitrogen 
(Carlsbad, CA); all other reagents for cell growth were from Thermo Fisher Hyclone (Logan, 
UT). Cells were grown at 37 °C in 5% CO2 and were harvested for seeding when they were ∼100% confluent. Before seeding the decellularized rat scaffold the HMECs were suspended in
2ml of growth media. The portal vein, hepatic vein, and hepatic artery of the decellularized liver 
were utilized for delivering the HMECs.  
A multi-day seeding approach was utilized for these experiments in a similar fashion as 
section 7.3.6. However, 1 million HMECs were also seeded via the hepatic artery on days 1, 2, 
and 3. Scaffolds were then placed in an incubator at 37°C in 5% CO2 and cultured for an 
additional 24 hours following the 3rd seeding. After culture, seeded scaffolds were fixed in 10% 
neutral buffered formalin for subsequent histologic analysis. 
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7.4 RESULTS 
7.4 Rat liver perfusion decellularization 
Figure 28 shows macroscopic and microscopic images of liver before decellularization and after 
various steps in the decellularization process. The decellularization protocol consisted first of a 
freezing-thawing technique for at least 24 h to induce cellular lysis. The liver was then retrograde 
perfused through the IVC using 0.02% trypsin/0.05% EGTA and 3% Triton X-100/0.05% EGTA 
with washing and disinfection cycles for a total of 28 h (Fig. 28a). Figure 28b shows the 
generation of a translucent acellular liver ECM, retaining the gross anatomical features of the 
liver. 
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Figure 28. Schematic representation of the sequential whole-organ decellularization protocol (a) 
Representative macroscopic images of rat livers at various steps in the decellularization process 
(b). Histologic comparison of normal liver (c-f) and decellularized rat liver matrix (g-j): 
hematoxylin and eosin (c,g), collagen IV (red) (d,h), laminin (green) (e,i), and fibronective (red) 
(f, j). Sections were counterstained with DAPI (blue). Scale bars: 200	  µm.  
7.4.2 DNA Content 
Evidence suggests that xenogeneic DNA remnants can be the cause of "inflammatory reactions" 
following the implantation of derived scaffolds. (19) Thus, DNA content was analyzed and gel 
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electrophoresis confirmed that the DNA content of the decellularized liver matrix was 25.8 -13 
ng/ mg dry weight, which represents 0.47% of the DNA total content of a normal liver (547 [+ or 
-] 1176ng/mg dry weight) (Fig. 2i, note the logarithmic y-axis). Electrophoretic analysis 
confirmed that remaining DNA material consisted of fragments < 200 bp in length (Fig. 2j), 
confirming that degradation of cell contents was extensive. Histologic analysis with DAPI 
showed no visible nuclear material in the decellularized liver matrix (Fig. 2k). 
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Figure 29. Scanning electron microscopy image showing the extracellular matrix within the 
parenchyma of normal liver (1), and decellularizved liver open spaces previously occupied by 
hepatic parenchymal cells (b). Representative SEM images of Glisson’s capsul of fresh liver (C, 
D) after liver decellularization (e,f). Growth factor content of decellularized liver matrix and
normal liver, hepatocyte growth factor (HGF) (G), and basic fibroblast growth factor (bFGF) (H) 
DNA content of the decellularized liver matrix and native liver as determined with a PicoGreen 
Assay (I,J) the presence of intact nuclear material was evaluated bys staining the decellularized 
liver and native liver using DAPI (K). Scale bars: 10um (A-F). 
133
7.4.3 Morphology 
Histologic analysis of the decellularized liver showed the absence of cellular components 
compared to native liver (Fig. 1c, g). Immunolabeling characterization of the liver ECM showed 
the preservation of collagen IV, laminin, and fibrin ogen, indicating a similar structural 
composition of the matrix to that of intact liver (Fig. 1d-f, h-j). Ultrastructural characterization of 
the decellularized liver matrix showed the absence of cells; the honey-comb spaces represent the 
footprint of hepatocyte removal (Fig. 2a, b). One important consideration in the organ 
decellularization process is the integrity of the collagenous capsule covering the external surface 
of the liver, that is, Glisson's capsule. A meticulous analysis of Glisson's capsule by both light 
microscopy and SEM in the present study showed complete integrity of the Glisson's capsule 
(Fig. 2e, f). Fresh liver from normal rats was used as control (Fig. 2c, d). 
7.4.4 Growth Factor Content 
The content of HGF in the decellularized liver matrix was 39 [+ or -] 1.7ng/g dry weight and the 
content of bFGF was 13 [+ or -] 1 ng/g dry weight. Native liver HGF content was 72 [+ or -] 
7.5ng/g dry weight and bFGF was 34 [+ or -] 0.3ng/g dry weight. These results show that more 
than 50% of HGF and ~ 40% of bFGF were preserved in the decellularized liver matrix 
compared with the native liver (Fig. 2g, h). 
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7.4.5 Vascular Cast 
Vascular casting of the hepatic portal and hepatic arterial vascular networks of the decellularized 
liver matrix were intact (Fig. 3a), an important feature for subsequent vascular 
endothelialization. In previous studies (4) it was demonstrated that only the portal and central 
venous system were preserved. Engineering of a complete liver graft would, however, require an 
intact and complete arterial system and, importantly, an intact bile drainage system. Thus, a 
corrosion cast of the decellularized liver matrix was created and showed the existence and 
preservation of the entire vascular system (portal vein, hepatic artery vasculature, central vein, 
and biliary tract) similar to normal liver (Fig. 3b, c). 
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Figure 30. (A) Vascular cast of a native rat liver. (B) Vascular network of a decellularized rat 
liver scaffold.  The venous network (blue) and the arterial network (red). 
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7.4.6 Investigation of Key Endothelial Cell Seeding Variables 
Results showed that of the four factors investigated for endothelial seeding, cell density and rate 
of media perfusion had the greatest effect on the resulting vascular network.  As seeding density 
and media perfusion rate were increased, endothelial coverage and viability also increased. 
Within three days of culture, seeded endothelial cells attached to the scaffold, displayed a 
flattened appearance, and a microvascular network was formed (Figure 31). Interestingly, cells 
seeded from the hepatic vein co-localized with cells seeded from the portal vein. Conclusions 
from this study are that endothelial coverage of major vessels within the decellularized liver 
scaffold is achievable after 3 days of culture. Increasing seeding density and media perfusion rate 
increases vessel coverage and cell viability 
Figure 31. Representative H&E images from each seeding condition listed in Table 1. Scale bar 
= 50µm 
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7.4.7 Corline Heparin Coating and Its Effects on HMECs 
Corline heparin product’s interactions with Human Microvascular Endothelial Cells (HMECs) 
were determined.  Specifically, we (1) determined the cytotoxicity, if any, of the Corline product 
on HMECs, (2) determined if the Corline product has an impact on endothelial cell attachment, 
and (3) determined if the Corline Heparin product can be applied on top of the HMECs after 
seeding. 
Figure 32: 40,000 HMECs were seeded onto collagen coated plates with the addition of CHC or 
free Heparin for a length of 2 and 4 days.  Results show that free heparin inhibits the 
proliferation of HMECs, but CHC, at low concentrations, does not.  Furthermore, higher cell 
proliferation was seen when CHC was added before seeding compared to adding CHC after 
seeding.  
Number of HMECs 
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To test the effect of CHC upon endothelial cell attachment, native porcine hepatic vessels were 
isolated from healthy market weight pigs.  These vessels were decellularized using our 
established published protocol for the decellularization of whole livers.  Next, the decelled 
vessels were either coated with the Corline heparin conjugate or not coated.  HMECs were 
cultured on the vessels for 4 and 7 days and fixed in 10% neutral buffered formalin.   
At both 4 and 7 days there does not appear to be a difference in HMEC cell attachment, 
viability, or confluence when comparing the uncoated decellularized liver vessels with Corline 
coated decellularized liver vessels. 
Figure 33: HMECs Cultured on uncoated decellularized liver vessels (left) and Corline coated 
decellularized liver vessels (right) for four (top) and seven (bottom) days.  At both 4 and 7 days 
there does not seem to be a difference in HMEC cell attachment, viability, or confluence when 
comparing the uncoated decellularized liver vessels with Corline coated decellularized liver 
vessels. 
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To experimentally test the effect of CHC applied after HMEC seeding, native porcine 
hepatic vessels were isolated from healthy market weight pigs.  These vessels were 
decellularized using our established published protocol for the decellularization of whole livers.  
Next, we coated the decellularized liver vessel with CHC, and HMECs were culture on it (count 
as day0). On day2 media containing CHC was added.  Samples were collected on day 4 and 7. 
The samples were fixed in 10% neutral buffered formalin and were stained with H&E to 
assess their attachment and viability. At both 4 and 7 days there was nodifference in HMEC 
viability or confluence between the samples with no CHC added on day 2 vs. samples with CHC 
added on day 2. 
Figure 34. HMECs Cultured on CHC coated decellularized liver vessels with no CHC added on 
day 2 (left) and Corline coated decellularized liver vessels with CHC added on day two (right) 
for four (top) and seven (bottom) days.  At both 4 and 7 days there does not appear to be a 
difference in HMEC viability or confluence between the samples with no CHC added on day 2 
vs. samples with CHC added on day 2. 
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7.4.8 Reconstruction of the Venous Network 
Following the first set of experiments conducted, in which we investigated key endothelial cell 
seeding variables, we then developed a new method for delivering endothelial cells within a 
decellularized rat liver. For one decellularized rat liver, endothelial cell seeding was performed 
on 3 separate days (10 million per day) as opposed to the previous method of 30 million cells 
seeded at the same time.  Histologic assessment of the graft showed endothelial coverage of 
several major vessels within the decellularized rat liver as well as sinusoidal space. This 
microvascular formation within the sinusoidal space was not seen with previous seedings. 
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Figure 35. (A) Representative H&E images from our newly developed method of seeding 
microvascular endothelial cells within a decellularized rat liver. Endothelial cell coverage of 
major vessels as well as the sinusoidal space can be seen throughout the seeded scaffold. (B) 
HMECs delivered via the portal vein (red) co-localized with HMECs delivered via the hepatic 
vein (green) 
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7.4.9 Reconstruction of the Arterial Network 
Figure 36. Isolation and cannulation of the hepatic artery allowed for endothelial cell delivery 
throughout the hepatic arterial network.  After 3 days of culture an arterial network was formed 
and could be visualized via H&E.  TUNEL stained showed a majority of cells are viable.  
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7.5 DISCUSSION 
One of the major challenges for whole organ engineering is to produce large volume tissues 
capable of being connected to the recipient’s blood supply for clinical applications. Pervious 
work in the field of bioengineer liver tissue has been met with many obstacles including cell 
sourcing, efficient cell seeding, vascularization of the engineered tissue, and provision of 
authentic cues for tissue development. The experiments conducted in this chapter were aimed at 
developing a technology that will provide meaningful progress toward engineering a fully 
functional hepatic vascular network within a decellularized liver scaffold. To do so, we presented 
here a method of decellularization that was used to fabricate a naturally derived whole-organ 
bioscaffold. We used the vascular channels as a conduit for reseeding human microvascular 
endothelial cells inside the bioscaffold. The three-dimensional liver bioscaffold provided spatial 
information for cell localization and engraftment, and supported cellular proliferation and 
phenotype maintenance. These developed methods offer a potential technique for fabrication of 
human liver tissue that can be readily transplanted into host animals or used for studies of liver 
cell biology, physiology, toxicology, and drug discovery with further development. 
Previously, decellularization of tissue was performed by submersion of the tissue within a 
detergent solution under agitation to allow cell removal in bulk from the surface of the tissue 
moving inward. These approaches were successful for decellularization of smaller samples (up to 
5 mm in thickness), whereas in thicker specimens the core of the tissue remained cellular. To 
circumvent this limitation, we took advantage of the native liver vascular network by perfusing 
the detergent through this network and distributing it throughout the entire liver. This gentle 
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procedure preserves the architecture of the liver matrix and vascular system. The choice of 
detergent for the production of whole organ bioscaffolds using perfusion may also impact the 
preservation of important biochemical cues. In chapters 5 and 6 we showed that harsh ionic 
detergents such as SDS facilitate rapid removal of cells from dense tissues and can yield a 
functional bioscaffold, but they may damage some ECM components. Therefore, we opted to use 
a mild nonionic detergent, Triton X-100. We found that this detergent could successfully 
decellularize the whole liver by the removal of a majority of cellular DNA. These studies 
highlight the utility of perfusion decellularization to generate whole organ bioscaffolds with 
significant potential for organ bioengineering. 
Typically, neovascularization of bioengineered tissues was addressed by supplementing 
cells with angiogenic growth factors or fabricating scaffolds from synthetic material that allowed 
micro-patterning of vascular tree-like structures. When growth factors are used alone, they tend 
to create only a microvasculature consisting of small and fragile capillaries, and therefore this 
technique is only applicable for the engineering of smaller size tissues. An alternative fabrication 
method is using a micropatterning technique that can be scaled up to larger sizes by modular 
construction. However, currently this method cannot replicate the progressive complexity and 
ECM composition of the native liver vascular tree. The bioscaffolds generated from whole livers 
produced via our decellularization method retain the complexity of multiple size vessels that can 
deliver fluids from the larger vena cava or the portal vein and reach each individual liver lobule. 
An additional advantage of this method is the retention of important ECM molecules 
required for site-specific engraftment and/or differentiation of different cell types that are present 
in the liver. Prior research showed that liver-specific stem cells can be isolated and differentiated 
to hepatic fate. We used human microvascular endothelial cells to recellularize the bioscaffolds. 
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The advantage of seeding human microvascular endothelial cells is that they are consistent in 
their proliferation rate, they are easy to maintain in culture, and they are associated with a low 
experimental cost.  This allowed us to perform many recellularization experiments before 
moving to more clinically relevant iPSC derived human endothelial cells. 
 A major obstacle in producing large-volume tissues is the delivery of adequate numbers 
of cells to the entire thickness of the tissue. Commonly used methods for cell seeding into 
scaffolds employ static, dynamic, or perfusion bioreactor seeding, resulting in seeding of cells 
that can only penetrate several millimeters below the surface, with further engraftment dependent 
on active migration of the cells. Alternatively, previous methods to recellularize organ scaffolds 
have relied heavily on direct cell injection that damaged the scaffold microarchitecture and 
produced heterogeneous scaffold seeding. The perfusion method introduced here supports cell 
infusion through both the venous and arterial vascular networks and deposition throughout the 
thickness of the bioscaffold, achieving greater seeding efficiency without compromising the 
integrity of the bioscaffold. Furthermore, by accessing different vessels that feed into the liver, 
we were able to deliver cells selectively to different compartments of the liver tissue. Endothelial 
cells delivered through the vena cava selectively seeded larger and smaller blood vessels up to 
the pericentral area of the liver lobule, without reaching the periportal space of the lobule where 
the final branching vessels of portal vein are located. On the other hand, cells seeded through the 
portal vein, which delivers blood from the intestine and other organs to the liver, reached 
predominantly the periportal area of the liver lobule without extensive penetration to its 
pericentral space. These seeded endothelial cells cover the entire circumference of a vascular 
channel and maintained cell-cell junctions. Thus, simultaneous utilization of both vascular routes 
for cell seeding enables complete access to the entire length of the vascular network, which has 
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an essential importance for prevention of blood clotting and ultimately failure to transplant the 
bioengineered liver.  
This study demonstrates that three-dimensional biologic scaffolds composed of liver 
extracellular matrix have the capability to become a completely re-endothelializes scaffold 
closely mimicking the native three-dimensional structure of liver tissue. The bioscaffold may 
also prove as a good tool to study normal tissue and organ development as well as liver 
pathology. Ultimately, this technology may bring us closer to the ultimate goal of providing 
bioengineered livers for transplantation. 
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 8.0  SYSTEMATIC DEVELOPMENT OF METHODS FOR SEEDING 
HEPATOCYTES WITHIN A 3-DIMENSIONAL LIVER BIOSCAFFOLD 
8.1 ABSTRACT 
A major hurdle preventing whole organ engineering of the liver from translation to pre-clinical 
animal models includes the lack of an effective method for delivering hepatocytes to their native 
location.  The objective of the work in this chapter was to develop a preferred method of 
delivering hepatocytes into a 3-dimensional liver scaffold achieving cell engraftment and 
functionality.  Results showed higher viability, albumin and urea production with a trans-
capsular injection method compared to infusion via the vasculature. These findings are important 
for eventual clinical translation of whole organ engineering.  
8.2 INTRODUCTION 
The critical shortage of viable donor organs for patients with end-stage organ failure continues to 
worsen with no immediate solution in sight. More than 120,000 patients are on the organ 
transplant list in the United States alone, and 18 patients die every day waiting for a donor 
organ[304]. Artificial organ devices such as dialysis machines, ventricular assist devices, and 
extracorporeal membrane oxygenation (ECMO) machines provide temporary support, but are 
inadequate and unsustainable long-term solutions. Whole organ engineering using naturally 
occurring three-dimensional bioscaffolds has emerged in recent years as a potential solution to 
the donor shortage [83, 305, 306]. This approach is based upon the concept that functional organ 
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tissue can be engineered by cell seeding a three-dimensional scaffold composed of homologous 
extracellular matrix (ECM). This approach would include immediate or near immediate in-situ 
transplantation of the cell seeded scaffold, providing the requisite perfusion by the host 
circulation with appropriate micro-environmental cues, nutrients, and signaling factors necessary 
for organ development, maintenance, and life-sustaining function. 
In 2008, perfusion decellularization was described as a technique to generate acellular 
whole organ scaffolds from cadaveric organs [23]. Decellularizing agents were delivered via the 
native vasculature of the native heart and thereby distributed throughout the entire mass of the 
organ. This technique produced an acellular three-dimensional cardiac bioscaffold composed of 
naturally occurring extracellular matrix (ECM)[48, 83].  Theoretically, the resultant bioscaffold 
using this approach is ideal because the biochemical composition, micro and macro architecture, 
and extracellular cues would all be present. This technique has also been used to decellularize 
other whole organs such as heart [196], liver [24, 193-195, 197-200], lung [25, 201-203], 
pancreas[204], and kidney [205, 206]. 
\ The generation of a fully functional organ has yet to be accomplished, but several 
intermediate milestones have been reached. Current hurdles to successful long termpre-clinical 
animal studies include the re-establishment of a non-thrombotic microvasculature and an 
effective method for delivering and maintaining viable and functional parenchymal cells to their 
native location[25, 307]. Organ specific parenchymal cell function has been reported following 
bioreactor-assisted in vitro cell seeding[24, 194, 195].  
The work described herein utilizes the liver as the test organ but the fundamental 
concepts may apply to all organs. Cell seeding techniques have not been systematically 
approached by isolating single key variables such as cell seeding density, perfusion pressure, 
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oxygen concentration, and other factors.  Although such an effort can be exhaustive, a reasonable 
effort to identify a preferred technique is essential for success.  Most reports to date have used 
perfusion techniques for both endothelial cell and parenchymal components. 
Techniques employed in recellularization of whole-organ scaffolds are typically 
adaptations of methods from a wide range of procedures including traditional cell culture, tissue-
engineering, cell-transplantation therapies, and isolated-organ perfusion. The recellularization 
process can be considered in two major steps. The first is cell seeding, in which the goal is 
distribution of parenchymal and non-parenchymal cell types to their native three-dimensional 
location within the liver scaffold. The second is perfusion culture, which is typically utilized to 
prepare the cells for in vivo transplantation by providing them with physiological conditions in-
vitro.  Typically, cells are either injected directly into the organ with a needled syringe or 
introduced via vascular perfusion with the expectation that the cells will migrate to their native 
site, proliferate, and self-assemble. Cell seeding efficiency has varied greatly. 
The objective of the present study was to identify a perferred method of delivering 
parenchymal cells into the 3-dimensional liver bioscaffold and then to combine that method with 
the endothelial cell seeding methods developed in Chapter 7.   
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8.3 MATERIALS AND METHODS 
Whole rat livers were decellularized using an established protocol to produce an acellular 3-
dimensional liver bioscaffold.  Two different methods of seeding hepatocytes into the 3-
dimensional liver biscaffold were also evaluated: (1) direct parenchymal injection and (2) 
infusion via portal and hepatic veins. Metabolic activity of the engrafted hepatocytes was 
evaluated by quantification of albumin and urea production. Engrafted cell morphology and 
expression of hepatic specific genes were also used to evaluate the two seeding methods. 
8.3.1 Animals 
Female Sprague-Dawley rats (250–300g; Charles River Laboratories) were used for hepatocyte 
isolation and preparation of the three dimensional liver scaffolds.  The animals were cared for in 
accordance with the guidelines set by the Committee on Laboratory Resources, National 
Institutes of Health, and Institutional Animal Care and Use Committee of University of 
Pittsburgh. 
8.3.2 Preparation of 3-dimensional liver bioscaffold 
The harvested livers of Sprague-Dawley rats were frozen at -80ºC for at least 24 h before 
decellularization to aid in cell lysis. The liver was thawed at room temperature in 1 x PBS. 
Decellularization was conducted by a retrograde perfusion technique at 8 mL/min, in which 
solutions flowed through the cannula, into the IVC, and throughout the vasculature of the liver. 
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Livers were placed in 500mL of 0.02% trypsin/0.05% EGTA solution at 37ºC, allowing the 
solution to flow through the liver for 2 h. Deionized water was perfused through the liver for 15 
min followed by 15 min of 2 x PBS. The 3% Triton X-100/0.05% EGTA solution was perfused 
through the liver vasculature for 18–24 h with the solution being changed after 1, 4, and 16 h. A 
deionized water wash for 15 min followed by 2 x PBS wash for 15 min was repeated once, 
followed by a deionized water wash for 30 min and 2 x PBS wash for 30 min to aid in cell lysis 
and remove any recirculating debris. The three-dimensional liver bioscaffold was then perfused 
with 0.1% (v/v) peracetic acid/4% EtOH for 1 h. Acidic conditions were neutralized by PBS and 
deionized water washes twice for 15 min each.  
8.3.3 Donor rat liver harvest  
Surgical plane anesthesia was induced and maintained using inhalation of 1.5%–3% of 
isofluorane. The abdominal cavity was opened by a ventral midline incision extending from the 
pubis to the xyphoid process and the animals were injected intravenously with heparin (200 
units). The inferior vena cava (IVC) and the portal vein were clamped. The portal vein and IVC 
were then cannulated with an 18G cannula, and 5–10mL of phosphate-buffered saline (PBS) 
containing heparin was injected. The diaphragm was cut to transect the superior vena cava and 
IVC. The liver was removed and stored in a cell culture dish filled with PBS solution. The liver 
was then rinsed with 10–20mL of PBS solution containing heparin (200 units). The livers were 
frozen at - 80ºC completely immersed in PBS solution before perfusion was performed for organ 
decellularization. 
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8.3.4 Primary rat hepatocyte isolation  
Surgical plane anesthesia was induced and rats were maintained at this plane of anesthesia by 
inhalation of 1.5% – 3% isofluorane. Rat hepatocytes were harvested using a two-step 
collagenase digestion method. The isolation technique involved cannulation and perfusion 
through the hepatic portal vein with calcium and magnesium-free Hanks’ salt solution followed 
by media containing collagenase at a flow rate of 12 mL/min as previously described. Viability 
was assessed by trypan blue exclusion and was routinely > 80%. The yield of the isolated 
hepatocytes was 5.0 – 7.0 x 108 viable cells per liver. 
8.3.5 Hepatocyte seeding of three-dimensional liver scaffolds 
Trans-capsular injection 
A total of 1.5×106 cells (hepatocytes) suspended in 125 microliters of culture medium were 
delivered through twenty-five injections of 5  µL each into different hepatic lobes of the 
decellularized liver matrix with a 27G needle and a 1-cc tuberculin syringe. After 40  min of 
perfusion, the perfusate was collected, and the viability and the number of cells not retained in 
the liver were determined. To calculate the engraftment efficiency, the perfusate was collected 
and the number and viability of cells not retained in the liver (i.e., in the perfusate) was 
determined with a hemacytometer and trypan blue exclusion. The total number of cells retained 
in the decellularized liver represented the difference between the initial number of cells seeded 
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and the number of cells present in the perfusate after seeding. Reseeded scaffolds were perfused 
with hepatocyte culture media for 3 days flow through the portal and hepatic veins at a rate of 2 
ml/min.  Media was collected each day for albumin and urea quantification. 
Infusion via the portal vein 
A total of 1.5×106 cells (hepatocytes) suspended in 125 microliters of culture medium were 
delivered through a port located in the main chamber connected to the portal vein. The cells were 
infused via the portal vein at a rate of 2 ml/min until all cells entered the liver. After 40  min, the 
perfusate was collected, and the viability and the number of cells not retained in the liver were 
determined. Reseeded scaffolds were cultured in hepatocyte culture media for 3 days with 
continuous flow through the portal vein at a rate of 2 ml/min.  Media was collected each day for 
albumin and urea quantification. 
8.3.6 Investigating injection volume 
Porcine liver ECM hydrogels, at a concentration of 8 mg/ml, were injected with varying injection 
bolus volumes of hepatocytes to determine the effect of injection volume on hepatocyte viability 
and functionality.  Injection volumes of 5ul, 10ul and 20ul were investigated. The effect of 
varying injection volume on hepatocyte viability and function was assessed through ammonia 
metabolism, albumin production and transcription profiling of hepatocyte specific genes.  Each 
porcine liver ECM hydrogel was injected with 500,000 primary rat hepatocytes and cultured  
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8.3.7 Functional assessment of seeded hepatocytes 
Measurement of albumin secretion 
Conditioned media was collected on days one, two, and three and stored at -80°C until analysis. 
Hepatocyte secretion of albumin was measured using a commercially available kit (Bethel 
Laboratories, Texas). At least three samples were collected from each culture condition and each 
sample was measured in triplicate.  
Measurement of urea section 
Primary rat hepatocyte metabolism of ammonia was measured. Media was aspirated and 
hepatocytes were incubated with 2.5 mM NH4Cl in hepatocyte maintenance media for two hours 
at 37°C. The conditioned media was collected and the concentration of NH3N was measured 
using a commercially available kit (Wako Pure Chemical Industries, Tokyo, Japan). At least 
three samples were collected from each culture condition and each sample was measured in 
triplicate.  
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Quantitative real-time PCR 
Total RNA from cell lysates was isolated using Trizol reagent as instructed by the manufacturer. 
RNA concentration was determined by spectrophotometer at 260 nm. The purity of RNA was 
determined by spectrophotometry using the 280nm=260nm ratio, and the integrity checked by 
agarose gel electrophoresis stained with ethidium bromide.  
RNA was stored at - 80ºC until further use. mRNA expression levels of albumin, BSEP, and 
NTCP were determined using TaqMan quantitative RT-PCR assays. From each group, 2 mg of 
total RNA was incubated with 5U RNA qualified (RQ) DNAse, 5 mL 10RQ buffer in a total 
volume of 10 mL at 378C for 30 min. The samples were then incubated with 1 mL RQ DNase 
Stop Solution at 65ºC for 10 min. The DNAse-treated RNA was then incubated with 1 mL of 
random hexamer primers (100 ng=L) at 70ºC for 5 min for cDNA synthesis. cDNA generation 
continued with incubation at 37ºC for 60 min with the following reagents: 1 mL deoxynucleotide 
triphosphate (dNTP) (10mM of each), 5 mL MMLV 5, and 1 mL MMLV RT for a total volume 
of 12 mL.  
TaqMan one-step RT-PCR assays were performed with 4 ng of each RNA sample in a final 
reaction volume of 72 mL prepared from TaqMan one-step RT-PCR Master Mix Reagents Kit. 
Assays were performed using an Applied Biosystems’ ABI Prism 7900HT sequence detection 
system. An initial RT step occurred for 30 min at 488 and was subsequently followed by heating 
to 95ºC for 10 min followed by 40 cycles of 95ºC for 15 s and 60ºC for 1 min. 
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8.3.8 Seeding of endothelial cells and hepatocytes within a decellularized rat liver 
The addition of functional, viable hepatocytes to the re-endothelialized liver scaffold was also 
been achieved.  Following re-endothelialization, primary rat hepatocytes were delivered via 5ul 
syringe injections into the parenchymal space of the decellularized scaffold.  The hepatocytes 
were cultured for 3 days within the re-endothelialized scaffold.  Histologic assessment confirms 
the hepatocytes are viable and they have integrated with the endothelial cells 
8.4 RESULTS 
8.4.1 Hepatocyte seeding portal vein infusion vs. trans-capsular injection 
Representative H&E image of hepatocytes 3 days post seeding using the portal vein infusion 
technique and the trans-capsular syringe injection are shown in Figure 37.  Seeding hepatocytes 
via the portal vein of the decellularized rat scaffold results is vascular occlusions and prevents 
media flow through the scaffold.  Syringe injection of primary rat hepatocytes directly into the 
parenchymal space of the decellularized rat liver scaffold results in higher functionality 
compared to portal vein infusion (Figure 37).  
157
Figure 37. Representative H&E image of hepatocytes seeded via infusion (top left) and syringe 
injection (top right) three days post seeding.  Engraftment efficiency, albumin production, and 
urea production from each technique (bottom row). 
158
8.4.2 Optimization of injection size 
Injection volume was also evaluated for its effect on hepatocyte function following seeding. The 
function of hepatocytes was assessed by analyzing the transcription profile of hepatocyte specific 
genes namely Albumin, CYP1A1, CYP1A2, CYP3A2, Connexin-32. Pig liver extracellular 
matrix (PLECM) gel was used for this experiment instead of whole decellularized rat livers. 
Results revealed that decreasing injection volume increased hepatocyte viability and 
functionality (Figure 38). Studies that have been published on the effects of cell density on the 
hepatocyte viability, proliferation, and function indicate that for hepatocytes to survive in an in-
vitro environment aggregation of hepatocytes is essential. Aggregation is postulated to promote 
viability and function. However, aggregation is double edge sword as large aggregation of cells 
would be toxic for the survival of tissue and minimal aggregation would hamper the viability of 
the cells.  
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Figure 38. Albumin and Urea secretion from primary rat hepatocytes injected into porcine liver 
ECM gels using various injection volumes (top row). Effect of concentration and injection 
volume on function of hepatocytes seeded in PLECM gel. mRNA expression of Albumin, 
CYP1A1, CYP1A2, CYP3A2, Connexin-32(middle and bottom rows).  mRNA expression 
normalized to Cyclophilin a gene. Error bars show mean ± standard deviation, and * indicates 
significance at p<0.05. Sample size is n=3. 
160
8.4.3 Co-seeding of hepatocytes and endothelial cells 
The addition of functional, viable hepatocytes to the re-endothelialized liver scaffold has also 
been achieved.  Following re-endothelialization, primary rat hepatocytes were delivered via 5ul 
syringe injections into the parenchymal space of the decellularized scaffold.  The hepatocytes 
were cultured for 3 days within the re-endothelialized scaffold.  Histologic assessment confirms 
the hepatocytes are viable and they have integrated with the endothelial cells (Figure 39). 
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Figure 39. Viable endothelial cells and hepatocytes following culture within a decellularized rat 
scaffold.  TUNEL is a common method for detecting DNA fragmentation that results from 
apoptotic signaling cascades. The TUNEL positive cells are brown and the TUNEL negative 
cells are glue.  A majority of the hepatocytes and endothelial cells are negative, meaning they are 
not apoptotic. Scale bar = 50µm 
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8.5 DISCUSSION 
The current study was motivated by the need to optimize hepatocyte seeding within a 
decellularized liver scaffold in order to enhance viability and functionality of the hepatocytes. 
The appropriate spatial distribution of hepatocytes following seeding into a 3-D liver scaffold is 
essential for regeneration of a native like hepatic tissue.  The results of the study reveal that 
decreasing cell seeding density and injection volume increased hepatocyte viability and 
functionality. Studies that have been published on the effects of cell density on the hepatocyte 
viability, proliferation, and function indicate that for hepatocytes to survive in an in-vitro 
environment aggregation of hepatocytes is essential. Aggregation is postulated to promote 
viability and function. However, aggregation is double edge sword as large aggregation of cells 
would be toxic for the survival of tissue and minimal aggregation would hamper the viability of 
the cells. Falasca et al. showed that contact between hepatocyte cells was established following 
perfusion of hepatocyte into alginate beads, a weak adhesive matrix, within 6 hours of seeding. 
The cell-cell contacts were characterized by actin, and cytokeratin along adhesion junctions, as 
well as gap junctions characterized by connexins.  
In the current study, the expression of Connexin-32 was found to be higher when 5ul of 
hepatocytes alone at a density of 8.36 x 106 /ml was injected into the PLECM gels compared to 
PLECM gels injected at 10ul or 20 ul and at a cell density of 12.5 x 106 /ml or 25 x 106 /ml.  
The higher fold expression of Connexin-32 transcripts at injection volume of 5ul and at a density 
of 8.36 x 106 /ml hepatocytes indicates that 5ul injection size and concentration of 8.3 x 10 6  are 
preferred for achieving cell-cell contact between adjacent hepatocyte cells without inducing 
clumping that would be toxic to tissue health. The expression of albumin was very high in 
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PLECM gels and in decellularized liver scaffolds seeded with hepatocytes alone. This is 
consistent with results from other studies wherein biodegradable polymers seeded with 
hepatocytes survived with high rate of albumin secretion (Vacanti et al., Dvir-ginzberg et al.). 
The high rate of albumin secretion is in fact observed in native rat livers too, which secrete 140–
170 pg/cell/day( Takahashi et al.).  
The current study highlights the significance of hepatocyte delivery and injection volume 
when reseeding a decellularized liver scaffold. This study demonstrates that three-dimensional 
biologic scaffolds composed of liver extracellular matrix have the capability to become a 
completely re-endothelializes scaffold closely mimicking the native three-dimensional structure 
of liver tissue. The bioscaffold may also prove as a good tool to study normal tissue and organ 
development as well as liver pathology. Ultimately, this technology may bring us closer to the 
ultimate goal of providing bioengineered livers for transplantation. 
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9.0 IMPROVING HEPATIC FUNCTION OF PRIMARY RAT HEPATOCYTES USING 
ENZYMATICALLY DIGEST LIVER ECM FROM VARIOUS SPECIES 
9.1 ABSTRACT 
Whole organ engineering and cell-based regenerative medicine approaches are being 
investigated as potential therapeutic options for end-stage liver failure. However, a major 
challenge of these strategies is the loss of hepatic specific function after hepatocytes are removed 
from their native microenvironment. The objective of the present study was to determine if 
solubilized liver extracellular matrix, when used as a media supplement, can better maintain 
hepatocyte phenotype compared to type I collagen alone or solubilized ECM harvested from a 
non-liver tissue source. Liver extracellular matrix (LECM) from four different species was 
isolated via liver tissue decellularization, solubilized, and then used as a media supplement for 
primary rat hepatocytes (PRH). The four species of LECM investigated were human, porcine, 
canine and rat. Cell morphology, albumin secretion, ammonia metabolism, and hepatic specific 
gene activity were used to assess maintenance of hepatocyte function. Biochemical and 
mechanical characterization of each LECM was also conducted. Results showed that PRH’s 
treated with canine and porcine LECM maintained their phenotype to a greater extent compared 
to all other groups. PRH’s treated with canine and porcine LECM showed increased bile 
production, increased albumin production, and the formation of multinucleated cells.  The 
findings of the present study suggest that solubilized liver ECM can support in-vitro hepatocyte 
culture and should be considered for whole organ engineering and cell-based approaches for 
treating end-stage liver failure. 
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9.2 INTRODUCTION 
In vitro culture of hepatocytes is associated with rapid dedifferentiation and decreased 
hepatocyte-specific functions such as albumin secretion and ammonia metabolism, and loss of 
hepatocyte polarity [308, 309]. The identification of a substrate or media supplement that can 
maintain a functional hepatocyte differentiation profile would represent a significant 
advancement toward development of a cell-based therapies, including tissue-engineered liver 
grafts for treatment of end-stage liver disease and 2-D hepatocyte culture systems. 
Individual extracellular matrix (ECM) components or combinations of desired ECM 
components have been used as substrates for hepatocyte culture systems for several decades 
[310-314]. Although cell culture substrates composed of individual ECM proteins such as type-I 
collagen, laminin, and fibronectin have facilitated primary rat hepatocyte attachment, 
maintenance of selected liver-specific functions, and preservation of hepatocyte polarity and 
morphology for short periods of culture, these systems are insufficient to prevent 
dedifferentiation of hepatocytes [59, 315]. 
Conventional in vitro culture models for hepatocytes include the use of a sandwich 
configuration in which hepatocytes are either placed between two layers of type-I collagen or 
Matrigel (MG) or cultured on type-I collagen overlaid with MG [316-319]. Sandwich culture of 
primary hepatocytes maintains hepatocyte polarity and morphology better than hepatocytes 
cultured on a single layer of type-I collagen or MG [71, 320, 321]. Furthermore, hepatocyte-
specific functions, such as albumin secretion, urea synthesis, and cytochrome P450 
responsiveness and inducibility are enhanced when the sandwich culture model is used [308, 
310, 322-325].  
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It is plausible that enzymatically digested ECM derived from the liver itself might be a 
useful media supplement for hepatocyte culture. Although rat liver matrix might theoretically be 
superior to that from other species for the maintenance of rat hepatocyte function, we compared 
liver ECM from various species using primary rat hepatocytes to determine species-specific 
advantages. The objective of the present study was to compare the ability of porcine, human, rat, 
and canine liver ECM, and heterologous ECM derived from porcine small intestinal mucosa and 
urinary bladder to support the primary rat hepatocyte (PRH) albumin secretion, ammonia 
metabolism and normal hepatocyte morphology. Biochemical and mechanical analysis of 
hydrogels created from these species of LECM was also conducted to more fully characterize 
species-specific differences. 
9.3 MATERIALS AND METHODS 
9.3.1 Overview of Experimental Design 
Liver extracellular matrix was isolated from porcine, canine, human, and rat livers. Each liver 
tissue was subjected to the same decellularization protocol, which consisted of comminuting the 
liver into cubes of approximately 0.5 cm2, exposing the tissue to trypsin/EGTA, inducing cell 
lysis with the detergent Triton X-100, rinsing with phosphate buffered saline and deionized water 
and disinfecting with peracetic acid. The resulting liver ECM from each species was lyophilized, 
powdered and pepsin solubilized.  The composition of each was determined by quantifying DNA 
content, base pair length, sulfated glycosaminoglycan content and by performing a SDS-PAGE 
gel.  Hydrogels from each group were formed and rheological properties were quantified. The 
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fiber network of the hydrogels was imaged using scanning electron microscopy. Finally, the 
ability of each liver ECM to support hepatocyte phenotype in-vitro was determined.  Primary rat 
hepatocytes were isolated and cultured on rat tail collagen I.  Solubilized liver ECM from each 
species was added to the culture media over a 7 day culture. Non-supplemented media, pepsin, 
and media supplemented with ECM from porcine small intestinal submucosa (SIS) or urinary 
bladder matrix (UBM) were used heterologous controls.  Albumin production, ammonia 
metabolism, and hepatic specific  cell morphology were assessed for each treatment group.    
9.3.2 Tissue Decellularization 
The methods used to isolate liver ECM have been previously described [52, 59, 195, 326]. Livers 
were harvested from market weight pigs (110–130 kg), adult dogs, and adult Sprague Dawley 
rats immediately after euthanasia. Non-diseased, human liver tissue was obtained with 
Institutional Review Board approval from one human donor liver of an unknown age.  The 
tissues were rinsed with Type 1 water and frozen at -80ºC until used. Each liver tissue was cut 
into 0.5 cm3 pieces with a scalpel and subjected to three separate 15-min washes in deionized 
water with mechanical agitation on an orbital shaker. The sections were then gently massaged to 
aid in cell lysis and soaked in 0.02% trypsin/0.05% EGTA at 37ºC for 2 h. The tissue was rinsed 
in type 1 water, and the massaging was repeated followed by mechanical agitation of the liver 
sections in 3% Triton X-100 for 18-24 h. The rinsing was repeated until all visible remnants of 
cellular material were removed. After processing, the liver ECM from each species was 
immersed in a solution of 0.1% peracetic acid followed by repeated rinses in type 1 water or 
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phosphate-buffered saline (PBS) at pH 7.4. The extent of decellularization was determined by 
quantification of remaining DNA (described below).  
Harvest of small intestinal submucosa and urinary bladder matrix has been described 
previously in detail [142, 327-330]. In brief, to prepare SIS, small intestine was obtained from 6-
month-old pigs and the majority of the mucosa and the entire serosa and muscularis externa 
layers were mechanically delaminated from the intestine. The remaining submucosa, muscularis 
mucosa, and stratum compactum layers were then washed with water and treated with 0.1% 
peracetic acid/4% ethanol for 1 hr.  
Porcine urinary bladders were harvested from market weight pigs, and the urothelial, 
serosal, muscular and submucosal layers were removed by mechanical delamination. The 
remaining tissue consisted of intact basement membrane and tunica propria, which was rinsed 
with deionized water and then treated with 0.1% peracetic acid/4% ethanol on an orbital shaker 
for 2 h. The UBM was then rinsed twice with PBS for 15 min each followed by two 15 min 
rinses in deionized water 
All decellularized tissues were embedded in paraffin, sectioned (5 µm), mounted onto 
microscope slides, and stained with hematoxylin and eosin (H&E) and DAPI. 
9.3.3 Assessment of DNA and Glycosaminoglycan Content 
DNA was extracted from all samples of liver ECM as previously described [240, 251, 331]. 
After lyophilization, LECM scaffolds were powdered using a Wiley Mill and filtered through a 
60-mesh screen. One hundred milligrams of lyophilized, powdered liver ECM was digested with
proteinase K digestion buffer (100 mM NaCl, 10 mM Tris HCl (pH = 8), 25 mM EDTA (pH = 
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8), 0.5% SDS, 0.1 mg/mL proteinase K) at 50ºC for 48 h. The digest was extracted twice using 
25:24:1 (v/v/v) phenol/chloroform/isoamyl alcohol.  DNA was precipitated from the aqueous 
phase at 20ºC with the addition of 2 volumes of ethanol and 0.1 volume of 3 M sodium acetate 
(pH = 5.2). The DNA was then centrifuged at 10,000 g for 10 min and resuspended in 1 mL of 
TE buffer (10 mM Tris (pH = 8), 1 mM EDTA).  
The concentration of each extracted DNA sample was determined using Quant-iT 
PicoGreen dsDNA Assay Kit (Invitrogen) following the manufacturer’s recommended protocol. 
A standard curve was constructed by preparing samples of known DNA concentrations from 0 to 
1000 ng/mL and concentration of DNA was found by linear interpolation of the standard curve. 
Samples were read using SpectraMax M2 Plate Reader (Molecular Devices, Sunnyvale, CA). 
DNA samples were diluted to ensure their absorbance properties fell within the linear region of 
the standard curve.  
Sulfated glycosaminoglycan (sGAGs) concentration in LECM samples was determined 
using the Blyscan Sulfated Glycosaminoglycan Assay Kit (Biocolor Ltd, Belfast, Northern 
Ireland). For extraction of sGAGs, lyophilized ECM scaffolds were powdered using a Wiley 
Mill and filtered through a 60-mesh screen. Samples were prepared by digestion of 50 mg/mL 
dry weight of each sample with 0.1 mg/mL proteinase K in buffer (10 mm Tris–HCl, pH 8, 100 
mm NaCl, 25 mm EDTA) for 48 h at 50 °C. Digested samples were assayed following the 
manufacturer's protocol. 
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9.3.4 Enzymatic Digestion and Hydrogel Formation 
The method used to prepare a hydrogel of harvested ECM has been previously described [251, 
328].  The protocol was modified to produce a gel form of each liver ECM. First, a powdered 
form of the liver ECM was produced from cubic pieces of liver ECM. The hydrated, disinfected 
liver ECM was lyophilized overnight. Lyophilized tissue of liver ECM from each species was 
cut into small pieces, powdered using a Wiley Mill, and then filtered through a 60-mesh screen. 
One gram of lyophilized LECM powder and 100 mg of pepsin (2000–3000 U=mg) were mixed 
in 100 mL of 0.01 M HCl and stirred until all visible particles were soluble (between 24-72 h) at 
room temperature (25ºC). The final viscous solution of pepsin digested liver ECM had a pH of 
approximately 3.0–4.0. A hydrogel was formed from the solubilized liver ECM by neutralizing 
the pH to 7.4 and diluting the ECM pre-gel solution to 8 mg ECM/ mL, then incubating at 37 °C 
for approximately 40 minutes.  
9.3.5 Scanning Electron Microscopy and Fiber Network Architecture Analysis 
Scanning electron microscopy was used to examine the surface topography of human, porcine, 
rat, and canine LECM hydrogels. Five hundred micron thick hydrogels were prepared and then 
fixed in cold 2.5% glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA) for 1 h followed 
by three 15 min washes in 1x PBS. Hydrogels were dehydrated in a graded series of alcohol (30, 
50, 70, 90, 100% ethanol) for 15 min per wash, and then placed in 100% ethanol overnight. 
Hydrogels were washed 3 additional times in 100% ethanol for 15 min each and critical point 
dried using a Leica EM CPD030 Critical Point Dryer (Leica Microsystems, Buffalo Grove, IL, 
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USA) with carbon dioxide as the transitional medium. Hydrogels were then sputter-coated with a 
4.5 nm thick gold/palladium alloy coating using a Sputter Coater 108 Auto (Cressington 
Scientific Instruments, UK) and imaged with a JEOL JSM6330f scanning electron microscope 
(JEOL, Peabody, MA, USA). 
Fiber network descriptors were determined from SEM images of each liver ECM 
including: porosity, pore size, node density (number of fibers intersections per µm2), 
connectivity (number of fibers connected at each node) and fiber diameter. Porosity was 
described as the percentage of each image composed of pores. Automated extraction of these 
fiber architectural features was achieved with a previously described algorithm [260]. Briefly, 
the SEM image was digitally processed by a cascade of steps including equalization with a 3x3 
median filter, local thresholding through the Otsu method, thinning, smoothing, morphological 
operators, skeletonization, binary filtering for Delaunay network refinement, and ultimately the 
detection of fiber network architecture and its descriptors. 
9.3.6 Liver ECM Hydrogel Rheological Testing 
Rheological properties were determined for each of the various liver ECM hydrogels using a 
previously described method [251]. Briefly, the pH of the ECM digest was neutralized to 7.4 and 
the digest was then diluted to a concentration of 8 mg ECM/ ml. The pregel solution was then 
placed on a rheometer (AR 2000, TA Instruments) operating with a 40 mm parallel plate 
geometry, pre-cooled to 10 °C. Temperature was controlled within 0.1 °C using a Peltier plate. 
Mineral oil was spread along the edge to minimize evaporation of the sample. After loading, the 
steady sheer viscosity of each sample was measured by applying a stress of 1 Pa at a frequency 
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of 0.159 Hz. The temperature was then rapidly increased to 37 °C and a small oscillatory strain 
of 0.5% was imposed to track gelation kinetics. After complete gelation, a creep test of 1 Pa for 
20s was performed to verify that there was no slip between the ECM hydrogel and the rheometer 
plates. 
9.3.7 SDS-Page Gel Electrophoresis with Silver Stain 
Protein composition of each LECM digest was compared qualitatively using SDS Page and gel 
electrophoresis. To compare proteins of a low molecular weight, 5 µg of each ECM digest was 
added to a 4-20% polyacrylamide gel and run at 120V for two hours. To compare proteins of a 
high molecular weight, 5 µg of each ECM digest was added to a 4-20% polyacrylamide gel and 
run at 120V for seven hours. The gels were stored in fixing buffer overnight and then stained 
with a Pierce™ Silver Stain for Mass Spectrometry Kit (Life Technologies) following the 
manufacturer’s instructions. 
9.3.8 Rat Hepatocyte Isolation and Culture 
Primary rat hepatocytes (PRH) were isolated using a previously established method [195]. 
Surgical plane anesthesia was induced and mice were maintained at this plane of anesthesia by 
inhalation of 1.5%–3% isofluorane. Rat hepatocytes were harvested using a two-step collagenase 
digestion method. The isolation technique involved cannulation and perfusion through the 
hepatic vein with calcium and magnesium-free Hanks' salt solution followed by media 
containing 400µg/ml collagenase (Seromed, Collagenase Type CLS II) at a flow rate of 10 
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ml/min as previously described.14 Viability was assessed by trypan blue exclusion and was 
routinely >90%. The yield of the isolated hepatocytes was 5.0–6.0×107 cells per liver. The cells 
were used immediately following isolation. 
Cells were seeded on 6-well rat tail type I collagen coated plates and allowed to culture 
for one day in hepatocyte basal media. After one day, media was changed and supplemented 
with 50 µg/mL of human LECM, 50 µg/mL of porcine LECM, 50 µg/mL of canine LECM, or 
50 µg/mL of rat LECM.  Non-supplemented media, 10 µg/mL pepsin, and supplementation with 
50 µg/mL UBM or 50 µg/mL of SIS were included as controls. Conditioned media from each 
well was collected on days 2, 5, and 7 and tested for albumin production. Images were taken on 
days 2, 5, and 7 to compare cell morphology. PRH metabolism of ammonia to urea was 
measured on day 7 of culture.  
9.3.9 Measurement of albumin secretion 
The conditioned media was collected from rat hepatocyte cultures on days 2, 5, and 7, and stored 
at -80ºC until analysis. Hepatocyte secretion of albumin was measured using a commercially 
available kit (Bethyl Laboratories, Montgomery, TX). At least three samples were collected from 
each culture condition and each sample was measured in duplicate.  
9.3.10 Ammonia metabolism assay 
Primary rat hepatocyte metabolism of ammonia was measured on day 7 of culture for each 
group. The media was aspirated and hepatocytes were incubated with 2.5 mM NH4Cl in 
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hepatocyte basal media for two hours at 37ºC. The conditioned media was collected and the 
concentration of urea was measured using a commercially available kit (Bioassay Systems CA, 
USA). At least three samples were collected from each culture condition and each sample was 
measured in duplicate.  
9.3.11 Statistical Analysis 
The DNA quantification, sGAG content, fiber network analysis, rheological data, albumin 
production, and ammonia metabolism values are all presented as the mean ± the standard error of 
the mean. Statistical analysis was performed using a one-way ANOVA evaluating each treatment 
group (canine liver ECM, porcine liver ECM, etc.) within each assay using GraphPad software. 
A post-hoc Tukey test was conducted with a p-value <0.05 considered statistically significant.  
9.4. RESULTS 
9.4.1 Liver Tissue Decellularization and DNA Assessment 
Hematoxylin and eosin (H&E) staining showed pink eosinophilic staining typical of collagen, 
whereas no basophilic staining typical of cellular nuclear material was observed. DAPI nuclear 
stain of the decellularized tissue was absent indicating loss of intact  nuclear content (Figure 40). 
Histologic examination of human liver ECM was not conducted due to the limited quantity of the 
material.  
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DNA quantification showed that human liver ECM contained 641 ng DNA/mg dry 
weight ECM, porcine liver ECM contained 98.0 ng DNA/mg dry weight ECM, canine liver 
ECM contained 563 ng DNA/mg dry weight ECM, and rat liver ECM contained 408 ng 
DNA/mg dry weight ECM. Only porcine liver ECM meets the previously established 
decellularization criteria of being below 200 ng DNA/mg dry weight ECM [83, 129]. However, 
all species show at least an 89% decrease in DNA content over native tissue and were considered 
adequately decellularized for the purposes of this study.   
Quantification of sulfated glycosaminoglycan showed significant differences between 
species. Human LECM contained the most sGAG per g dry weight ECM while porcine LECM 
contained the least (10,907±124 µg sGAG/ g dry weight ECM and 583±183 µg sGAG/ g dry 
weight ECM respectively).  
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Figure 40. H&E and DAPI histologic staining of tissue following the decellularization process 
(a) for canine liver (top row), porcine (middle row), and rat (bottom row) (a). Double-stranded
DNA quantification of the liver tissue from human, porcine, and rat species showed significant 
removal compared with native liver tissue (b). sGAG quantification indicates human LECM 
contained significantly more sGAGs per gram of dry weight when compared with the other 
groups (c).  
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9.4.2 Liver ECM Fiber Network Architecture 
SEM images of liver ECM hydrogels derived from porcine, human, rat, and canine liver tissue 
showed that each species has a distinct collagen fiber architecture (Figure 41). Quantitative 
analysis with the fiber architecture algorithm found that porcine liver ECM has a more dense 
fiber network as indicated by smaller pores compared to canine liver ECM.  
Figure 41. Scanning electron microscopy images of liver ECM hydrogels derived from human 
(a), porcine (b), canine (c), and rat (d). These images show a distinct species-specific collagen 
fiber architecture. Scale bar represents 1µm.  
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9.4.3 Liver ECM Hydrogel Rheological Testing 
Results from the creep test showed porcine and canine LECM pre-gel to be more viscous than rat 
or human.  The time sweep tests showed that porcine LECM has a higher storage modulus (G’) 
than all other groups, indicating greater gel stiffness. Rat LECM gels more quickly than all other 
species, while the human, canine, and porcine LECM all reach fifty percent gelation in a similar 
time frame (Figure 42).   
Figure 42. Rheological properties of human, porcine, canine, and rat liver ECM hydrogels at a 
concentration of 8mg/ml.  Pre-gel viscosity (a), representative time sweep (b), time to 50% 
gelation (c), and maximum storage modulus (d).  
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9.4.4 SDS PAGE Gel Electrophoresis with Silver Stain 
 
SDS PAGE analysis of the various liver ECMs showed that each species contained enriched 
quantities of high molecular weight components compared to SIS hydrogel while UBM hydrogel 
contained a greater quantity of high molecular weight fractions than all liver ECM hydrogels.  
The SIS hydrogel also contained fewer low molecular weight fractions compared to the liver 
ECM hydrogels and the UBM hydrogel (Figure 43). Each liver ECM showed a distinctive 
banding pattern. For example, the canine liver ECM has a band ~200kD that does not appear in 
the human, porcine, or rat liver ECMs.  There are also similarities across the various species of 
liver ECM.  For example, all liver ECM hydrogels show a low molecular weight band ~12 kD 
and this band is shared with UBM hydrogel.   
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Figure 43.  SDS PAGE gel followed by silver stain for human, porcine, canine, and rat liver 
ECMs.  UBM and SIS were run as non-liver ECM controls. High molecular weight components 
(top) and low molecular weight components (bottom). 
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9.4.5 Primary Rat Hepatocyte Culture 
PRH’s treated with canine and porcine LECM maintained their phenotype to a greater extent 
than all other groups (Figure 44). Images of PRH’s treated with canine and porcine LECM show 
increased bile production and the formation of multinucleate cells, both markers of maintained 
hepatocyte phenotype.   
Increased albumin production for hepatocytes treated with canine and porcine LECM on 
day 5 indicates these cells have increased function. Results showed a 472±70% increase in 
albumin production of hepatocytes treated with canine LECM and a 427±79% increase in 
albumin production of hepatocytes treated with porcine LECM over the collagen and pepsin 
controls from days 2-5 of culture. Ammonia metabolism was not different between groups.  
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Figure 44. Representative morphologic images of primary rat hepatocytes cultured on rat tail 
collagen I alone (a), 1mg/ml pepsin (b), and 50ug/ml of UBM (c), SIS (d), porcine liver ECM 
(e), canine liver ECM (f), human liver ECM (g), and rat liver ECM (h) added to the media.   
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Figure 45. Functional rat hepatocyte data from day 7 of the in-vitro culture with the addition of 
pepsin, solubilized UBM, SIS, rat liver ECM, human liver ECM, canine liver ECM, and porcine 
liver ECM added to the media. Albumin secretion from day 0 to 2 (a), from day 2 to 5 (b), and 
from day 5 to 7 (c) and ammonia metabolism on day 7 of culture (d). 
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9.5 DISCUSSION 
Media supplemented with pepsin solubilized ECM derived from porcine and canine liver was 
shown to support rat hepatocyte (PRH) function and better maintain hepatocyte phenotype 
compared to rat hepatocytes cultured with non-supplemented media. These findings are 
important because it has been well documented that during in-vitro culture hepatocytes quickly 
dedifferentiate and lose hepatic specific functions[316, 332, 333].  This study also showed that 
there are species differences in LECM and surprisingly, xenogeneic canine and porcine LECM 
supported primary rat hepatocytes better than rat LECM. Though it is not clear that similar 
results would be seen with human hepatocytes, the findings of the present study suggest that 
solubilized LECM could be a useful media supplement for hepatocytes and that the species 
source of the ECM should be an important consideration.  
Cell based liver engineering strategies would benefit significantly from a culture 
supplement or substrate that maintains hepatocyte phenotype function during ex-vivo culture. It 
has been shown that biologic scaffolds composed of ECM provide a more physiologically 
relevant culture substrate compared to individual ECM proteins such as purified collagen[59, 
315]. Liver tissue used in this study was processed in a manner designed to preserve ECM 
proteins derived from the liver in physiologically relevant amounts (e.g. Type-I, IV, VI, III, XI, 
XIX, heparin sulfate proteoglycan, ECM-bound growth factors, laminin, biglycan, tenascin, 
fibronectin).  
Recent studies have suggested that tissue- and organ-specific ECM can promote site 
appropriate differentiation of progenitor cells and maintain site appropriate phenotype in in vitro 
culture systems, though this is not a requirement of all tissues [185, 334, 335]. Since the ECM of 
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each tissue and organ is produced by the resident parenchymal cells and logically represents the 
ideal scaffold or substrate for these cells, it is intuitive that a substrate composed of liver-derived 
ECM would be favorable for hepatocytes. Previous studies have shown that hepatic sinusoidal 
endothelial cells (SECs) maintained their differentiated phenotype the longest when cultured on 
ECM derived from the liver, as compared to SECs cultured on ECM derived from small intestine 
or urinary bladder [70]. Lin et. al. compared rat hepatocytes cultured on PLECM biologic 
scaffolds to well characterized hepatocyte culture models (type-1 collagen sandwich 
configuration or a single layer of type-1 collagen) [9]. Hepatocytes survived up to 45 days on a 
sheet form of PLECM and several liver-specific functions such as albumin synthesis, urea 
production, and P-450 IA1 activity were markedly enhanced compared to the growth and 
metabolism of cells cultured on a single layer of type-1 collagen. These results suggest that intact 
LECM biologic scaffolds provide tissue-specific signals. However, the use of a solubilized ECM 
media supplement has not previously been investigated for the purpose of hepatocyte culture.  
The decellularization protocol used in this study was developed for porcine liver and 
designed to maintain as much of the native porcine LECM components while fully removing 
cellular content. Different decellularization methods can selectively affect the composition of 
ECM after processing [247], therefore we chose to decellularize all species of LECM according 
to the same protocol to eliminate this as a variable. However, the uniform method resulted in 
differences in both DNA and sulfated GAG composition.  
The enhanced maintenance of primary rat hepatocytes function and phenotype for those 
cells cultured with porcine and canine liver ECM compared to cells cultured with human and rat 
liver ECM or rat tail collagen I may be due to differences in the composition and physical 
properties of the respective ECM. The results described herein indicate that liver ECM derived 
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from human, canine, porcine, and rat liver each have a distinct biochemical profile as well as 
differences in gel stiffness and fiber architecture.  Just as tissue specific differences have been 
shown to modulate hepatic cell function[52, 70], the present study shows that species-specific 
differences can also modulate the function of hepatocytes. A comprehensive analysis of the 
biochemical composition and proteomic profile of each liver ECM would help identify these 
factors which of these differences contribute to maintenance of hepatocyte phenotype.   
The present study shows that pepsin solubilized liver ECM, though far from perfect, 
provides a useful media supplement for hepatocyte culture. By helping to maintain hepatocyte 
phenotype and function, solubilized LECM  has the potential to enhance drug discovery culture 
systems, whole organ engineering of the liver, and hepatocyte cell transplantation therapies.  
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10.0 DISCUSSION 
The present dissertation was aimed at developing fundamental technology that will 
provide meaningful progress toward engineering organized functional hepatic tissue within a 
decellularized liver scaffold. One of the major challenges for whole organ engineering is to 
produce large volume tissues capable of being connected to the recipient’s blood supply for 
clinical applications. Pervious work in the field of bioengineer liver tissue has been met with 
many obstacles including cell sourcing, efficient cell seeding, vascularization of the engineered 
tissue, and provision of authentic cues for tissue development. In order to overcome these 
challenges, we first conducted a set of experiments aimed at investigated the effect of commonly 
used decellularization agents on a biologic scaffold.  Using that knowledge, we then developed a 
method of decellularization that was used to fabricate a naturally derived whole-liver 
bioscaffold. We used the vascular channels of this scaffold as a conduit for reseeding human 
microvascular endothelial cells throughout the bioscaffold. Next, we developed a method of 
delivering functional hepatocytes to their native parenchymal location within the liver 
bioscaffold.  The three-dimensional liver bioscaffold provided spatial information for cell 
localization and engraftment, and supported cellular proliferation and phenotype maintenance. In 
the final study we developed a method of enhancing hepatic function of the seeded hepatocytes 
by using enzymatically digest liver ECM to the media as a supplement. These developed 
methods offer a potential technique for fabrication of human liver tissue that can be readily 
transplanted into host animals or used for studies of liver cell biology, physiology, toxicology, 
and drug discovery with further development. 
188
Previously, decellularization of tissue was performed by submersion of the tissue within a 
detergent solution under agitation to allow cell removal in bulk from the surface of the tissue 
moving inward. These approaches were successful for decellularization of smaller samples (up to 
5 mm in thickness), whereas in thicker specimens the core of the tissue remained cellular. To 
circumvent this limitation, we took advantage of the native liver vascular network by perfusing 
the detergent through this network and distributing it throughout the entire liver. This gentle 
procedure preserves the architecture of the liver matrix and vascular system. The choice of 
detergent for the production of whole organ bioscaffolds using perfusion may also impact the 
preservation of important biochemical cues. In chapters 5 and 6 we showed that harsh ionic 
detergents such as SDS facilitate rapid removal of cells from dense tissues and can yield a 
functional bioscaffold, but they may damage some ECM components. Therefore, we opted to use 
a mild nonionic detergent, Triton X-100. We found that this detergent could successfully 
decellularize the whole liver by the removal of a majority of cellular DNA. These studies 
highlight the utility of perfusion decellularization to generate whole organ bioscaffolds with 
significant potential for organ bioengineering. 
Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a powerful surface 
analysis technique to probe biological structures with high mass resolution and surface 
specificity. In chapter 6 we report the use of ToF-SIMS to distinguish the basement membrane 
complex of scaffolds prepared by treatment with water, 0.1% SDS 1% SDS, 4% Deoxycholate, 8 
mM CHAPS or 3% Triton X-100 for 24 hours. The results of the study demonstrate that each 
decellularization agent used to prepare a biologic scaffold creates in a unique surface.  The 
resulting ECM scaffold is associated with distinct ultrastructural and compositional 
characteristics and that these surface characteristics are dependent on both the damage the 
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decellularization agent has caused to the native extracellular matrix as well as the residual 
components left behind by the decellularization agent. It was also shown by using principal 
component analysis of the negative ion spectra is capable of separating sample types based on 
residual cellular components (Native and PAA treated) or detergent type (SDS vs. 
Deoxycholate). Furthermore, this revealed the presence of residual detergent in SDS treated and 
deoxycholate treated samples.  However, the level of residual detergent content between 
deoxycholate samples varied.  All dexocyholate samples were prepared from the sample porcine 
bladder, so source tissue variation does not explain the variation in residual deoxycholate. It was 
also demonstrated that ToF-SIMS is a highly sensitive method for the detection and 
differentiation of the molecular composition of the outermost surface of an ECM scaffold. 
Further, ToF-SIMS may represent a method for future identification of previously unknown 
surface species as well as for the prediction of cell–scaffold interactions and subsequent 
remodeling events. Finally, the richness of molecular detail in the ToF-SIMS spectra suggests 
that ToF-SIMS may be useful for quality control of commercialized ECM-based regenerative 
scaffold products and for standardization of these scaffolds.  
 In Chapter 7 we addressed one of the major challenges in whole organ engineering, 
engineering a functional vascular network within a biologic scaffold. Typically, 
neovascularization of bioengineered tissues was addressed by supplementing cells with 
angiogenic growth factors or fabricating scaffolds from synthetic material that allowed micro-
patterning of vascular tree-like structures. When growth factors are used alone, they tend to 
create only a microvasculature consisting of small and fragile capillaries, and therefore this 
technique is only applicable for the engineering of smaller size tissues. An alternative fabrication 
method is using a micropatterning technique that can be scaled up to larger sizes by modular 
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construction. However, currently this method cannot replicate the progressive complexity and 
ECM composition of the native liver vascular tree. The bioscaffolds generated from whole livers 
produced via our decellularization method retain the complexity of multiple size vessels that can 
deliver fluids from the larger vena cava or the portal vein and reach each individual liver lobule. 
 An additional advantage of this method is the retention of important ECM molecules 
required for site-specific engraftment and/or differentiation of different cell types that are present 
in the liver. Prior research showed that liver-specific stem cells can be isolated and differentiated 
to hepatic fate. We used human microvascular endothelial cells to recellularize the bioscaffolds. 
The advantage of seeding human microvascular endothelial cells is that they are consistent in 
their proliferation rate, they are easy to maintain in culture, and they are associated with a low 
experimental cost.  This allowed us to perform many recellularization experiments before 
moving to more clinically relevant iPSC derived human endothelial cells. 
 A major obstacle in producing large-volume tissues is the delivery of adequate numbers 
of endothelial cells to the entire vascular network of the bioscaffold. The perfusion method 
developed in chapter 7 uses cell infusion through both the venous and arterial vascular networks 
and deposition throughout the thickness of the bioscaffold, achieving greater seeding efficiency 
without compromising the integrity of the bioscaffold. Furthermore, by accessing different 
vessels that feed into the liver, we were able to deliver cells selectively to different compartments 
of the liver tissue. Endothelial cells delivered through the vena cava selectively seeded larger and 
smaller blood vessels up to the pericentral area of the liver lobule, without reaching the periportal 
space of the lobule where the final branching vessels of portal vein are located. On the other 
hand, cells seeded through the portal vein, which delivers blood from the intestine and other 
organs to the liver, reached predominantly the periportal area of the liver lobule without 
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extensive penetration to its pericentral space. These seeded endothelial cells cover the entire 
circumference of a vascular channel and maintained cell-cell junctions. Thus, simultaneous 
utilization of both vascular routes for cell seeding enables complete access to the entire length of 
the vascular network, which has an essential importance for prevention of blood clotting and 
ultimately failure to transplant the bioengineered liver.  This study demonstrates that three-
dimensional biologic scaffolds composed of liver extracellular matrix have the capability to 
become a completely re-endothelializes scaffold closely mimicking the native three-dimensional 
structure of liver tissue. The bioscaffold may also prove as a good tool to study normal tissue and 
organ development as well as liver pathology. Ultimately, this technology may bring us closer to 
the ultimate goal of providing bioengineered livers for transplantation. 
 Next, in chapter 8 we aimed to optimize hepatocyte seeding concentration and volume 
within a decellularized liver scaffold in order to enhance viability and functionality of the 
hepatocytes. The appropriate spatial distribution of hepatocytes following seeding into a 3-D 
liver scaffold is essential for regeneration of a native like hepatic tissue. The results of the study 
reveal that decreasing cell seeding density and injection volume increased hepatocyte viability 
and functionality. Studies that have been published on the effects of cell density on the 
hepatocyte viability, proliferation, and function indicate that for hepatocytes to survive in an in-
vitro environment aggregation of hepatocytes is essential. Aggregation is postulated to promote 
viability and function. However, aggregation is double edge sword as large aggregation of cells 
would be toxic for the survival of tissue and minimal aggregation would hamper the viability of  
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the cells. Falasca et al. showed that contact between hepatocyte cells was established following 
perfusion of hepatocyte into alginate beads, a weak adhesive matrix, within 6 hours of seeding. 
The cell-cell contacts were characterized by actin, and cytokeratin along adhesion junctions, as 
well as gap junctions characterized by connexins.  
Lastly, in chapter 9 we showed that media supplemented with pepsin solubilized ECM 
derived from porcine and canine liver was shown to support rat hepatocyte (PRH) function and 
better maintain hepatocyte phenotype compared to rat hepatocytes cultured with non-
supplemented media. These findings are important because it has been well documented that 
during in-vitro culture hepatocytes quickly dedifferentiate and lose hepatic specific functions 
[316, 332, 333].  This study also showed that there are species differences in LECM and 
surprisingly, xenogeneic canine and porcine LECM supported primary rat hepatocytes better 
than rat LECM. Though it is not clear that similar results would be seen with human hepatocytes, 
the findings of the present study suggest that solubilized LECM could be a useful media 
supplement for hepatocytes and that the species source of the ECM should be an important 
consideration.  
 Cell based liver engineering strategies would benefit significantly from a culture 
supplement or substrate that maintains hepatocyte phenotype function during ex-vivo culture. It 
has been shown that biologic scaffolds composed of ECM provide a more physiologically 
relevant culture substrate compared to individual ECM proteins such as purified collagen[59, 
315]. Liver tissue used in this study was processed in a manner designed to preserve ECM 
proteins derived from the liver in physiologically relevant amounts (e.g. Type-I, IV, VI, III, XI, 
XIX, heparin sulfate proteoglycan, ECM-bound growth factors, laminin, biglycan, tenascin, 
fibronectin).   
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 The enhanced maintenance of primary rat hepatocytes function and phenotype for those 
cells cultured with porcine and canine liver ECM compared to cells cultured with human and rat 
liver ECM or rat tail collagen I may be due to differences in the composition and physical 
properties of the respective ECM. The results described herein indicate that liver ECM derived 
from human, canine, porcine, and rat liver each have a distinct biochemical profile as well as 
differences in gel stiffness and fiber architecture.  Just as tissue specific differences have been 
shown to modulate hepatic cell function [52, 70], the present study shows that species-specific 
differences can also modulate the function of hepatocytes. A comprehensive analysis of the 
biochemical composition and proteomic profile of each liver ECM would help identify these 
factors which of these differences contribute to maintenance of hepatocyte phenotype.  This 
study shows that pepsin solubilized liver ECM, though far from perfect, provides a useful media 
supplement for hepatocyte culture. By helping to maintain hepatocyte phenotype and function, 
solubilized LECM has the potential to enhance drug discovery culture systems, whole organ 
engineering of the liver, and hepatocyte cell transplantation therapies. 
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